FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Peng, SY
   He, JW
   Huang, JS
   Tan, JW
   Liu, MF
   Liu, XS
   Wu, YF
AF Peng, Suyuan
   He, Jiawei
   Huang, Jiasheng
   Tan, Jiaowang
   Liu, Meifang
   Liu, Xusheng
   Wu, Yifan
TI A chronic kidney disease patient awareness questionnaire: Development
   and validation
SO PLOS ONE
LA English
DT Article
ID SYSTEMATIC ANALYSIS; LIFE EXPECTANCY; GLOBAL BURDEN; EXERCISE;
   PROGRESSION; MANAGEMENT; PROGRAM; CARE; CKD
AB Background
   With the advance of medical care, chronic non-communicable diseases, like chronic kidney disease (CKD), have become the predominant diseases around the world. With heavy society and economy burden, we shall make full use of chronic disease management, including precision therapies. And the prerequisite for implementing precision medicine is to fully understand the characteristics of patients. Being the basis of the Knowledge-Attitude-Practice Model, patient's awareness is essential to conduct individualized treatments. However, there have been no validated questionnaires specific to the awareness of patients with CKD. Therefore, this study aims to develop and validate an awareness questionnaire for patients with CKD.
   Methods
   From March 2013 to September 2014, a cross-sectional study was conducted at Guangdong Provincial Hospital of Chinese Medicine. Age 18 or above were enrolled in the study. After signing the informed consent, they received a self-developed questionnaire to evaluate their CKD-related awareness. Then we collected their demographic data for further analyses. We also conducted item analyses/validity and reliability analysis to filter out improper items and to retain the eligible ones.
   Results
   We totally distributed 110 copies of the questionnaires and 100 of them were returned. After item analyses, 2 items were excluded because of Cronbach's Alpha analysis. In total, 18 items were retained, comprising the final set of the questionnaire. For validity analysis, 4 components could explain the cumulative 73.966% extraction sums of the squared loadings; for reliability analysis, the Guttman Split-Half coefficient was 0.918.
   Conclusions
   This awareness questionnaire has favorable validity and reliability. It is a sound method for evaluating and measuring levels of disease-related awareness in CKD patients.
C1 [Peng, Suyuan; He, Jiawei; Huang, Jiasheng; Tan, Jiaowang; Liu, Meifang] Guangzhou Univ Chinese Med, Clin Coll 2, Guangzhou, Guangdong, Peoples R China.
   [Peng, Suyuan; He, Jiawei; Huang, Jiasheng; Tan, Jiaowang; Liu, Meifang; Liu, Xusheng] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Nephrol Dept, Guangzhou, Guangdong, Peoples R China.
   [Wu, Yifan] Guangzhou Univ, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Chron Dis Management Dept, Guangzhou, Guangdong, Peoples R China.
RP Wu, YF (reprint author), Guangzhou Univ, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Chron Dis Management Dept, Guangzhou, Guangdong, Peoples R China.
EM wuyifan007@gzucm.edu.cn
FU Guangzhou Sci-tech Program: Standardization and Telemedicine System
   Construction of Nutrition Therapy in Chronic Kidney Disease
   [2016201604030022]; Guangdong Provincial Department of Science and
   Technology Program: Development and Evaluation of Adherence Scale for
   Integrative Chinese and Western Medication in Patients with Chronic
   Kidney Disease [2014A020221087]; Guangdong Provincial Hospital of
   Traditional Chinese Medicine [YN2018ZWB04]
FX This research was funded by Guangzhou Sci-tech Program: Standardization
   and Telemedicine System Construction of Nutrition Therapy in Chronic
   Kidney Disease (2016201604030022 to YW), Guangdong Provincial Department
   of Science and Technology Program: Development and Evaluation of
   Adherence Scale for Integrative Chinese and Western Medication in
   Patients with Chronic Kidney Disease (2014A020221087 to YW), and the
   Guangdong Provincial Hospital of Traditional Chinese Medicine
   (YN2018ZWB04 to YW). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Access GBDH Quality Collaborators, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, DOI 10.1016/S0140-6736(17)30818-8]
   Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309
   Bisallah CI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192276
   Chen J, 2018, CANCER MANAG RES, V10, P1565, DOI 10.2147/CMAR.S166008
   CHURCHILL GA, 1979, J MARKETING RES, V16, P64, DOI 10.2307/3150876
   CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957
   Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025
   Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046
   Floege J, 2019, KIDNEY INT, V95, P268, DOI 10.1016/j.kint.2018.10.018
   Greenwood SA, 2012, NEPHROL DIAL TRANSPL, V27, P126, DOI 10.1093/ndt/gfs272
   HOWARD KI, 1962, EDUC PSYCHOL MEAS, V22, P731, DOI 10.1177/001316446202200407
   Jain N, 2014, NAT REV NEPHROL, V10, P712, DOI 10.1038/nrneph.2014.192
   Jansen RG, 2003, BEHAV RES METH INS C, V35, P391, DOI 10.3758/BF03195516
   Johansen KL, 2012, AM J KIDNEY DIS, V59, P126, DOI 10.1053/j.ajkd.2011.10.008
   Jurkovitz CT, 2012, AM J KIDNEY DIS, V59, pS24, DOI 10.1053/j.ajkd.2011.11.019
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X
   Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x
   McMahon EJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-137
   Mekki K, 2012, INT UROL NEPHROL, V44, P237, DOI 10.1007/s11255-010-9875-8
   Mulango ID, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1653-7
   Piccoli GB, 2018, NEPHROL DIAL TRANSPL, V33, P189, DOI 10.1093/ndt/gfx358
   Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280
   Roshanravan B, 2017, AM J KIDNEY DIS, V69, P837, DOI 10.1053/j.ajkd.2017.01.051
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Shah A, 2012, AM J KIDNEY DIS, V59, pS16, DOI 10.1053/j.ajkd.2011.10.042
   SNEDECOR G. W, 1989, STAT METHODS
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Tillyard G, 2019, QUAL HEALTH RES, V29, P1277, DOI 10.1177/1049732318816675
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Wuhl E, 2008, PEDIATR NEPHROL, V23, P705, DOI 10.1007/s00467-008-0789-y
   Zelle DM, 2017, NAT REV NEPHROL, V13, P319, DOI 10.1038/nrneph.2017.44
   Zhang Luxia, 2019, Kidney Int Suppl (2011), V9, pe1, DOI 10.1016/j.kisu.2018.11.001
   2012, J ORTHOP SURG-HONG K, V20, P55, DOI DOI 10.1177/2309499101202000111
   2013, J RENAL NUTR, V23, P164, DOI DOI 10.1053/J.JRN.2012.10.004
   2018, LANCET, V392, P2052, DOI DOI 10.1016/S0140-6736(18)31694-5
   2018, CLIN J AM SOC NEPHRO, V13, P1085, DOI DOI 10.2215/CJN.00340118
   1986, PREV MED, V15, P475
   1975, J AM DIET ASS, V66, P28
   2012, SCAND J OCCUP THER, V19, P2, DOI DOI 10.3109/11038128.2010.525721
   2001, BRAIN INJURY, V15, P435, DOI DOI 10.1080/02699050010005896
   1991, J PERS ASSESS, V57, P521, DOI DOI 10.1207/S15327752JPA5703_10
NR 43
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2019
VL 14
IS 5
AR e0216391
DI 10.1371/journal.pone.0216391
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HW5AX
UT WOS:000466702600016
PM 31050683
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Border, R
   Corley, RP
   Brown, SA
   Hewitt, JK
   Hopfer, CJ
   Stallings, MC
   Wall, TL
   Young, SE
   Rhee, SH
AF Border, Richard
   Corley, Robin P.
   Brown, Sandra A.
   Hewitt, John K.
   Hopfer, Christian J.
   Stallings, Michael C.
   Wall, Tamara L.
   Young, Susan E.
   Rhee, Soo Hyun
TI Predictors of adult outcomes in clinically- and legally-ascertained
   youth with externalizing problems
SO PLOS ONE
LA English
DT Article
ID LIFE-COURSE-PERSISTENT; DIAGNOSTIC INTERVIEW SCHEDULE; LIMITED
   ANTISOCIAL PATHWAYS; CALLOUS-UNEMOTIONAL TRAITS; CONDUCT DISORDER;
   FOLLOW-UP; OPPOSITIONAL DEFIANT; SUBSTANCE USE; BEHAVIOR; CHILDREN
AB Externalizing problems (EP), including rule-breaking, aggression, and criminal involvement, are highly prevalent during adolescence, but the adult outcomes of adolescents exhibiting EP are characterized by heterogeneity. Although many youths' EP subside after adolescence, others' persists into adulthood. Characterizing the development of severe EP is essential to prevention and intervention efforts. Multiple predictors of adult antisocial personality disorder (ASPD) and legal outcomes of a large sample (N = 1205) of clinically- or legally-ascertained adolescents (ages 12-19 years) with severe EP were examined. Many psychosocial predictors hypothesized to predict persistence of EP demonstrated zero-order associations with adult outcomes, but accounted for little unique variation after accounting for baseline conduct disorder symptoms (CD) and demographic factors. Baseline measures of intelligence, which explained independent variation in legal outcomes, provided the only consistent exception to this pattern, though future work is needed to parse these effects from those of socioeconomic factors. CD severity during adolescence is a parsimonious index of liability for persistence of EP into adulthood that explains outcome variance above and beyond all other demographic and psychosocial predictors in this sample.
C1 [Border, Richard; Corley, Robin P.; Hewitt, John K.; Hopfer, Christian J.; Stallings, Michael C.; Rhee, Soo Hyun] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.
   [Border, Richard; Corley, Robin P.; Hewitt, John K.; Stallings, Michael C.; Rhee, Soo Hyun] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.
   [Border, Richard] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.
   [Brown, Sandra A.; Wall, Tamara L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Hopfer, Christian J.; Young, Susan E.] Univ Colorado Denver, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA.
RP Border, R (reprint author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.; Border, R (reprint author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.; Border, R (reprint author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.
EM richard.border@colorado.edu
FU National Institute on Drug Abuse [DA005131, DA011015, DA012845,
   DA021905, DA035804]; National Institute of Mental Health [MH016880]
FX This work was funded by National Institute on Drug Abuse
   (https://www.drugabuse.gov/) grants DA005131 (JKH), DA011015 (N/A),
   DA012845 (N/A), DA021905 (SAB), DA035804 (CJH) and National Institute of
   Mental Health (https://www.nimh.nih.gov/) grant MH016880 (JKH). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andershed H, 2018, J PSYCHOPATHOL BEHAV, V40, P16, DOI 10.1007/s10862-018-9659-5
   Anderson KG, 2007, ADDICT BEHAV, V32, P2377, DOI 10.1016/j.addbeh.2007.02.006
   Bassarath L, 2001, CAN J PSYCHIAT, V46, P609, DOI 10.1177/070674370104600704
   Bates D., 2014, LME4 LINEAR MIXED EF, DOI DOI 10.18637/JSS.V067.I01
   Bergman LR, 2009, AGGRESSIVE BEHAV, V35, P164, DOI 10.1002/ab.20298
   Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74
   Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01
   Burt SA, 2012, J ABNORM CHILD PSYCH, V40, P1059, DOI 10.1007/s10802-012-9632-9
   Burt SA, 2011, J ABNORM CHILD PSYCH, V39, P633, DOI 10.1007/s10802-011-9491-9
   Button TMM, 2007, J ABNORM PSYCHOL, V116, P554, DOI 10.1037/0021-843X.116.3.554
   Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01
   Christensen RHB, 2015, STAND, V19
   Coleman J, 2012, THE SCHOOL YEARS
   Colins O, 2011, CAN J PSYCHIAT, V56, P44, DOI 10.1177/070674371105600108
   Colins OF, 2018, J PSYCHOPATHOL BEHAV, V40, P6, DOI 10.1007/s10862-018-9653-y
   Corley RP, 2004, ROBUSTNESS GENOME SC
   Dodge KA, 2003, DEV PSYCHOL, V39, P349, DOI 10.1037/0012-1649.39.2.349
   Elliott D. S., 1989, MULTIPLE PROBLEM YOU
   Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P924, DOI 10.1111/jcpp.12102
   Fanti KA, 2017, AM J ORTHOPSYCHIAT, V87, P62, DOI 10.1037/ort0000143
   Farrington DP, 2005, CLIN PSYCHOL PSYCHOT, V12, P177, DOI 10.1002/cpp.448
   FARRINGTON DP, 1991, CRIMINAL BEHAVIOR ME, V0001
   First M. B., 1994, DIAGNOSTIC STAT MANU
   FISHER PW, 1993, J AM ACAD CHILD PSY, V32, P666, DOI 10.1097/00004583-199305000-00026
   Fox J., 2016, POLYCOR POLYCHORIC P
   Frick PJ, 2016, S AFR J PSYCHOL, V46, P160, DOI 10.1177/0081246316628455
   Gelhorn HL, 2005, J CHILD PSYCHOL PSYC, V46, P580, DOI 10.1111/j.1469-7610.2004.00373.x
   Greene RW, 2002, AM J PSYCHIAT, V159, P1214, DOI 10.1176/appi.ajp.159.7.1214
   Grove AB, 2008, AGGRESS VIOLENT BEH, V13, P169, DOI 10.1016/j.avb.2008.03.001
   Heaton RK, 1991, PSYCHOL ASSESSMENT R
   Henry B., 1993, CRIMINAL BEHAVIOR ME, V3, P97
   Hopfer CJ, 2003, J AM ACAD CHILD PSY, V42, P710, DOI 10.1097/01.CH1.0000046848.56865.54
   Hopfer CJ, 2003, J AM ACAD CHILD PSY, V42, P834, DOI 10.1097/01.CHI.0000046874.56865.85
   Hyde LW, 2016, AM J PSYCHIAT, V173, P903, DOI 10.1176/appi.ajp.2016.15111381
   Hyde LW, 2015, J ABNORM PSYCHOL, V124, P329, DOI 10.1037/abn0000029
   Isen J, 2010, CLIN PSYCHOL REV, V30, P423, DOI 10.1016/j.cpr.2010.02.003
   Jennings WG, 2012, J CRIM JUST, V40, P472, DOI 10.1016/j.jcrimjus.2012.07.001
   LAHEY BB, 1995, J ABNORM PSYCHOL, V104, P83, DOI 10.1037/0021-843X.104.1.83
   Lahey BB, 2005, J CONSULT CLIN PSYCH, V73, P389, DOI 10.1037/0022-006X.73.3.389
   Loeber R, 2007, DEV PSYCHOPATHOL, V19, P867, DOI 10.1017/S0954579407000429
   Manninen M, 2013, NORD J PSYCHIAT, V67, P289, DOI 10.3109/08039488.2012.738245
   McCart MR, 2006, J ABNORM CHILD PSYCH, V34, P527, DOI 10.1007/s10802-006-9031-1
   Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104
   Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097
   MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674
   Moos R, 1994, FAMILY ENV SCALE MAN
   MORRIS TP, 2014, BMC MED RES METHODOL, V14
   Murray J, 2010, CAN J PSYCHIAT, V55, P633, DOI 10.1177/070674371005501003
   Nock MK, 2006, PSYCHOL MED, V36, P699, DOI 10.1017/S0033291706007082
   PLOMIN R, 1988, DEV PSYCHOL, V24, P738, DOI 10.1037/0012-1649.24.5.738
   R Core Team, 2018, R LANG ENV STAT COMP
   Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490
   Robins L, 1986, WHO ADAMHA CIDI SAM
   Robins L N., 2000, DIAGNOSTIC INTERVIEW
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rutter M., 1994, J FAMILY PSYCHOL, V8, P170, DOI DOI 10.1037/0893-3200.8.2.170
   Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014
   Skardhamar T, 2010, CRIMINOLOGY, V48, P295, DOI 10.1111/j.1745-9125.2010.00185.x
   Stan Development Team, 2018, RSTAN R INTERFACE ST
   Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0
   Trim RS, 2015, EMERG ADULTHOOD, V3, P265, DOI 10.1177/2167696815573791
   Tuvblad C, 2011, BEHAV GENET, V41, P629, DOI 10.1007/s10519-011-9463-4
   van Buuren, J STAT SOFTW, DOI [10.18637/jss.v045.i03, DOI 10.18637/JSS.V045.I03]
   Vermeiren R, 2000, EUR ARCH PSY CLIN N, V250, P133, DOI 10.1007/s004060070029
   Wall TD, 2016, J CHILD PSYCHOL PSYC, V57, P976, DOI 10.1111/jcpp.12569
   Walters GD, 2011, J CONSULT CLIN PSYCH, V79, P96, DOI 10.1037/a0021519
   Wechsler D, 2003, WECHSLER INTELLIGENC
   Wechsler D, 1997, WAIS 3 WECHSLER ADUL
   Wechsler D., 1981, WAIS R MANUAL WECHSL
   Weiss B, 2005, J CONSULT CLIN PSYCH, V73, P1036, DOI 10.1037/0022-006X.73.6.1036
   White IR, 2010, COMPUT STAT DATA AN, V54, P2267, DOI 10.1016/j.csda.2010.04.005
   Woolfenden SR, 2002, ARCH DIS CHILD, V86, P251, DOI 10.1136/adc.86.4.251
   Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393
NR 73
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 1
PY 2018
VL 13
IS 11
AR e0206442
DI 10.1371/journal.pone.0206442
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ0DG
UT WOS:000449027600050
PM 30383806
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gialamas, A
   Kinnell, A
   Mittinty, MN
   Davison, B
   Singh, G
   Lynch, J
AF Gialamas, Angela
   Kinnell, Angela
   Mittinty, Murthy N.
   Davison, Belinda
   Singh, Gurmeet
   Lynch, John
TI Association of anthropometric measures and cardiovascular risk factors
   in children and adolescents: Findings from the Aboriginal Birth Cohort
   study
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; BLOOD-PRESSURE; LEG LENGTH; PUBERTAL CHANGES;
   FETAL ORIGINS; ADULT HEALTH; TRUNK LENGTH; FOLLOW-UP; HEIGHT; CHILDHOOD
AB This study examined the association of anthropometric measures including height, leg length, trunk length and body mass index (BMI) at 11 and 18 years with systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) at 11 and 18 years. We analysed data from 661 participants from the Aboriginal Birth Cohort study a longitudinal study based in the Northern Territory, Australia. Associations between anthropometric measures and cardiovascular risk factors were investigated in linear regression analyses adjusted for confounding, with imputation for missing data. In adjusted analyses, increasing leg length [males: 0.47mmHg/cm (0.23, 0.72); females: 0.50mmHg/cm (0.18, 0.83)], trunk length [males: 0.50mmHg/cm (0.28, 0.73); females: 0.57mmHg/cm (0.33, 0.81)] and height [males: 0.32mmHg/cm (0.16, 0.48); females: 0.32mmHg/cm (0.12, 0.52)] at 11 years was associated with higher SBP at 11 years. When these exposures were measured at 18 years the effect on SBP at 18 years had attenuated, and only increased trunk length was associated with higher SBP at 18 years for both sexes [males: 0.46mmHg/cm (0.05, 0.87); females: 0.69mmHg/cm (0.30, 1.08)]. We observed little association between height, leg length and trunk length and DBP, total cholesterol, LDL-c and HDL-c. Increased BMI was associated with elevated SBP and DBP at 11 and 18 years. Our findings suggest that height, leg length, and trunk length measured at 11 and 18 years was generally not associated with cardiovascular risk factors at 11 and 18 years. However, greater childhood BMI was associated with higher blood pressure and this association persisted into adolescence. This study contributes to the limited body of evidence on the association between measures of early anthropometry and cardiovascular risk among the Australian Aboriginal population.
C1 [Gialamas, Angela; Kinnell, Angela; Mittinty, Murthy N.; Lynch, John] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.
   [Davison, Belinda; Singh, Gurmeet] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Lynch, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.
RP Gialamas, A (reprint author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.
EM angela.gialamas@adelaide.edu.cn
RI Gialamas, Angela/F-1295-2015
OI Gialamas, Angela/0000-0001-7440-8154
FU National Health and Medical Research Council of Australia [631947,
   1044639]
FX This work was supported by a National Health and Medical Research
   Council of Australia (https://www.nhmrc.gov.au/) Program Grant (grant
   number 631947) and a National Health and Medical Research Council of
   Australia Project Grant (grant number 1044639). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], GROWTH REF DAT 5 19
   Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R
   Australian Bureau of Statistics, 1988, CENS 86 AUSTR PROF S
   Australian Institute of Health and Welfare, 2015, HLTH WELF AUSTR AB T
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171
   Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235
   Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004
   Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047
   Cunningham J, 1998, OVERWEIGHT OBESITY I
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331
   Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949
   Fraser A, 2008, J EPIDEMIOL COMMUN H, V62, P48, DOI 10.1136/jech.2006.053181
   Friedemann C, 2012, BMJ-BRIT MED J, V25, P345
   Fujita Y, 2010, PEDIATR INT, V52, P689, DOI 10.1111/j.1442-200X.2010.03093.x
   Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473
   Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290
   Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142
   Kouda K, 2003, INT J EPIDEMIOL, V32, P1105, DOI 10.1093/ije/dyg207
   Langenberg C, 2003, J HYPERTENS, V21, P537, DOI 10.1097/01.hjh.0000052472.40108.4e
   Larkins N, 2017, J HYPERTENS, V35, P1801, DOI 10.1097/HJH.0000000000001401
   Lawlor DA, 2004, HEART, V90, P745, DOI 10.1136/hrt.2003.019950
   Lawrance M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-31
   Little R. J. A., 2002, STAT ANAL MISSING DA
   Lohman TG, 1988, ANTHROPOMETRIC STAND
   Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505
   Markey PG, 1998, TRENDS HLTH MOTHERS
   MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291
   MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13
   Nordestgaard BG, 2016, EUR HEART J, V37, P1944, DOI 10.1093/eurheartj/ehw152
   Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248
   Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S
   Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sayers SM, 2003, BMC INT HEALTH HUM R, V3, P1, DOI DOI 10.1186/1472-698X-3-1
   Sayers S, 2009, PAEDIATR PERINAT EP, V23, P548, DOI 10.1111/j.1365-3016.2009.01071.x
   Shankar RR, 2005, J CLIN ENDOCR METAB, V90, P163, DOI 10.1210/jc.2004-0926
   Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081
   Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821
   Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867
   Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005
   Wadsworth MEJ, 1997, PAEDIATR PERINAT EP, V11, P2, DOI 10.1046/j.1365-3016.1997.d01-7.x
   Wells JCK, 2014, INT J OBESITY, V38, P930, DOI 10.1038/ijo.2014.24
   Whitley E, 2012, J EPIDEMIOL COMMUN H, V66, P18, DOI 10.1136/jech.2009.104216
   Wong SN, 2006, BLOOD PRESS MONIT, V11, P281, DOI 10.1097/01.mbp.0000209082.09623.b4
   Yeung SLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38420
NR 49
TC 0
Z9 0
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2018
VL 13
IS 6
AR e0199280
DI 10.1371/journal.pone.0199280
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK0LV
UT WOS:000435802500065
PM 29927998
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pena, CS
   Costa, MA
   Oliveira, RPB
AF Pena, Carolina Silva
   Costa, Marcelo Azevedo
   Braga Oliveira, Rivert Paulo
TI A new item response theory model to adjust data allowing examinee choice
SO PLOS ONE
LA English
DT Article
ID MONTE-CARLO ESTIMATION; MISSING DATA; MOTIVATION; PARAMETERS; SCORES
AB In a typical questionnaire testing situation, examinees are not allowed to choose which items they answer because of a technical issue in obtaining satisfactory statistical estimates of examinee ability and item difficulty. This paper introduces a new item response theory (IRT) model that incorporates information from a novel representation of questionnaire data using network analysis. Three scenarios in which examinees select a subset of items were simulated. In the first scenario, the assumptions required to apply the standard Rasch model are met, thus establishing a reference for parameter accuracy. The second and third scenarios include five increasing levels of violating those assumptions. The results show substantial improvements over the standard model in item parameter recovery. Furthermore, the accuracy was closer to the reference in almost every evaluated scenario. To the best of our knowledge, this is the first proposal to obtain satisfactory IRT statistical estimates in the last two scenarios.
C1 [Pena, Carolina Silva; Costa, Marcelo Azevedo] Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil.
   [Pena, Carolina Silva] Univ Fed Minas Gerais, Proreitoria Grad, Belo Horizonte, MG, Brazil.
   [Braga Oliveira, Rivert Paulo] Univ Fed Ouro Preto, Dept Stat, Ouro Preto, MG, Brazil.
RP Pena, CS (reprint author), Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil.; Pena, CS (reprint author), Univ Fed Minas Gerais, Proreitoria Grad, Belo Horizonte, MG, Brazil.
EM carolinasend@gmail.com
CR ALBERT JH, 1992, J EDUC STAT, V17, P251, DOI 10.2307/1165149
   [Anonymous], 2010, CUST PRET IT EN POD
   BALDWIN TT, 1991, PERS PSYCHOL, V44, P51, DOI 10.1111/j.1744-6570.1991.tb00690.x
   Barrat A., 2008, DYNAMICAL PROCESSES
   Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283
   Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804
   Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806
   BOCK RD, 1972, PSYCHOMETRIKA, V37, P29
   BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806
   Borges P., 2011, PROVAS PRETESTE ENEM
   Bradlow ET, 1998, J EDUC BEHAV STAT, V23, P236, DOI 10.2307/1165246
   Brigham TA, 1979, CHOICE PERCEIVED CON
   Cankar G., 2010, METODOLOSKIZVEZKI, V7, P151
   Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921
   Chi M., 1982, ADV PSYCHOL HUMAN IN, P7
   Chi M. T. H., 1978, CHILDRENS THINKING W, P73
   Cordova DI, 1996, J EDUC PSYCHOL, V88, P715, DOI 10.1037/0022-0663.88.4.715
   Curtis S. M., 2010, J STAT SOFTW, V36, P1
   DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490
   FITZPATRICK AR, 1995, J EDUC MEAS, V32, P243, DOI 10.1111/j.1745-3984.1995.tb00465.x
   Fox J., 2010, NONLINEAR REGRESSION
   Fox JP, 2010, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-0742-4
   GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941
   Hambleton R. K, 1991, FUNDAMENTALS ITEM RE
   Jennings M., 1999, LANG TEST, V16, P426, DOI DOI 10.1177/026553229901600402
   Kieftenbeld V, 2012, APPL PSYCH MEAS, V36, P399, DOI 10.1177/0146621612446170
   Lewis T. G., 2009, NETWORK SCI THEORY A
   Linn RL, 1998, 485 CSE U CAL
   Little RJA, 1987, STAT ANAL MISSING DA
   Liu CW, 2017, BRIT J MATH STAT PSY, V70, P499, DOI 10.1111/bmsp.12097
   Lu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106747
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Patz RJ, 1999, J EDUC BEHAV STAT, V24, P342, DOI 10.3102/10769986024004342
   Pena CS, 2016, THESIS
   Plummer M., 2003, P 3 INT WORKSH DISTR
   Powers DE, 2000, APPL MEAN EDUC, V12, P257
   R Core Team, 2015, R LANG ENV STAT COMP
   Rasch G, 1960, PROBABILISTIC MODELS
   ROCKLIN TR, 1995, J EDUC PSYCHOL, V87, P103, DOI 10.1037/0022-0663.87.1.103
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Siegler RS, 1997, J EXP PSYCHOL GEN, V126, P71, DOI 10.1037/0096-3445.126.1.71
   Smeeth L., 2014, INT J EPIDEMIOLOGY
   Spiegelhalter D., 2003, WINBUGS USER MANUAL
   Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281
   van der Aalst W, 2014, IEEE INT ENTERP DIST, P1, DOI 10.1109/EDOC.2014.11
   WAINER H, 1994, J EDUC MEAS, V31, P183, DOI 10.1111/j.1745-3984.1994.tb00442.x
   Wang WC, 2012, J EDUC MEAS, V49, P419, DOI 10.1111/j.1745-3984.2012.00184.x
   WANG XB, 1995, APPL MEAS EDUC, V8, P211, DOI 10.1207/s15324818ame0803_2
NR 48
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 1
PY 2018
VL 13
IS 2
AR e0191600
DI 10.1371/journal.pone.0191600
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU3ZZ
UT WOS:000423793400024
PM 29389996
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Baker, KK
   Padhi, B
   Torondel, B
   Das, P
   Dutta, A
   Sahoo, KC
   Das, B
   Dreibelbis, R
   Caruso, B
   Freeman, MC
   Sager, L
   Panigrahi, P
AF Baker, Kelly K.
   Padhi, Bijaya
   Torondel, Belen
   Das, Padmalaya
   Dutta, Ambarish
   Sahoo, Krushna Chandra
   Das, Bhabani
   Dreibelbis, Robert
   Caruso, Bethany
   Freeman, Matthew C.
   Sager, Lauren
   Panigrahi, Pinaki
TI From menarche to menopause: A population-based assessment of water,
   sanitation, and hygiene risk factors for reproductive tract infection
   symptoms over life stages in rural girls and women in India
SO PLOS ONE
LA English
DT Article
ID ABNORMAL VAGINAL DISCHARGE; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS;
   PREGNANT-WOMEN; EMOTIONAL DISTRESS; PRETERM DELIVERY; HEALTH;
   ASSOCIATION; INSECURITY; STRESS
AB Women face greater challenges than men in accessing water, sanitation, and hygiene (WASH) resources to address their daily needs, and may respond to these challenges by adopting unsafe practices that increase the risk of reproductive tract infections (RTIs). WASH practices may change as women transition through socially-defined life stage experiences, like marriage and pregnancy. Thus, the relationship between WASH practices and RTIs might vary across female reproductive life stages. This cross-sectional study assessed the relationship between WASH exposures and self-reported RTI symptoms in 3,952 girls and women from two rural districts in India, and tested whether social exposures represented by reproductive life stage was an effect modifier of associations. In fully adjusted models, RTI symptoms were less common in women using a latrine without water for defecation versus open defecation (Odds Ratio (OR) = 0.69; Confidence Interval (CI) = 0.48, 0.98) and those walking shorter distances to a bathing location (OR = 0.79, CI = 0.63, 0.99), but there was no association between using a latrine with a water source and RTIs versus open defecation (OR = 1.09; CI = 0.69, 1.72). Unexpectedly, RTI symptoms were more common for women bathing daily with soap (OR = 6.55, CI = 3.60, 11.94) and for women washing their hands after defecation with soap (OR = 10.27; CI = 5.53, 19.08) or ash/soil/ mud (OR = 6.02; CI = 3.07, 11.77) versus water only or no hand washing. WASH practices of girls and women varied across reproductive life stages, but the associations between WASH practices and RTI symptoms were not moderated by or confounded by life stage status. This study provides new evidence that WASH access and practices are associated with self-reported reproductive tract infection symptoms in rural Indian girls and women from different reproductive life stages. However, the counterintuitive directions of effect for soap use highlights that causality and mechanisms of effect cannot be inferred from this study design. Future research is needed to understand whether improvements in water and sanitation access could improve the practice of safe hygiene behaviors and reduce the global burden of RTIs in women.
C1 [Baker, Kelly K.; Sager, Lauren] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA.
   [Padhi, Bijaya; Das, Padmalaya; Dutta, Ambarish; Sahoo, Krushna Chandra; Das, Bhabani] Asian Inst Publ Hlth, Bhubaneswar, India.
   [Torondel, Belen] London Sch Hyg & Trop Med, London, England.
   [Dreibelbis, Robert] Univ Oklahoma, Norman, OK 73019 USA.
   [Caruso, Bethany; Freeman, Matthew C.] Emory Univ, Atlanta, GA 30322 USA.
   [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Omaha, NE USA.
RP Baker, KK (reprint author), Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA.
EM kelly-k-baker@uiowa.edu
OI Dreibelbis, Robert/0000-0002-9716-0419; Baker,
   Kelly/0000-0002-3774-2628; Dutta, Ambarish/0000-0002-4019-7472; Caruso,
   Bethany/0000-0001-9738-9857
FU Sanitation and Hygiene Applied Research for Equity (SHARE) consortium;
   UK Department for International Development [PO 6981]
FX This research received financial support from the Sanitation and Hygiene
   Applied Research for Equity (SHARE) consortium
   (https//www..shareresearchorg/), which was funded by the UK Department
   for International Development (grant no. PO 6981). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aggarwal Arun Kumar, 2004, Journal of Communicable Diseases, V36, P1
   Ahuja Maninder, 2016, J Midlife Health, V7, P126
   Al Riyami A, 2005, MED PRIN PRACT, V14, P92, DOI 10.1159/000083918
   Alexander M, 2007, INT FAM PLAN PERSPEC, V33, P150, DOI 10.1363/ifpp.33.150.07
   Alijahan Rahele, 2014, Iran J Reprod Med, V12, P47
   Anand E, 2015, SEX REPROD HEALTHC, V6, P249, DOI 10.1016/j.srhc.2015.06.001
   Ashorn P, 2015, NESTLE NUTR WORKS SE, V81, P37, DOI 10.1159/000365802
   Bahram Amini, 2009, Oman Med J, V24, P288, DOI 10.5001/omj.2009.58
   Balsara ZP, 2010, J HEALTH POPUL NUTR, V28, P501
   Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464
   Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275
   Betha K, 2016, INFECT DIS OBSTET GY, V2016
   Bhilwar Meenakshi, 2015, J Nat Sci Biol Med, V6, pS29, DOI 10.4103/0976-9668.166059
   Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103
   Cammack AL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.054
   Caruso BA, 2015, LANCET, V386, P650, DOI 10.1016/S0140-6736(15)61497-0
   Chen QX, 2013, AM J PUBLIC HEALTH, V103, pE67, DOI 10.2105/AJPH.2012.300995
   Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9
   Cohen BE, 2012, WOMEN HEALTH ISS, V22, pE461, DOI 10.1016/j.whi.2012.06.005
   Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445
   Crucitti T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016310
   Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311
   Dambhare Dharampal G, 2012, Glob J Health Sci, V4, P105, DOI 10.5539/gjhs.v4n1p105
   Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777
   Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3
   Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584
   Fisher J, 2008, P I CIVIL ENG-MUNIC, V161, P223, DOI 10.1680/muen.2008.161.4.223
   Goto A, 2005, J EPIDEMIOL, V15, P163, DOI 10.2188/jea.15.163
   Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63
   HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883
   Jaya, 2009, INT PERSPECT SEX R H, V35, P97, DOI 10.1363/ipsrh.35.097.09
   Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006
   Kenyon CR, 2014, CURR OPIN OBSTET GYN, V26, P448, DOI 10.1097/GCO.0000000000000112
   Kerubo E, 2016, SEX TRANSM INFECT, V92, P251, DOI 10.1136/sextrans-2015-052371
   Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905
   Khawaja M, 2009, J WOMENS HEALTH, V18, P1701, DOI 10.1089/jwh.2008.0962
   Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c
   Kojima N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2282-3
   Krupp K, 2007, Glob Public Health, V2, P395, DOI 10.1080/17441690701238031
   Lata Indu, 2010, Indian J Community Med, V35, P285, DOI 10.4103/0970-0218.66855
   Li XD, 2014, EUR J CLIN MICROBIOL, V33, P1525, DOI 10.1007/s10096-014-2103-1
   Lien PT, 2002, STUD FAMILY PLANN, V33, P217, DOI 10.1111/j.1728-4465.2002.00217.x
   Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416
   ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x
   Mbizvo M E, 2004, Cent Afr J Med, V50, P41
   McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa
   McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.07t
   Murphy K, 2016, J INFECT DIS, V214, pS29, DOI 10.1093/infdis/jiw140
   Nagarkar Aarti, 2015, Indian J Sex Transm Dis AIDS, V36, P18, DOI 10.4103/0253-7184.156690
   Narayankhedkar A, 2015, J SEX TRANSM DIS, V2015
   Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243
   Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15
   Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851
   Paige DM, 1998, J NURSE-MIDWIFERY, V43, P83, DOI 10.1016/S0091-2182(97)00161-4
   Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451
   Patel V, 2006, ARCH GEN PSYCHIAT, V63, P404, DOI 10.1001/archpsyc.63.4.404
   Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072
   Patel V, 2008, J PSYCHOSOM RES, V64, P255, DOI 10.1016/j.jpsychores.2007.10.015
   Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x
   Romoren M, 2007, B WORLD HEALTH ORGAN, V85, P297, DOI 10.2471/BLT.06.031922
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031
   SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405
   Sharma A. K., 2004, Journal of Communicable Diseases, V36, P93
   Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022
   Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004
   Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x
   Sznajder KK, 2014, INT J OCCUP ENV HEAL, V20, P33, DOI 10.1179/2049396713Y.0000000053
   Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008
   Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165
   Tumwine JK, 2002, UGANDA COUNTRY STUDY, Vxix
   van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290
   Winter SC, 2016, INT J ENVIRON HEAL R, V26, P291, DOI 10.1080/09603123.2015.1111309
   Wojcik A, 2013, INT J OCCUP MED ENV, V26, P477, DOI 10.2478/s13382-013-0118-y
   Wutich A, 2009, MED ANTHROPOL Q, V23, P436, DOI 10.1111/j.1548-1387.2009.01072.x
   Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042
   ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047
NR 79
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2017
VL 12
IS 12
AR e0188234
DI 10.1371/journal.pone.0188234
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO8CU
UT WOS:000417110700010
PM 29206842
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Chesnais, M
   Lecuru, F
   Mimouni, M
   Ngo, C
   Fauconnier, A
   Huchon, C
AF Chesnais, Marion
   Lecuru, Fabrice
   Mimouni, Myriam
   Ngo, Charlotte
   Fauconnier, Arnaud
   Huchon, Cyrille
TI A pre-operative predictive score to evaluate the feasibility of complete
   cytoreductive surgery in patients with epithelial ovarian cancer
SO PLOS ONE
LA English
DT Article
ID SUBOPTIMAL CYTOREDUCTION; LAPAROSCOPY; CARCINOMA; RESECTABILITY
AB Objective
   Postoperative residual tumor is the major prognostic factor in ovarian cancer. The feasibility of complete cytoreductive surgery is assessed by laparoscopy. Our goal was to develop a predictive score prior to laparoscopy to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
   Methods
   We developed a score to predict incomplete cytoreductive surgery by performing multiple logistic regressions after bootstrap procedures on data from a retrospective cohort of 247 patients with advanced ovarian cancer. This score was validated on a different population of 45 patients with ovarian cancer.
   Results
   Four criteria were independently associated with incomplete cytoreduction, confirmed by surgery: BMI > 30 kg/m(2) (adjusted odds ratio [aOR], 3.07; 95% confidence interval [95% CI], 1.0-9.6), CA125 > 100 IU/L (aOR, 3.99; 95% CI, 1.6-10.1), diaphragmatic and/or omental carcinomatosis by CT-Scan (aOR, 5.82; 95% CI, 2.6-13.1), and positive parenchymal metastases by PET/CT (aOR, 3.59; 95% CI, 1.0-12.8). The 100-point score was based on these criteria. The area-under-the-curve of the score was 0.79 (95% CI, 0.73-0.86). In the validation group, no patient ranked in the high-risk group of incomplete cytoreductive surgery had a complete upfront cytoreductive surgery (95% CI 0-16). Three of 29 patients for whom primary complete cytoreduction was not possible were classified in the group at low risk of incomplete cytoreductive surgery (12%; 95% CI 4-27).
   Conclusion
   This pre-operative score may be useful for distinguishing which patients may have complete cytoreductive surgery from those who will receive neoadjuvant chemotherapy, while avoiding unnecessary laparoscopy.
C1 [Chesnais, Marion; Mimouni, Myriam; Fauconnier, Arnaud; Huchon, Cyrille] Univ Versailles St Quentin En Yvelines, EA Clin Risks & Safety Womens Hlth 7285, Montigny Le Bretonneux, France.
   [Lecuru, Fabrice; Mimouni, Myriam; Ngo, Charlotte] Hop Europeen Georges Pompidou, AP HP, Gynecol Oncol Ctr Paris Descartes, Paris, France.
   [Lecuru, Fabrice] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France.
   [Lecuru, Fabrice] Univ Paris 05, INSERM, Fac Med, UMR S 1124, Paris, France.
   [Mimouni, Myriam; Ngo, Charlotte; Fauconnier, Arnaud; Huchon, Cyrille] CHI Poissy St Germain, Dept Gynecol & Obstet, Poissy, France.
RP Chesnais, M (reprint author), Univ Versailles St Quentin En Yvelines, EA Clin Risks & Safety Womens Hlth 7285, Montigny Le Bretonneux, France.
EM marion_chesnais@hotmail.com
CR Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248
   Brun JL, 2008, GYNECOL ONCOL, V110, P354, DOI 10.1016/j.ygyno.2008.04.042
   Byrom J, 2002, BJOG-INT J OBSTET GY, V109, P369, DOI 10.1111/j.1471-0528.2002.01216.x
   Chereau E, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.856
   Chi DS, 2006, GYNECOL ONCOL, V101, P224, DOI 10.1016/j.ygyno.2005.10.037
   de Jong D, 2007, ONCOLOGY-BASEL, V72, P293, DOI 10.1159/000113051
   Dessapt AL, SURG ONCOLOGY, V25, P326
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   Fagotti A, 2005, GYNECOL ONCOL, V96, P729, DOI 10.1016/j.ygyno.2004.11.031
   Fagotti A, 2006, ANN SURG ONCOL, V13, P1156, DOI 10.1245/ASO.2006.08.021
   Fagotti A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.052
   Gerestein CG, 2011, ANTICANCER RES, V31, P4043
   Jacquet P, 1996, Cancer Treat Res, V82, P359
   Morice P, 2004, E MEM ACAD NATL CHIR, V3, p35 
   Reuss A, 2009, CANCER, V15, P1234
   Gomez-Hidalgo NR, 2015, GYNECOL ONCOL, V137, P553, DOI 10.1016/j.ygyno.2015.03.049
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rutten MJ, 2017, J CLIN ONCOL, V35, P613, DOI 10.1200/JCO.2016.69.2962
   Rutten MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009786.pub2
   Suidan RS, 2014, GYNECOL ONCOL, V134, P455, DOI 10.1016/j.ygyno.2014.07.002
   Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806
NR 21
TC 4
Z9 4
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2017
VL 12
IS 11
AR e0187245
DI 10.1371/journal.pone.0187245
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM0ME
UT WOS:000414659600029
PM 29117194
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Coertjens, L
   Donche, V
   De Maeyer, S
   Vanthournout, G
   Van Petegem, P
AF Coertjens, Liesje
   Donche, Vincent
   De Maeyer, Sven
   Vanthournout, Gert
   Van Petegem, Peter
TI To what degree does the missing-data technique influence the estimated
   growth in learning strategies over time? A tutorial example of
   sensitivity analysis for longitudinal data
SO PLOS ONE
LA English
DT Article
ID PATTERN-MIXTURE MODELS; ATTRITION; IMPUTATION; TRAJECTORIES;
   PERFORMANCE; PSYCHOLOGY; VARIABLES; BIAS
AB Longitudinal data is almost always burdened with missing data. However, in educational and psychological research, there is a large discrepancy between methodological suggestions and research practice. The former suggests applying sensitivity analysis in order to the robustness of the results in terms of varying assumptions regarding the mechanism generating the missing data. However, in research practice, participants with missing data are usually discarded by relying on listwise deletion. To help bridge the gap between methodological recommendations and applied research in the educational and psychological domain, this study provides a tutorial example of sensitivity analysis for latent growth analysis. The example data concern students' changes in learning strategies during higher education. One cohort of students in a Belgian university college was asked to complete the Inventory of Learning Styles-Short Version, in three measurement waves. A substantial number of students did not participate on each occasion. Change over time in student learning strategies was assessed using eight missing data techniques, which assume different mechanisms for missingness. The results indicated that, for some learning strategy sub-scales, growth estimates differed between the models. Guidelines in terms of reporting the results from sensitivity analysis are synthesised and applied to the results from the tutorial example.
C1 [Coertjens, Liesje] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.
   [Coertjens, Liesje; Donche, Vincent; De Maeyer, Sven; Van Petegem, Peter] Univ Antwerp, Fac Social Sci, Dept Educ Sci, Antwerp, Belgium.
   [Vanthournout, Gert] Artesis Plantin Univ Coll, Antwerp, Belgium.
RP Coertjens, L (reprint author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.; Coertjens, L (reprint author), Univ Antwerp, Fac Social Sci, Dept Educ Sci, Antwerp, Belgium.
EM Liesje.coertjens@uclouvain.be
RI Van Petegem, Peter/R-5494-2016; Donche, Vincent/N-4817-2019; De Maeyer,
   Sven/K-7446-2015
OI Van Petegem, Peter/0000-0002-4078-7800; Donche,
   Vincent/0000-0002-9405-3896; Coertjens, Liesje/0000-0003-1209-5089; De
   Maeyer, Sven/0000-0003-2888-1631
FU University of Antwerp
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: The research
   reported in this article was supported by a grant from the "Special
   Research Fund: New Research Initiatives" from the Research Board of the
   University of Antwerp (www.uantwerp.be) offered to PVP and VD. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Allison P., 2009, SAGE HDB QUANTITATIV, P72, DOI DOI 10.4135/9780857020994.N4
   Busato VV, 1998, BRIT J EDUC PSYCHOL, V68, P427, DOI 10.1111/j.2044-8279.1998.tb01302.x
   Byrne B. M., 2010, STRUCTURAL EQUATION
   Cheema JR, 2014, REV ED RES
   Coertjens L, 2017, HIGH EDUC, V73, P499, DOI 10.1007/s10734-016-0093-x
   Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330
   Crameri A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01042
   Dantan E, 2008, INT J BIOSTATISTICS
   Demirtas H, 2003, STAT MED, V22, P2553, DOI 10.1002/sim.1475
   Donche V, 2008, STYLE CULTURAL DIFFE, P49
   Duncan T. E., 2006, INTRO LATENT VARIABL
   Enders C. K, 2010, APPL MISSING DATA AN
   Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7
   Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640
   Feldman BJ, 2012, J EDUC BEHAV STAT, V37, P703, DOI 10.3102/1076998612458701
   Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1
   Foster EM, 2004, EVALUATION REV, V28, P434, DOI 10.1177/0193841X04264662
   Germeijs V, 2007, J VOCAT BEHAV, V70, P223, DOI 10.1016/j.jvb.2006.10.004
   Glynn RJ, 1986, DRAWING INFERENCES S, P115
   Graham JM, 2003, STRUCT EQU MODELING, V10, P142, DOI 10.1207/S15328007SEM1001_7
   Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   GRAHAM JW, 1993, J APPL PSYCHOL, V78, P119, DOI 10.1037/0021-9010.78.1.119
   GRAHAM JW, 1999, STAT STRATEGIES SMAL, P1
   Grittner U, 2011, INT J METH PSYCH RES, V20, P50, DOI 10.1002/mpr.330
   Hardt J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-184
   Hawkinson LE, 2013, EARLY CHILD RES Q, V28, P388, DOI 10.1016/j.ecresq.2012.10.002
   Heckman JJ, 1976, ANN ECON SOC MEAS, P4
   Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64
   Hox JJ, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P15
   Jackling B., 2005, ACCOUNT FINANC, V45, P597, DOI DOI 10.1111/J.1467-629X.2005.00142.X
   Jelicic H, 2010, J YOUTH ADOLESCENCE, V39, P816, DOI 10.1007/s10964-010-9542-5
   Jelicic H, 2009, DEV PSYCHOL, V45, P1195, DOI 10.1037/a0015665
   Johnson DR, 2011, J MARRIAGE FAM, V73, P926, DOI 10.1111/j.1741-3737.2011.00861.x
   Little R. J. A., 2002, STAT ANAL MISSING DA
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302
   LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350
   Little R, 2009, CH CRC HANDB MOD STA, P409
   Mazumdar S, 2007, J PSYCHIATR RES, V41, P1032, DOI 10.1016/j.jpsychires.2006.09.007
   Molenberghs G, 2009, CH CRC HANDB MOD STA, P395
   Molenberghs G, 2009, CH CRC HANDB MOD STA, P501
   Moreno-Betancur M, 2013, STAT METHODS MED RES, P1
   Muthen B, 2011, PSYCHOL METHODS, V16, P17, DOI 10.1037/a0022634
   Muthen LK, 2010, MPLUS SHORT COURSES2
   Nicholson JS, 2017, INT J BEHAV DEV, V41, P143, DOI 10.1177/0165025415618275
   Peeters M, 2015, EUR J DEV PSYCHOL, V12, P377, DOI 10.1080/17405629.2015.1049526
   Peugh JL, 2004, REV EDUC RES, V74, P525, DOI 10.3102/00346543074004525
   Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501
   Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838
   Rombach I, 2016, QUAL LIFE RES, V25, P1613, DOI 10.1007/s11136-015-1206-1
   Roy J, 2003, BIOMETRICS, V59, P829, DOI 10.1111/j.0006-341X.2003.00097.x
   Rubin D. B., 1987, MULTIPLE IMPUTATION
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Singer JD, 2003, APPL LONGITUDINAL DA
   Thijs H, 2002, BIOSTATISTICS, V3, P245, DOI 10.1093/biostatistics/3.2.245
   Thoemmes F, 2014, MULTIVAR BEHAV RES, V49, P443, DOI 10.1080/00273171.2014.931799
   Vanthournout G, 2012, EDUC RES INT, DOI 10.1155/2012/152747
   Vermunt JD, 2005, HIGH EDUC, V49, P205, DOI 10.1007/s10734-004-6664-2
   Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594
   Wothke W, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P219
   Xu S, 2011, J EDUC BEHAV STAT, V36, P237, DOI 10.3102/1076998610375836
   Yang MS, 2015, BRIT J MATH STAT PSY, V68, P246, DOI 10.1111/bmsp.12043
   Yang MS, 2014, PSYCHOL METHODS, V19, P188, DOI 10.1037/a0033804
   Yang XW, 2008, STAT MED, V27, P2826, DOI 10.1002/sim.3111
   Zeegers P, 2001, BRIT J EDUC PSYCHOL, V71, P115, DOI 10.1348/000709901158424
NR 67
TC 2
Z9 2
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2017
VL 12
IS 9
AR e0182615
DI 10.1371/journal.pone.0182615
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG8GZ
UT WOS:000410669200004
PM 28902849
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jordan, P
   Shedden-Mora, MC
   Lowe, B
AF Jordan, Pascal
   Shedden-Mora, Meike C.
   Loewe, Bernd
TI Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7)
   in primary care using modern item response theory
SO PLOS ONE
LA English
DT Article
ID ASSESSING FIT; DEPRESSION; PREVALENCE
AB Objective
   The Generalized Anxiety Disorder scale (GAD-7) is one of the most frequently used diagnostic self-report scales for screening, diagnosis and severity assessment of anxiety disorder. Its psychometric properties from the view of the Item Response Theory paradigm have rarely been investigated. We aimed to close this gap by analyzing the GAD-7 within a large sample of primary care patients with respect to its psychometric properties and its implications for scoring using Item Response Theory.
   Methods
   Robust, nonparametric statistics were used to check unidimensionality of the GAD-7. A graded response model was fitted using a Bayesian approach. The model fit was evaluated using posterior predictive p-values, item information functions were derived and optimal predictions of anxiety were calculated.
   Results
   The sample included N = 3404 primary care patients (60% female; mean age, 52,2; standard deviation 19.2) The analysis indicated no deviations of the GAD-7 scale from unidimensionality and a decent fit of a graded response model. The commonly suggested ultra-brief measure consisting of the first two items, the GAD-2, was supported by item information analysis. The first four items discriminated better than the last three items with respect to latent anxiety.
   Conclusion
   The information provided by the first four items should be weighted more heavily. Moreover, estimates corresponding to low to moderate levels of anxiety show greater variability. The psychometric validity of the GAD-2 was supported by our analysis.
C1 [Jordan, Pascal; Shedden-Mora, Meike C.; Loewe, Bernd] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.
   [Jordan, Pascal; Shedden-Mora, Meike C.; Loewe, Bernd] Schon Klin Hamburg Eilbek, Hamburg, Germany.
   [Jordan, Pascal] Univ Hamburg, Fac Psychol & Movement Sci, Dept Psychol Methods, Hamburg, Germany.
RP Jordan, P (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.; Jordan, P (reprint author), Schon Klin Hamburg Eilbek, Hamburg, Germany.; Jordan, P (reprint author), Univ Hamburg, Fac Psychol & Movement Sci, Dept Psychol Methods, Hamburg, Germany.
EM pascal.jordan@uni-hamburg.de
FU German Ministry of Education and Research (BMBF) [01KQ100213]
FX Funding provided by German Ministry of Education and Research (BMBF),
   Grant number: 01KQ100213; Link: https://www.bmbf.de/en/index.html. The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   Borsboom D, 2006, PSYCHOMETRIKA, V71, P425, DOI 10.1007/s11336-006-1447-6
   Curtis S. M., 2010, J STAT SOFTW, V36, P1
   DOBSON KS, 1985, CLIN PSYCHOL REV, V5, P307, DOI 10.1016/0272-7358(85)90010-8
   Gelman A, 1996, STAT SINICA, V6, P733
   Gelman A., 2014, BAYESIAN DATA ANAL
   HOLLAND PW, 1986, ANN STAT, V14, P1523, DOI 10.1214/aos/1176350174
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
   Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006
   Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Lowe B., 2017, PSYCHOSOMATIC MED
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Mokken R. J., 1971, THEORY PROCEDURE SCA
   MURAKI E, 1993, APPL PSYCH MEAS, V17, P351, DOI 10.1177/014662169301700403
   Raykov T, 2004, BRIT J MATH STAT PSY, V57, P21, DOI 10.1348/000711004849295
   Rose M, 2012, PSYCHOSOM MED, V74, P338, DOI 10.1097/PSY.0b013e3182547392
   ROSENBAUM PR, 1984, PSYCHOMETRIKA, V49, P425, DOI 10.1007/BF02306030
   Rosseel Y, 2012, J STAT SOFTW, V48, P1
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006
   Seung W, 2016, LORDIF LOGISTIC ORDI
   Shedden-Mora MC, 2016, J PSYCHOSOM RES, V80, P23, DOI 10.1016/j.jpsychores.2015.11.004
   Sijtsma K., 2002, INTRO NONPARAMETRIC
   Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0
   Sinharay S, 2005, J EDUC MEAS, V42, P375, DOI 10.1111/j.1745-3984.2005.00021.x
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797
   van der Ark LA, 2007, J STAT SOFTW, V20
   Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065
   Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24
   Zhu XW, 2011, J EDUC MEAS, V48, P81, DOI 10.1111/j.1745-3984.2011.00132.x
NR 33
TC 5
Z9 5
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 3
PY 2017
VL 12
IS 8
AR e0182162
DI 10.1371/journal.pone.0182162
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC5AR
UT WOS:000406853600070
PM 28771530
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Patel, SA
   Deepa, M
   Shivashankar, R
   Ali, MK
   Kapoor, D
   Gupta, R
   Lall, D
   Tandon, N
   Mohan, V
   Kadir, MM
   Fatmi, Z
   Prabhakaran, D
   Narayan, KMV
AF Patel, Shivani A.
   Deepa, Mohan
   Shivashankar, Roopa
   Ali, Mohammed K.
   Kapoor, Deksha
   Gupta, Ruby
   Lall, Dorothy
   Tandon, Nikhil
   Mohan, Viswanathan
   Kadir, M. Masood
   Fatmi, Zafar
   Prabhakaran, Dorairaj
   Narayan, K. M. Venkat
TI Comparison of multiple obesity indices for cardiovascular disease risk
   classification in South Asian adults: The CARRS Study
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; WAIST CIRCUMFERENCE; SKINFOLD THICKNESS; ABDOMINAL
   OBESITY; INDIANS; FAT; IDENTIFICATION; COUNTRIES; ACCURATE; POINTS
AB Background We comparatively assessed the performance of six simple obesity indices to identify adults with cardiovascular disease (CVD) risk factors in a diverse and contemporary South Asian population.
   Methods 8,892 participants aged 20-60 years in 2010-2011 were analyzed. Six obesity indices were examined: body mass index (BMI), waist circumference (WC), waist-height ratio (WHtR), waist-hip ratio (WHR), log of the sum of triceps and subscapular skin fold thickness (LTS), and percent body fat derived from bioelectric impedance analysis (BIA). We estimated models with obesity indices specified as deciles and as continuous linear variables to predict prevalent hypertension, diabetes, and high cholesterol and report associations (prevalence ratios, PRs), discrimination (area-under-the-curve, AUCs), and calibration (index chi 2). We also examined a composite unhealthy cardiovascular profile score summarizing glucose, lipids, and blood pressure.
   Results No single obesity index consistently performed statistically significantly better than the others across the outcome models. Based on point estimates, WHtR trended towards best performance in classifying diabetes (PR = 1.58 [1.45-1.72], AUC = 0.77, men; PR = 1.59 [1.47-1.71], AUC = 0.80, women) and hypertension (PR = 1.34 [1.26,1.42], AUC = 0.70, men; PR = 1.41 [1.33,1.50], AUC = 0.78, women). WC (mean difference = 0.24 SD [0.21- 0.27]) and WHtR (mean difference = 0.24 SD [0.21,0.28]) had the strongest associations with the composite unhealthy cardiovascular profile score in women but not in men.
   Conclusions WC and WHtR were the most useful indices for identifying South Asian adults with prevalent diabetes and hypertension. Collection of waist circumference data in South Asian health surveys will be informative for population-based CVD surveillance efforts.
C1 [Patel, Shivani A.; Ali, Mohammed K.; Narayan, K. M. Venkat] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Patel, Shivani A.; Shivashankar, Roopa; Ali, Mohammed K.; Gupta, Ruby; Tandon, Nikhil; Prabhakaran, Dorairaj; Narayan, K. M. Venkat] Ctr Control Chron Condit, Gurgaon, Haryana, India.
   [Deepa, Mohan; Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India.
   [Shivashankar, Roopa; Gupta, Ruby; Prabhakaran, Dorairaj] Publ Hlth Fdn India, Gurgaon, Haryana, India.
   [Kapoor, Deksha; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India.
   [Lall, Dorothy] Inst Publ Hlth Bengaluru, Bengaluru, Karnataka, India.
   [Kadir, M. Masood; Fatmi, Zafar] Aga Khan Univ, Karachi, Sindh, Pakistan.
RP Patel, SA (reprint author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.; Patel, SA (reprint author), Ctr Control Chron Condit, Gurgaon, Haryana, India.
EM s.a.patel@emory.edu
RI Fatmi, Zafar/P-2696-2019; Lall, Dorothy/N-1751-2019; Fatmi, Syed Zafar
   Ahmed/P-4075-2019; Prabhakaran, Dorairaj/B-4147-2011
OI Lall, Dorothy/0000-0002-2776-2182; Prabhakaran,
   Dorairaj/0000-0002-3172-834X; Fatmi, Zafar/0000-0001-7212-6858
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health; Department of Health and Human Services [HHSN268200900026C];
   United Health Group (Minneapolis, MN, USA); Wellcome Trust; UK
   universities [WT084754/Z/08/A]
FX The CARRS Study was funded in part by the National Heart, Lung, and
   Blood Institute of the National Institutes of Health, Department of
   Health and Human Services (contract no. HHSN268200900026C) and the
   United Health Group (Minneapolis, MN, USA). RS is supported by a
   Wellcome Trust Capacity Strengthening Strategic Award Extension phase to
   the Public Health Foundation of India and a consortium of UK
   universities (WT084754/Z/08/A). The sponsors were not involved with
   study design, data collection, data analysis, or decision to submit the
   manuscript for publication.
CR Ahmad O. B., 2001, GPE DISCUSSION PAPER, V31
   Bodicoat DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090813
   Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930
   Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920
   Dehghan M, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-26
   Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x
   Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3
   Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066
   Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x
   Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68
   Huxley R, 2007, DIABETES CARE, V30, P3116, DOI 10.2337/dc07-1455
   International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF
   Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Liu F. F., 2013, PLOS ONE, V8
   Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111
   Mohan V, 2007, DIABETES OBES METAB, V9, P337, DOI 10.1111/j.1463-1326.2006.00612.x
   Mohan V, 2007, METABOLISM, V56, P961, DOI 10.1016/j.metabol.2007.02.009
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   MUST A, 1991, AM J CLIN NUTR, V53, P839
   Nair M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-701
   Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ramachandran A, 1997, DIABETES RES CLIN PR, V36, P121, DOI 10.1016/S0168-8227(97)00040-5
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380
   Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188
   Stookey JD, 2001, J NUTR, V131, p2433S
   Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   WANG J, 1994, AM J CLIN NUTR, V60, P23
   World Health Organization, 1995, PHYS STAT UINT ANT
   World Health Organization, 2011, WAIST CIRCUMFERENCE
   Wu CH, 2007, INT J OBESITY, V31, P1384, DOI 10.1038/sj.ijo.0803624
NR 36
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2017
VL 12
IS 4
AR e0174251
DI 10.1371/journal.pone.0174251
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EL
UT WOS:000400383600003
PM 28448582
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Suijker, JJ
   MacNeil-Vroomen, JL
   van Rijn, M
   Buurman, BM
   de Rooij, SE
   van Charente, EPM
   Bosmans, JE
AF Suijker, Jacqueline J.
   MacNeil-Vroomen, Janet L.
   van Rijn, Marjon
   Buurman, Bianca M.
   de Rooij, Sophia E.
   van Charente, Eric P. Moll
   Bosmans, Judith E.
TI Cost-effectiveness of nurse-led multifactorial care to prevent or
   postpone new disabilities in community-living older people: Results of a
   cluster randomized trial
SO PLOS ONE
LA English
DT Article
ID COMPREHENSIVE GERIATRIC ASSESSMENT; QUALITY-OF-LIFE; FUNCTIONAL DECLINE;
   ECONOMIC-EVALUATION; ELDERLY-PEOPLE; HOME VISITS; INTERDISCIPLINARY
   INTERVENTION; MANAGEMENT INTERVENTION; INTEGRATED CARE; MISSING DATA
AB Objective To evaluate the cost-effectiveness of nurse-led multifactorial care to prevent or postpone new disabilities in community-living older people in comparison with usual care.
   Methods We conducted cost-effectiveness and cost-utility analyses alongside a cluster randomized trial with one-year follow-up. Participants were aged >= 70 years and at increased risk of functional decline. Participants in the intervention group (n = 1209) received a comprehensive geriatric assessment and individually tailored multifactorial interventions coordinated by a community-care registered nurse with multiple follow-up visits. The control group (n = 1074) received usual care. Costs were assessed from a healthcare perspective. Outcome measures included disability (modified Katz-Activities of Daily Living (ADL) index score), and quality-adjusted life-years (QALYs). Statistical uncertainty surrounding Incremental Cost-Effectiveness Ratios (ICERs) was estimated using bootstrapped bivariate regression models while adjusting for confounders.
   Results There were no statistically significant differences in Katz-ADL index score and QALYs between the two groups. Total mean costs were significantly higher in the intervention group (EUR 6518 (SE 472) compared with usual care (EUR 5214 (SE 338); adjusted mean difference (sic) 1457 (95% CI: 572; 2537). Cost-effectiveness acceptability curves showed that the maximum probability of the intervention being cost-effective was 0.14 at a willingness to pay (WTP) of EUR 50,000 per one point improvement on the Katz-ADL index score and 0.04 at a WTP of EUR 50,000 per QALY gained.
   Conclusion The current intervention was not cost-effective compared to usual care to prevent or postpone new disabilities over a one-year period. Based on these findings, implementation of the evaluated multifactorial nurse-led care model is not to be recommended.
C1 [Suijker, Jacqueline J.; van Charente, Eric P. Moll] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.
   [MacNeil-Vroomen, Janet L.; van Rijn, Marjon; Buurman, Bianca M.; de Rooij, Sophia E.] Acad Med Ctr, Dept Internal Med, Geriatr Med Sect, Amsterdam, Netherlands.
   [de Rooij, Sophia E.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.
   [Bosmans, Judith E.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
   [Bosmans, Judith E.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Suijker, JJ (reprint author), Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.
EM b.m.vanes@amc.uva.nl
OI Bosmans, Judith/0000-0002-1443-1026
FU ZonMW 'The Netherlands Organization for Health Research and Development'
   (ZonMw) [313020201]; Dutch National Care for the Elderly Programme
FX This work was supported by ZonMW 'The Netherlands Organization for
   Health Research and Development' (ZonMw no. 313020201) and was part of
   the Dutch National Care for the Elderly Programme.
   http://www.zonmw.nl/en/.
CR Beaton K, 2014, GERIATRICS GERONTOLO
   Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348
   Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6
   Blom J, 2016, AGE AGEING, V45, P30, DOI 10.1093/ageing/afv174
   Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74
   Boumans CAM, 2010, HANDLEIDING KOSTENON
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Centraal Bureau voor de Statistiek, 2010, PRIJS
   Cesari M, 2014, J GERONTOLOGY A
   Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x
   Department of Health, 2001, NATIONAL SERVICE FRA
   Drubbel I NR, 2013, FRAILTY SCREENING OL
   Dutch College of General Practitioners, 2011, COR VAL GEN PRACT UT
   Eekhout I, 2014, J CLIN EPIDEMIOL, V67, P335, DOI 10.1016/j.jclinepi.2013.09.009
   Eklund K, 2009, HEALTH SOC CARE COMM, V17, P447, DOI 10.1111/j.1365-2524.2009.00844.x
   Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719
   Fairhall N, 2015, J AM MED DIR ASSOC, V16, P41, DOI 10.1016/j.jamda.2014.07.006
   Fairhall N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-120
   Faria R, 2014, PHARMACOECONOMICS, V32, P1157, DOI 10.1007/s40273-014-0193-3
   Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amerpe.2007.04.031
   Hardy SE, 2006, J GERONTOL A-BIOL, V61, P272, DOI 10.1093/gerona/61.3.272
   Health Counsil of the Netherlands, 2008, HLTH CAR ELD MULT
   Hebert R, 2010, J GERONTOL B-PSYCHOL, V65, P107, DOI 10.1093/geronb/gbp027
   Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298
   Jones R, 2004, FAM PRACT, V21, P597, DOI 10.1093/fampra/cmh603
   Kehusmaa S, 2010, J REHABIL MED, V42, P949, DOI 10.2340/16501977-0623
   Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574
   Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016
   Lin JS, 2012, J AM GERIATR SOC, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x
   Looman WM, 2016, FAMILY PRACTICE
   Lutomski JE, 2015, J CLIN EPIDEMIOLOGY
   Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941
   Mayo-Wilson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089257
   Melis RJF, 2008, J GERONTOL A-BIOL, V63, P275, DOI 10.1093/gerona/63.3.275
   Metzelthin SF, 2015, AGE AGEING, V44, P390, DOI 10.1093/ageing/afu200
   Rechel B, 2009, CAN HLTH SYSTEMS RES
   Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977
   Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022
   Stuck AE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001889
   Suijker JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158714
   Suijker JJ, 2014, J CLIN EPIDEMIOL, V67, P1121, DOI 10.1016/j.jclinepi.2014.05.014
   Suijker JJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-85
   van Dalen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093372
   van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037
   van Leeuwen KM, 2015, J AM GERIATR SOC, V63, P2494, DOI 10.1111/jgs.13834
   van Leeuwen KM, 2015, VALUE HEALTH, V18, P35, DOI 10.1016/j.jval.2014.09.006
   van Rijn M, 2016, AGE AGEING, V45, P894, DOI 10.1093/ageing/afw157
   WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
   Williamson EJ, 2014, RESPIROLOGY, V19, P303, DOI 10.1111/resp.12238
NR 54
TC 1
Z9 1
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2017
VL 12
IS 4
AR e0175272
DI 10.1371/journal.pone.0175272
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KD
UT WOS:000399874800019
PM 28414806
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lange, A
   Sunden-Cullberg, J
   Magnuson, A
   Hultgren, O
AF Lange, Anna
   Sunden-Cullberg, Jonas
   Magnuson, Anders
   Hultgren, Olof
TI Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in
   Sepsis and High Levels Are Associated with an Increased Risk of
   Mortality
SO PLOS ONE
LA English
DT Article
ID PROGRAMMED DEATH-1; IMPROVES SURVIVAL; SEPTIC SHOCK; COSTIMULATORY
   MOLECULES; CELL-ACTIVATION; PD-1; EXPRESSION; CTLA-4; BTLA; FORM
AB Introduction and aims
   B- and T-lymphocyte Attenuator (BTLA), Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed Death 1 (PD-1) are co-inhibitory receptors that regulate T cell activation. In the present study of ICU-treated patients we measured plasma concentrations of their soluble isoforms, with the aim to evaluate their potential as sepsis biomarkers and utility as prognostic indicators.
   Methods
   101 patients with sepsis, 28 patients with non-infectious critical illness (ICU controls) and 31 blood donors (healthy controls, HC) were included in the study. Plasma concentrations of soluble BTLA (sBTLA), CTLA-4 (sCTLA-4) and PD-1 (sPD-1) were measured with ELISA in serial blood samples. Comparisons were made with Mann-Whitney Utest and correlations were assessed with Spearman's Rank correlation test. Cox proportional hazard models, with sBTLA and sPD-1 as fixed and sBTLA as time-varying covariates, were used to determine association with 28-day mortality.
   Results
   sBTLA levels were significantly higher in the sepsis cohort (median 14 ng/mL, IQR 8-29) compared to ICU controls (9 ng/mL, IQR 5-26, p = 0.048) and HC (2.9 ng/mL, IQR 0.9-9.1, p<0.01), and correlated to SOFA score. sBTLA levels were higher in 28 day sepsis non-survivors than in survivors (baseline median 28 ng/mL, IQR 13-41 vs 13 ng/mL, IQR 8-23, p = 0.04). After adjustment for age and comorbidities, the relative risk of 28 day mortality was nearly 5-fold higher in sepsis patients with a baseline sBTLA > 21 ng/mL, compared to those with a level below this threshold. sBTLA was even more associated with mortality in the time-varying analysis. sPD-1 levels were lower in the sepsis cohort compared to HC but not compared to ICU controls and were not associated with mortality. sCTLA-4 was detectable in only one subject.
   Conclusion
   Plasma concentrations of soluble BTLA were increased early in sepsis/septic shock and correlated to severity of disease. A baseline concentration >21 ng/mL was associated with a poor prognosis.
C1 [Lange, Anna] Univ Orebro, Sch Med Sci, Dept Infect Dis, Orebro, Sweden.
   [Sunden-Cullberg, Jonas] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Infect Dis, Stockholm, Sweden.
   [Sunden-Cullberg, Jonas] Karolinska Univ Hosp Huddinge, Ctr Infect Med, Karolinska Inst, Stockholm, Sweden.
   [Magnuson, Anders] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden.
   [Hultgren, Olof] Univ Orebro, Sch Med Sci, Dept Microbiol & Immunol, Orebro, Sweden.
RP Lange, A (reprint author), Univ Orebro, Sch Med Sci, Dept Infect Dis, Orebro, Sweden.
EM anna.lange@regionorebrolan.se
FU Research Committee Region Orebro County; Nyckelfonden Region Orebro
   County; Olle Engkvist fund; Signe and Olof Wallenius trust; ALF;
   Karolinska University Hospital, Huddinge, Research Foundation
FX The study was conducted with the financial support from research grants
   from the Research Committee Region Orebro County, Nyckelfonden Region
   Orebro County, the Olle Engkvist fund, the Signe and Olof Wallenius
   trust, ALF project funding, and the Karolinska University Hospital,
   Huddinge, Research Foundation.
CR Atesoglu EB, 2014, CLIN APPL THROMB HEM
   Bernard A, 2002, TRANSPLANTATION, V73, pS31, DOI 10.1097/00007890-200201151-00011
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404
   Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829
   Boulougouris G, 1998, J IMMUNOL, V161, P3919
   Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037
   Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x
   Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711
   Chen H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086214, 10.1371/journal.pone.0085631]
   Cheng TT, 2016, SHOCK, V45, P40, DOI 10.1097/SHK.0000000000000479
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214
   Greisen SR, 2014, SCAND J RHEUMATOL, V43, P101, DOI 10.3109/03009742.2013.823517
   Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112
   Hamers L, 2015, MINERVA ANESTESIOL, V81, P426
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552
   Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce
   Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Liu CP, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0859-z
   Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y
   Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649
   Oya Y, 2008, ARTHRITIS RHEUM-US, V58, P2498, DOI 10.1002/art.23674
   Roger PM, 2012, J CRIT CARE, V27, P384, DOI 10.1016/j.jcrc.2012.04.010
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003
   Saverino D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112509
   Schulte W, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/165974
   Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289
   Shao R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1024-4
   Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131
   Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641
   Simone R, 2014, SOLUBLE FORM CTLA 4, V2014
   Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069
   Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026
   Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727
   Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844
   Wang X, APPL MONOCLONAL ANTI, P1557
   Wang X., 2012, MATH PROBL ENG, V2012, P12, DOI DOI 10.1016/J.AUTC0N.2012.10.012
   Wang XF, 2007, TISSUE ANTIGENS, V69, P145, DOI 10.1111/j.1399-0039.2006.00710.x
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Yanaba K, 2016, J DERMATOL
   Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059
   Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354
NR 48
TC 10
Z9 11
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2017
VL 12
IS 1
AR e0169176
DI 10.1371/journal.pone.0169176
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH3AE
UT WOS:000391639100023
PM 28056053
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Raykov, YP
   Boukouvalas, A
   Baig, F
   Little, MA
AF Raykov, Yordan P.
   Boukouvalas, Alexis
   Baig, Fand
   Little, Max A.
TI What to Do When K-Means Clustering Fails: A Simple yet Principled
   Alternative Algorithm
SO PLOS ONE
LA English
DT Article
ID DIRICHLET PROCESS MIXTURE; PARKINSONS-DISEASE; HETEROGENEITY; INFERENCE;
   SUBTYPES; MODEL
AB The K-means algorithm is one of the most popular clustering algorithms in current use as it is relatively fast yet simple to understand and deploy in practice. Nevertheless, its use entails certain restrictive assumptions about the data, the negative consequences of which are not always immediately apparent, as we demonstrate. While more flexible algorithms have been developed, their widespread use has been hindered by their computational and technical complexity. Motivated by these considerations, we present a flexible alternative to K-means that relaxes most of the assumptions, whilst remaining almost as fast and simple. This novel algorithm which we call MAP-DP (maximum a-posteriori Dirichlet process mixtures), is statistically rigorous as it is based on nonparametric Bayesian Dirichlet process mixture modeling. This approach allows us to overcome most of the limitations imposed by K-means. The number of clusters K is estimated from the data instead of being fixed a-priori as in K-means. In addition, while K-means is restricted to continuous data, the MAP-DP framework can be applied to many kinds of data, for example, binary, count or ordinal data. Also, it can efficiently separate outliers from the data. This additional flexibility does not incur a significant computational overhead compared to K-means with MAP-DP convergence typically achieved in the order of seconds for many practical problems. Finally, in contrast to K-means, since the algorithm is based on an underlying statistical model, the MAP-DP framework can deal with missing data and enables model testing such as cross validation in a principled way. We demonstrate the simplicity and effectiveness of this algorithm on the health informatics problem of clinical sub-typing in a cluster of diseases known as parkinsonism.
C1 [Raykov, Yordan P.; Little, Max A.] Aston Univ, Sch Math, Birmingham, W Midlands, England.
   [Boukouvalas, Alexis] Univ Manchester, Mol Sci, Manchester, Lancs, England.
   [Baig, Fand] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.
   [Little, Max A.] MIT, Media Lab, Cambridge, MA 02139 USA.
RP Raykov, YP (reprint author), Aston Univ, Sch Math, Birmingham, W Midlands, England.
EM yordan.raykov@gmail.com
FU Aston research centre for healthy ageing; National Institutes of Health;
   Parkinson's UK [J-1403]
FX This work was supported by Aston research centre for healthy ageing and
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027
   Beal M, 2002, ADV NEURAL INFORM PR, V14
   Berkhin P., 2006, GROUPING MULTIDIMENS, P25
   Bischof H, 1999, PATTERN ANAL APPL, V2, P59, DOI 10.1007/s100440050015
   Bishop C., 2006, PATTERN RECOGNITION
   BLACKWELL D, 1947, ANN MATH STAT, V18, P105, DOI 10.1214/aoms/1177730497
   Blei D., 2004, 21 INT C MACH LEARN
   Bogner C, 2013, ECOL INFORM, V15, P44, DOI 10.1016/j.ecoinf.2013.03.001
   Bordogna G, 2012, KNOWL-BASED SYST, V26, P9, DOI 10.1016/j.knosys.2011.06.012
   Bouveyron C, 2007, COMPUT STAT DATA AN, V52, P502, DOI 10.1016/j.csda.2007.02.009
   Casella G, 1996, BIOMETRIKA, V83, P81, DOI 10.1093/biomet/83.1.81
   Celebi ME, 2013, EXPERT SYST APPL, V40, P200, DOI 10.1016/j.eswa.2012.07.021
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Fei-Fei L, 2005, IEEE COMP SOC C COMP, V2
   Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014
   Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078
   Gershman SJ, 2012, J MATH PSYCHOL, V56, P1, DOI 10.1016/j.jmp.2011.08.004
   Griffiths TL, 2011, J MACH LEARN RES, V12, P1185
   Hamerly G., 2003, ADV NEURAL INFORM PR
   Hjort NL, 2010, BAYESIAN NONPARAMETR, V28
   Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318
   Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504
   Jain S, 2007, BAYESIAN ANAL, V2, P445, DOI 10.1214/07-BA219
   Jiang Ke, 2012, ADV NEURAL INFORM PR, V25, P3158
   Kurlan R, 2007, MOVEMENT DISORD, V22, P904, DOI 10.1002/mds.21415
   Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530
   Liu P, 2011, J ZHEJIANG UNIV-SC B, V12, P694, DOI 10.1631/jzus.B1100069
   LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489
   Luo C, 2014, ADV KNOWLEDGE DISCOV, P548
   MacEachern SN, 1998, J COMPUT GRAPH STAT, V7, P223, DOI 10.2307/1390815
   Molenberghs G, 2008, J ROY STAT SOC B, V70, P371, DOI 10.1111/j.1467-9868.2007.00640.x
   MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098
   Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653
   Neal RM, 2003, ANN STAT, V31, P705, DOI 10.1214/aos/1056562461
   Pelleg D., 2000, P 17 INT C MACH LEAR, V17, P727, DOI DOI 10.1007/3-540-44491-2_3
   Pitman J, 1997, ANN PROBAB, V25, P855
   Rabiner L. R., 1986, IEEE ASSP Magazine, V3, P4, DOI 10.1109/MASSP.1986.1165342
   Rasmussen C. E., 1999, P ADV NEURAL INFORM, V12, P554
   Raykov YP, ITERATIVE COLLAPSED
   Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Saeed F, 2013, MOL INFORM, V32, P591, DOI 10.1002/minf.201300004
   Snoek J., 2012, ADV NEURAL INFORM PR, V25, P2951
   Sung KK, 1998, IEEE T PATTERN ANAL, V20, P39, DOI 10.1109/34.655648
   Teh Y. W., 2010, ENCY MACHINE LEARNIN, P280, DOI DOI 10.1007/978-0-387-30164-8_219
   van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116
   Welling M, 2006, SIAM PROC S, P474
   Whye Teh Yee, 2006, J AM STAT ASSOC, V101, P476, DOI DOI 10.1198/016214506000000302
   Yang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091906
   Zhang W, 2010, KNOWL-BASED SYST, V23, P379, DOI 10.1016/j.knosys.2010.01.011
NR 50
TC 11
Z9 11
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2016
VL 11
IS 9
AR e0162259
DI 10.1371/journal.pone.0162259
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX1ZV
UT WOS:000384167300005
PM 27669525
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vroomen, JM
   Bosmans, JE
   Eekhout, I
   Joling, KJ
   van Mierlo, LD
   Meiland, FJM
   van Hout, HPJ
   de Rooij, SE
AF Vroomen, Janet MacNeil
   Bosmans, Judith E.
   Eekhout, Iris
   Joling, Karlijn J.
   van Mierlo, Lisa D.
   Meiland, Franka J. M.
   van Hout, Hein P. J.
   de Rooij, Sophia E.
TI The Cost- Effectiveness of Two Forms of Case Management Compared to a
   Control Group for Persons with Dementia and Their Informal Caregivers
   from a Societal Perspective
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIALS; QUALITY-OF-LIFE; ECONOMIC-EVALUATION;
   MISSING DATA; HEALTH-CARE; UTILITY; DESIGN; NEED
AB Objectives
   The objective of this article was to compare the costs and cost-effectiveness of the two most prominent types of case management in the Netherlands (intensive case management and linkage models) against no access to case management (control group) for people with already diagnosed dementia and their informal caregivers.
   Methods
   The economic evaluation was conducted from a societal perspective embedded within a two year prospective, observational, controlled, cohort study with 521 informal caregivers and community-dwelling persons with dementia. Case management provided within one care organization (intensive case management model, ICMM), case management where care was provided by different care organizations within one region (Linkage model, LM), and a group with no access to case management (control) were compared. The economic evaluation related incremental costs to incremental effects regarding neuropsychiatric symptoms (NPI), psychological health of the informal caregiver (GHQ-12), and quality adjusted life years (QALY) of the person with dementia and informal caregiver.
   Results
   Inverse-propensity-score-weighted models showed no significant differences in clinical or total cost outcomes between the three groups. Informal care costs were significantly lower in the ICMM group compared to both other groups. Day center costs were significantly lower in the ICMM group compared to the control group. For all outcomes, the probability that the ICMM was cost-effective in comparison with LM and the control group was larger than 0.97 at a threshold ratio of 0 (sic)/incremental unit of effect.
   Conclusion
   This study provides preliminary evidence that the ICMM is cost-effective compared to the control group and the LM. However, the findings should be interpreted with caution since this study was not a randomized controlled trial.
C1 [Vroomen, Janet MacNeil; de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Geriatr Med Sect, Dept Internal Med, Amsterdam, Netherlands.
   [Vroomen, Janet MacNeil] Yale Sch Med, Dept Biostat, New Haven, CT USA.
   [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.
   [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Eekhout, Iris] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands.
   [Joling, Karlijn J.; van Mierlo, Lisa D.; Meiland, Franka J. M.; van Hout, Hein P. J.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
   [Joling, Karlijn J.; van Mierlo, Lisa D.; Meiland, Franka J. M.; van Hout, Hein P. J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [de Rooij, Sophia E.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Dept Internal Med, Groningen, Netherlands.
RP Vroomen, JM (reprint author), Univ Amsterdam, Acad Med Ctr, Geriatr Med Sect, Dept Internal Med, Amsterdam, Netherlands.; Vroomen, JM (reprint author), Yale Sch Med, Dept Biostat, New Haven, CT USA.
EM janet.macneilvroomen@yale.edu
OI Bosmans, Judith/0000-0002-1443-1026
FU Dutch National Programme for Improving Care for Older Persons (ZonMw)
   [313080201]; Yale Claude D. Pepper Older Americans Independence Center
   [P30AG021342]
FX Research funding was provided by a governmental grant by the Dutch
   National Programme for Improving Care for Older Persons (ZonMw no
   313080201, www.zonmw.nl). The primary author was also funded by the Yale
   Claude D. Pepper Older Americans Independence Center (P30AG021342,
   http://medicine.yale.edu/intmed/geriatrics/peppercenter/) during the
   revision stage of this manuscript. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alzheimer Europe, 2006, WHO CAR STAT DEM CAR
   Alzheimer's Disease International, 2010, WORLD ALZHEIMER REPO
   [Anonymous], 2012, DEM PUBL HLTH PRIOR
   Banks P, 2004, INTEGRATING SERVICES, P101
   Briggs A, 2000, BRIT MED J, V321, P1362, DOI 10.1136/bmj.321.7273.1362
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Case Management Society of America, 2015, WHAT IS CAS MAN
   Centraal Bureau voor de Statistiek, 2010, PRIJS
   Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S
   Faria R, 2014, PHARMACOECONOMICS, V32, P1157, DOI 10.1007/s40273-014-0193-3
   Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903
   GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644
   Hakkart-van Roijen L, 2010, HANDLEIDING KOSTENON
   index Z, 2009, IND Z G STAND
   Jansen APD, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-133
   Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042145
   Joling KJ, 2010, AM J GERIAT PSYCHIAT, V18, P146, DOI 10.1097/JGP.0b013e3181bf9f0f
   Khanassov V, 2014, CLIN INTERV AGING, V9, P915, DOI 10.2147/CIA.S64723
   Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574
   MacNeil Vroomen J., 2015, EUR J HLTH EC
   Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944
   McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753
   McPhail S, 2008, MED CARE, V46, P1140, DOI 10.1097/MLR.0b013e31817d69a6
   Ministry of Health Welfare and Sport, 2009, GUID INT DEM CAR EXC
   Nixon RM, 2010, HEALTH ECON, V19, P316, DOI 10.1002/hec.1477
   Oostenbrink JB, 2004, HANDLEIDING KOSTENON
   Peeters JM, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-9
   Pimouguet C, 2010, J NUTR HEALTH AGING, V14, P669, DOI 10.1007/s12603-010-0314-4
   Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610506003462
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   R Core Team, 2014, R LANG ENV STAT COMP
   Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schafer J. L, 1997, ANAL INCOMPLETE MULT
   Schoenmakers B, 2010, MATURITAS, V66, P191, DOI 10.1016/j.maturitas.2010.02.009
   Stata Corp LP, 2011, STAT STAT SOFTW REL
   van Buuren S, 2012, FLEXIBLE IMPUTATION
   Van der Roest HG, 2008, ST HEAL T, V137, P210
   Van Mierlo LD, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-84
   Vroomen JM, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.011
   Vroomen JM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-132
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
   Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033
   Willan AR, 2006, STAT ANAL COST EFFEC
   Zwaanswijk Marieke, 2013, Open Nurs J, V7, P6, DOI 10.2174/1874434601307010006
NR 45
TC 6
Z9 6
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 21
PY 2016
VL 11
IS 9
AR e0160908
DI 10.1371/journal.pone.0160908
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW8GK
UT WOS:000383892700005
PM 27655234
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Qian, T
   Masino, AJ
AF Qian, Ting
   Masino, Aaron J.
TI Latent Patient Cluster Discovery for Robust Future Forecasting and
   New-Patient Generalization
SO PLOS ONE
LA English
DT Article
ID MISSING DATA; CLINICAL-TRIALS; CONCEPT DRIFT; MODELS; MIXTURE
AB Commonly referred to as predictive modeling, the use of machine learning and statistical methods to improve healthcare outcomes has recently gained traction in biomedical informatics research. Given the vast opportunities enabled by large Electronic Health Records (EHR) data and powerful resources for conducting predictive modeling, we argue that it is yet crucial to first carefully examine the prediction task and then choose predictive methods accordingly. Specifically, we argue that there are at least three distinct prediction tasks that are often conflated in biomedical research: 1) data imputation, where a model fills in the missing values in a dataset, 2) future forecasting, where a model projects the development of a medical condition for a known patient based on existing observations, and 3) newpatient generalization, where a model transfers the knowledge learned from previously observed patients to newly encountered ones. Importantly, the latter two tasks-future forecasting and new-patient generalizations-tend to be more difficult than data imputation as they require predictions to be made on potentially out-of-sample data (i.e., data following a different predictable pattern from what has been learned by the model). Using hearing loss progression as an example, we investigate three regression models and show that the modeling of latent clusters is a robust method for addressing the more challenging prediction scenarios. Overall, our findings suggest that there exist significant differences between various kinds of prediction tasks and that it is important to evaluate the merits of a predictive model relative to the specific purpose of a prediction task.
C1 [Qian, Ting; Masino, Aaron J.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.
RP Qian, T (reprint author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.
EM qiant@email.chop.edu
CR Aldous D. J., 1983, ECOLE ETE PROBABILIT, P1, DOI 10.1007/BFb0099421
   Bach S. H., 2010, ADV NEURAL INFORM PR, V23, P127
   Bates D, 2015, J STAT SOFTW, V67, P1
   Carpenter J, 2002, STAT MED, V21, P1043, DOI 10.1002/sim.1065
   Chao TK, 2009, J EVAL CLIN PRACT, V15, P32, DOI 10.1111/j.1365-2753.2008.00949.x
   Davis SE, 2016, AMIA 7 ANN JOINT SUM
   Fong A, 2015, J BIOMED INFORM, V58, P89, DOI 10.1016/j.jbi.2015.09.011
   Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101
   Grun B, 2007, COMPUT STAT DATA AN, V51, P5247, DOI 10.1016/j.csda.2006.08.014
   Hall JW, 1981, INT J PEDIATR OTORHI, V2, P156
   Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145
   Huang ZX, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9915-2
   Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018
   Jung K, 2015, J BIOMED INFORM, V58, P168, DOI 10.1016/j.jbi.2015.10.006
   Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001
   Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730
   MacEachern SN, 1998, J COMPUT GRAPH STAT, V7, P223, DOI 10.2307/1390815
   R Core Team, 2015, R LANG ENV STAT COMP
   Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410
   Roberts SJ, 1998, IEEE T PATTERN ANAL, V20, P1133, DOI 10.1109/34.730550
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rubin DB, 2004, MULTIPLE IMPUTATION
   Sajda P, 2006, ANNU REV BIOMED ENG, V8, P537, DOI 10.1146/annurev.bioeng.8.061505.095802
   Speier W, 2016, J BIOMED INFORM, V61, P260, DOI 10.1016/j.jbi.2016.04.005
   Sterne JAC, 2009, BMJ-BRIT MED J, V338, P1, DOI [DOI 10.1136/BMJ.B2393), DOI 10.1136/BMJ.B2393]
   Taslimitehrani V, 2016, J BIOMED INFORM, V60, P260, DOI 10.1016/j.jbi.2016.01.009
   Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302
   Tsymbal A, 2006, COMP MED SY, P679, DOI 10.1109/CBMS.2006.94
   Wang TT, 2016, J BIOMED INFORM, V61, P247, DOI 10.1016/j.jbi.2016.04.008
   Widmer G, 1996, MACH LEARN, V23, P69, DOI 10.1023/A:1018046501280
   Zliobaite I, 2010, ABS10104784 ARXIV CO, P1
NR 31
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2016
VL 11
IS 9
AR e0162812
DI 10.1371/journal.pone.0162812
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW5YN
UT WOS:000383723700016
PM 27636203
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Doering, S
   Bose-O'Reilly, S
   Berger, U
AF Doering, Stefan
   Bose-O'Reilly, Stephan
   Berger, Ursula
TI Essential Indicators Identifying Chronic Inorganic Mercury Intoxication:
   Pooled Analysis across Multiple Cross-Sectional Studies
SO PLOS ONE
LA English
DT Article
ID GOLD MINING AREAS; ENVIRONMENTAL ASSESSMENT; RISK-ASSESSMENT; MISSING
   DATA; EXPOSURE; CONTAMINATION; HEALTH; MINERS; PHILIPPINES; CHILDREN
AB Background
   The continuous exposure to inorganic mercury vapour in artisanal small-scale gold mining (ASGM) areas leads to chronic health problems. It is therefore essential to have a quick, but reliable risk assessing tool to diagnose chronic inorganic mercury intoxication. This study re-evaluates the state-of-the-art toolkit to diagnose chronic inorganic mercury intoxication by analysing data from multiple pooled cross-sectional studies. The primary research question aims to reduce the currently used set of indicators without affecting essentially the capability to diagnose chronic inorganic mercury intoxication. In addition, a sensitivity analysis is performed on established biomonitoring exposure limits for mercury in blood, hair, urine and urine adjusted by creatinine, where the biomonitoring exposure limits are compared to thresholds most associated with chronic inorganic mercury intoxication in artisanal small-scale gold mining.
   Methods
   Health data from miners and community members in Indonesia, Tanzania and Zimbabwe were obtained as part of the Global Mercury Project and pooled into one dataset together with their biomarkers mercury in urine, blood and hair. The individual prognostic impact of the indicators on the diagnosis of mercury intoxication is quantified using logistic regression models. The selection is performed by a stepwise forward/backward selection. Different models are compared based on the Bayesian information criterion (BIC) and Cohen's kappa is used to evaluate the level of agreement between the diagnosis of mercury intoxication based on the currently used set of indicators and the result based on our reduced set of indicators. The sensitivity analysis of biomarker exposure limits of mercury is based on a sequence of chi square tests.
   Results
   The variable selection in logistic regression reduced the number of medical indicators from thirteen to ten in addition to the biomarkers. The estimated level of agreement using ten of thirteen medical indicators and all four biomarkers to diagnose chronic inorganic mercury intoxication yields a Cohen's Kappa of 0.87. While in an additional stepwise selection the biomarker blood was not selected, the level of agreement based on ten medical indicators and only the three biomarkers urine, urine/creatinine and hair reduced Cohen's Kappa to 0.46. The optimal cut-point for the biomarkers blood, hair, urine and urine/creatinine were estimated at 11. 6 mu g/l, 3.84 mu g/g, 24.4 mu g/l and 4.26 mu g/g, respectively.
   Conclusion
   The results show that a reduction down to only ten indicators still allows a reliable diagnosis of chronic inorganic mercury intoxication. This reduction of indicators will simplify health assessments in artisanal small-scale gold mining areas.
C1 [Doering, Stefan; Bose-O'Reilly, Stephan] Univ Hosp Munich, WHO Collaborating Ctr Occupat Hlth, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.
   [Doering, Stefan; Berger, Ursula] Univ Munich, Dept Med Informat Sci Biometr & Epidemiol IBE, Munich, Germany.
   [Bose-O'Reilly, Stephan] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Innsbruck, Austria.
RP Bose-O'Reilly, S (reprint author), Univ Hosp Munich, WHO Collaborating Ctr Occupat Hlth, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.; Bose-O'Reilly, S (reprint author), UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Innsbruck, Austria.
EM stephan.boeseoreilly@med.uni-muenchen.de
FU "Global Environment Facility" (GEF), via "United Nations Industrial
   Organization" (UNIDO); World Health Organization" (WHO); "Ministry of
   Health of Mongolia"; DG Research [603946]
FX "Global Environment Facility" (GEF) funded, via "United Nations
   Industrial Organization" (UNIDO), the projects in the Philippines,
   Indonesia, Tanzania and Zimbabwe as part of the "Global Mercury Project"
   (GMP). The second project in Zimbabwe in 2006 was funded by a personal
   grant from Beate Lettmeier including in kind contributions from the
   "University of Munich" (LMU, Munich, Germany) and the "University for
   Health Sciences, Medical Informatics and Technology" (UMIT, Hall in
   Tirol, Austria). "World Health Organization" (WHO) and the "Ministry of
   Health of Mongolia" funded the projects in Mongolia. Additionally the
   "National Institute of Minamata Disease" (Minamata, Kumamoto, Japan) and
   the "Health and Safety Laboratory" (Harpur Hill, Buxton, United Kingdom
   gave in kind contributions to the Mongolian project. Two of the authors
   (SD, SB) receive money for the European Union project HEALS (Health and
   Environment-wide Associations based on Large Population Surveys). HEALS
   is funded by DG Research (Grant agreement no: 603946).
CR Akagi H, 2000, SCI TOTAL ENVIRON, V259, P31, DOI 10.1016/S0048-9697(00)00547-7
   Appleton JD, 2006, SCI TOTAL ENVIRON, V354, P198, DOI 10.1016/j.scitotenv.2005.01.042
   Appleton JD, 1999, SCI TOTAL ENVIRON, V228, P95, DOI 10.1016/S0048-9697(99)00016-9
   Appleton JD, 2004, CR04129 UNIDO EGGLO0
   Ashe K., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033305, DOI 10.1371/J0URNAL.P0NE.0033305]
   Baeuml J, 2011, MINERAL-BASEL, V1, P122, DOI 10.3390/min1010122
   Baeuml J, 2011, INT J HYG ENVIR HEAL, V215, P64, DOI 10.1016/j.ijheh.2011.06.005
   Basu N, 2015, INT J ENV RES PUB HE, V12, P5143, DOI 10.3390/ijerph120505143
   Beate L, 2010, SCI TOTAL ENVIRON, V408, P3530, DOI 10.1016/j.scitotenv.2010.04.027
   Bose-O'Reilly S, 2004, 03089 UNIDO EGGLO01G
   Bose-O'Reilly S, 2009, FIELD MISSION STUDY
   Bose-O'Reilly S, 2008, ENVIRON RES, V107, P89, DOI 10.1016/j.envres.2008.01.009
   Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P796, DOI 10.1016/j.scitotenv.2009.10.051
   Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P713, DOI 10.1016/j.scitotenv.2009.10.070
   Castilhos Z, 2015, ENVIRON SCI POLLUT R, V22, P11255, DOI 10.1007/s11356-015-4340-y
   Castilhos ZC, 2006, SCI TOTAL ENVIRON, V368, P320, DOI 10.1016/j.scitotenv.2006.01.039
   Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619
   Cordy P, 2011, SCI TOTAL ENVIRON, V410, P154, DOI 10.1016/j.scitotenv.2011.09.006
   Corral S, 2013, TOXICOL ENVIRON CHEM, V95, P344, DOI 10.1080/02772248.2013.766191
   Cortes-Maramba N, 2006, J ENVIRON MANAGE, V81, P126, DOI [10.1016/j.jenvman.2006.01.019, 10.1016/j.jenvman.2006.02.013]
   Counter SA, 2006, INT J OCCUP ENV HEAL, V12, P209, DOI 10.1179/oeh.2006.12.3.209
   Counter SA, 2005, INT J OCCUP ENV HEAL, V11, P132, DOI 10.1179/oeh.2005.11.2.132
   da Costa GM, 2008, ENVIRON RES, V107, P98, DOI 10.1016/j.envres.2007.08.004
   de Kom JFM, 1998, ENVIRON RES, V77, P91, DOI 10.1006/enrs.1998.3835
   Drasch G, 2001, SCI TOTAL ENVIRON, V267, P151, DOI 10.1016/S0048-9697(00)00806-8
   Drasch G., 2004, ELEMENTS THEIR COMPO, P931, DOI DOI 10.1002/9783527619634
   Gibb H, 2014, ENVIRON HEALTH PERSP, V122, P667, DOI 10.1289/ehp.1307864
   Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23
   Harari R, 1997, AM J IND MED, V32, P185, DOI 10.1002/(SICI)1097-0274(199709)32:3<185::AID-AJIM1>3.0.CO;2-X
   Kristensen AKB, 2014, INT ARCH OCC ENV HEA, V87, P579, DOI 10.1007/s00420-013-0902-9
   Lockowandt O, 1996, FROSTIGS DEV TEST VI, DOI [10.1016/j.ijheh.2011.06.007, DOI 10.1016/J.IJHEH.2011.06.007]
   Masur H., 2000, SCALES SCORES NEUROL
   Mazzachi B C, 2000, Clin Lab, V46, P53
   Nordberg GF, 2015, HDB TOXICOLOGY METAL
   Olivero-Verbel J, 2011, BIOL TRACE ELEM RES, V144, P118, DOI 10.1007/s12011-011-9046-5
   Paruchuri Y, 2010, SCI TOTAL ENVIRON, V408, P6079, DOI 10.1016/j.scitotenv.2010.08.022
   RISHER J, 2004, TOXICOLOGICAL PROFIL
   Rodrigues-Filho S, 2004, ENV HLTH ASSESSMENT
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Saunders JE, 2013, AUDIOL NEURO-OTOL, V18, P101, DOI 10.1159/000345470
   Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA424, DOI 10.1289/ehp.120-a424
   Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007
   Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312
   Spiegel SJ, 2005, LANCET, V366, P2070, DOI 10.1016/S0140-6736(05)67868-3
   Steckling N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-111
   Steckling N, 2011, SCI TOTAL ENVIRON, V409, P994, DOI 10.1016/j.scitotenv.2010.11.029
   Suvd D, 2015, PROCEDIA ENVIRON SCI, V30, P97, DOI 10.1016/j.proenv.2015.10.017
   Taylor H, 2005, SCI TOTAL ENVIRON, V343, P111, DOI 10.1016/j.scitotenv.2004.09.042
   Tomicic C, 2011, INT ARCH OCC ENV HEA, V84, P539, DOI 10.1007/s00420-011-0615-x
   UNEP Chemicals Branch, 2013, GLOB MERC ASS, DOI [10.1016/j.scitotenv.2010.08.022, DOI 10.1016/J.SCITOTENV.2010.08.022]
   van Straaten P, 2000, SCI TOTAL ENVIRON, V259, P105, DOI 10.1016/S0048-9697(00)00553-2
   van Wijngaarden E, 2013, NEUROTOXICOL TERATOL, V39, P19, DOI 10.1016/j.ntt.2013.06.003
   Williams BA, 2006, FINDING OPTIMAL CUTP
   Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177
   Yard EE, 2012, J MED TOXICOL, V8, P441, DOI 10.1007/s13181-012-0252-0
   Zimmer R., 1987, MOTOR FUNCTION TEST
NR 56
TC 7
Z9 7
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2016
VL 11
IS 8
AR e0160323
DI 10.1371/journal.pone.0160323
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV4EE
UT WOS:000382877200006
PM 27575533
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xiao, J
   Xu, QQ
   Wu, CL
   Gao, YX
   Hua, TQ
   Xu, CW
AF Xiao, Jing
   Xu, Qiongqiong
   Wu, Chuanli
   Gao, Yuexia
   Hua, Tianqi
   Xu, Chenwu
TI Performance Evaluation of Missing-Value Imputation Clustering Based on a
   Multivariate Gaussian Mixture Model
SO PLOS ONE
LA English
DT Article
AB Background
   It is challenging to deal with mixture models when missing values occur in clustering datasets.
   Methods and Results
   We propose a dynamic clustering algorithm based on a multivariate Gaussian mixture model that efficiently imputes missing values to generate a "pseudo-complete" dataset. Parameters from different clusters and missing values are estimated according to the maximum likelihood implemented with an expectation-maximization algorithm, and multivariate individuals are clustered with Bayesian posterior probability. A simulation showed that our proposed method has a fast convergence speed and it accurately estimates missing values. Our proposed algorithm was further validated with Fisher's Iris dataset, the Yeast Cell-cycle Gene-expression dataset, and the CIFAR-10 images dataset. The results indicate that our algorithm offers highly accurate clustering, comparable to that using a complete dataset without missing values. Furthermore, our algorithm resulted in a lower misjudgment rate than both clustering algorithms with missing data deleted and with missing-value imputation by mean replacement.
   Conclusion
   We demonstrate that our missing-value imputation clustering algorithm is feasible and superior to both of these other clustering algorithms in certain situations.
C1 [Xiao, Jing; Xu, Qiongqiong; Wu, Chuanli; Gao, Yuexia; Hua, Tianqi] Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Nantong 226019, Peoples R China.
   [Xu, Chenwu] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Genom,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.
RP Xu, CW (reprint author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Genom,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.
EM qtls@yzu.edu.cn
FU National Natural Science Foundation of China [31000539, 31391632,
   91535103]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions; National High-tech RAMP;D Program (863 Program)
   [2014AA10A601-5]; Natural Science Foundations of Jiangsu Province
   [BK20150010]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions [14KJA210005]
FX The research was supported by grants from the National Natural Science
   Foundation of China (31000539, 31391632 and 91535103), the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   the National High-tech R&D Program (863 Program, 2014AA10A601-5), the
   Natural Science Foundations of Jiangsu Province (BK20150010) and the
   Natural Science Foundation of the Jiangsu Higher Education Institutions
   (14KJA210005). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Carpenter J, 2012, MULTIPLE IMPUTATION
   Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8
   Dasgupta A, 1998, J AM STAT ASSOC, V93, P294, DOI 10.2307/2669625
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ghahramani Z., 1993, ADV NEURAL INFORM PR, V6, P120
   Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340
   Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830
   Hathaway RJ, 2001, IEEE T SYST MAN CY B, V31, P735, DOI 10.1109/3477.956035
   Hayes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052881
   Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126
   Hunt L, 2003, COMPUT STAT DATA AN, V41, P429, DOI 10.1016/S0167-9473(02)00190-1
   Jiao YB, 2013, SCI WORLD J, DOI 10.1155/2013/427072
   Johnoson RA, 1992, APPL MULTIVARIATE ST, P532
   Krizhevsky A., 2009, THESIS
   Li SY., 2004, ENGINEERING FUZZY MA
   MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1234/12345678
   McLachlan G.J., 1988, MIXTURE MODELS INFER
   Podofillini L, 2010, RELIAB ENG SYST SAFE, V95, P534, DOI 10.1016/j.ress.2010.01.004
   Qu Y, 2004, BIOINFORMATICS, V20, P1905, DOI 10.1093/bioinformatics/bth177
   Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576
   Rubin D. B, 1978, P SURV RES METH SECT, P20
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Sebzalli YM, 2001, ENG APPL ARTIF INTEL, V14, P607, DOI 10.1016/S0952-1976(01)00032-X
   SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O
   Shao J., 2000, J OFF STAT, V16, P113
   Si YQ, 2014, BIOINFORMATICS, V30, P197, DOI 10.1093/bioinformatics/btt632
   Siminski K, 2013, FUND INFORM, V123, P331, DOI 10.3233/FI-2013-814
   Titterington D., 1985, STAT ANAL FINITE MIX
   Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520
   Wang SC, 2006, LECT NOTES COMPUT SC, V4304, P1145
   Wylie MP, 1996, ICUPC '96 - 1996 5TH IEEE INTERNATIONAL CONFERENCE ON UNIVERSAL PERSONAL COMMUNICATIONS RECORD, VOLS 1 AND 2, P827, DOI 10.1109/ICUPC.1996.562692
   [ YANG Jun], 2008, [, Application of Statistics and Management], V27, P821
   Yang YH, 2003, INTERDISC STAT, P35
   Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977
   Zhang YT, 1983, INTRO MULTIVARIATE S, P401
NR 37
TC 1
Z9 1
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2016
VL 11
IS 8
AR e0161112
DI 10.1371/journal.pone.0161112
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT8TR
UT WOS:000381768800022
PM 27552203
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Swain, CA
   Smith, LC
   Nash, D
   Pulver, WP
   Lazariu, V
   Anderson, BJ
   Warren, BL
   Birkhead, GS
   McNutt, LA
AF Swain, Carol-Ann
   Smith, Lou C.
   Nash, Denis
   Pulver, Wendy P.
   Lazariu, Victoria
   Anderson, Bridget J.
   Warren, Barbara L.
   Birkhead, Guthrie S.
   McNutt, Louise-Anne
TI Postpartum Loss to HIV Care and HIV Viral Suppression among Previously
   Diagnosed HIV-Infected Women with a Live Birth in New York State
SO PLOS ONE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; LOW-INCOME;
   FOLLOW-UP; PROGRAM; TRANSMISSION; ENGAGEMENT; ADHERENCE; OUTCOMES;
   COHORT
AB Mother-to-child-transmission of HIV in the United States has been greatly reduced, with clear benefits for the child. However, little is known about factors that predict maternal loss to HIV care in the postpartum year. This retrospective cohort study included 980 HIV-positive women, diagnosed with HIV at least one year before pregnancy, who had a live birth during 2008-2010 in New York State. Women who did not meet the following criterion in the 12 months after the delivery-related hospital discharge were considered to be lost to HIV care: two or more laboratory tests (CD4 or HIV viral load), separated by at least 90 days. Adjusted relative risks (aRR) and 95% confidence intervals (CI) for predictors of postpartum loss to HIV care were identified with Poisson regression, solved using generalized estimating equations. Having an unsuppressed (>200 copies/mL) HIV viral load in the postpartum year was also evaluated. Overall, 24% of women were loss to HIV care during the postpartum year. Women with low participation in HIV care during preconception were more likely to be lost to HIV care during the postpartum year (aRR: 2.70; 95% CI: 2.09-3.49). In contrast, having a low birth weight infant was significantly associated with a decreased likelihood of loss to HIV care (aRR: 0.72; 95% CI: 0.53-0.98). While 75% of women were virally suppressed at the last viral load before delivery only 44% were continuously suppressed in the postpartum year; 12% had no viral load test reported in the postpartum year and 44% had at least one unsuppressed viral load test. Lack of engagement in preconception HIV-related health care predicts postpartum loss to HIV care for HIV-positive parturient women. Many women had poor viral control during the postpartum period, increasing the risk of disease progression and infectivity.
C1 [Swain, Carol-Ann; Smith, Lou C.; Anderson, Bridget J.; Warren, Barbara L.] New York State Dept Hlth, AIDS Inst, Albany, NY 12237 USA.
   [Swain, Carol-Ann; Smith, Lou C.; Lazariu, Victoria; Birkhead, Guthrie S.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
   [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA.
   [Pulver, Wendy P.] New York State Dept Hlth, Ctr Community Hlth, Albany, NY 12201 USA.
   [McNutt, Louise-Anne] SUNY Albany, Inst Hlth & Environm, Albany, NY 12222 USA.
   [Swain, Carol-Ann] New York State Dept Hlth, ESP, Corning Tower, Albany, NY 12237 USA.
RP Swain, CA (reprint author), New York State Dept Hlth, AIDS Inst, Albany, NY 12237 USA.; Swain, CA (reprint author), SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.; Swain, CA (reprint author), New York State Dept Hlth, ESP, Corning Tower, Albany, NY 12237 USA.
EM carolann.swain@health.ny.gov
FU Centers for Disease Control and Prevention, National HIV Surveillance
   System [13-1302, U62PS003966]
FX This study was supported by the Centers for Disease Control and
   Prevention 13-1302, National HIV Surveillance System U62PS003966. BJA is
   the principal investigator. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams JW, 2015, CLIN INFECT DIS
   Birkhead G. S., 2010, J PUBLIC HEALTH MAN, V16, P481
   Birkhead GS, 2000, AM J OBSTET GYNECOL, V183, P245, DOI 10.1067/mob.2000.105937
   Birkhead GS, 2010, J PUBLIC HEALTH MAN, V16, P492, DOI 10.1097/PHH.0b013e3181ee9b11
   DiBari JN, 2014, J PREGNANCY, DOI 10.1155/2014/530769
   Gardner L MG, 2015, C OPP INF RETR 2015
   Hu YYW, 2012, AIDS PATIENT CARE ST, V26, P471, DOI 10.1089/apc.2011.0371
   IBM, 2005, 2005 ASC SOFTW CORP
   Irvine MK, 2015, CLIN INFECT DIS, V60, P298, DOI 10.1093/cid/ciu783
   Lehrman S, 2002, AIDS CARE, V14, P751, DOI 10.1080/0954012021000031822
   Little RJAaR D. B., 2002, STAT ANAL MISSING DA
   Loftus H, 2015, INT J STD AIDS
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208
   Miranda WP, 2015, ELIMINATING MOTHER C
   Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f
   New York State Department of Health, HIV STD HCV PREV REL
   New York State Department of Health, 2003, GUID HLTH PROF NEWB
   New York State Department of Health, HIV UN CAR PROGR
   New York State Department of Health, ANN VIT STAT TABL TA
   New York State Department of Health, 2012, HIV AIDS SURV ANN RE
   Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242
   Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303
   Raghunathan TE, 2001, SURV METHODOL, V27, P1
   Raghunathan TE, 2002, IVEWARE IMPUTATION V
   Rana AI, 2010, J WOMENS HEALTH, V19, P1863, DOI 10.1089/jwh.2009.1880
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sabharwal CJ, 2014, J ACQUIR IMMUNE DEFI
   Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676
   Siddiqui R, 2014, AIDS PATIENT CARE ST, V28, P248, DOI 10.1089/apc.2013.0321
   Terzian AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029679
   Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151
   United States Census Bureau/American FactFinder, 2011, 2006 2010 AM COMM SU
   Weir S, 2011, WOMEN HEALTH ISS, V21, P277, DOI 10.1016/j.whi.2011.03.001
   White House Office of AIDS Policy, 2010, NAT HIV AIDS STRAT
   World Health Organization, RET HIV CAR PROGR DE
   World Health Organization, PACK ESS SERV PREGN
   ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 39
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2016
VL 11
IS 8
AR e0160775
DI 10.1371/journal.pone.0160775
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3KY
UT WOS:000381381100070
PM 27513953
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nishiuchi, H
   Taguri, M
   Ishikawa, Y
AF Nishiuchi, Hiromu
   Taguri, Masataka
   Ishikawa, Yoshiki
TI Using a Marginal Structural Model to Design a Theory-Based Mass Media
   Campaign
SO PLOS ONE
LA English
DT Article
ID PREVENTION; INFERENCE; BEHAVIOR
AB Background
   The essential first step in the development of mass media health campaigns is to identify specific beliefs of the target audience. The challenge is to prioritize suitable beliefs derived from behavioral theory. The purpose of this study was to identify suitable beliefs to target in a mass media campaign to change behavior using a new method to estimate the possible effect size of a small set of beliefs.
   Methods
   Data were drawn from the 2010 Japanese Young Female Smoker Survey (n = 500), conducted by the Japanese Ministry of Health, Labor and Welfare. Survey measures included intention to quit smoking, psychological beliefs (attitude, norms, and perceived control) based on the theory of planned behavior and socioeconomic status (age, education, household income, and marital status). To identify suitable candidate beliefs for a mass media health campaign, we estimated the possible effect size required to change the intention to quit smoking among the population of young Japanese women using the population attributable fraction from a marginal structural model.
   Results
   Thirteen percent of study participants intended to quit smoking. The marginal structural model estimated a population attributable fraction of 47 psychological beliefs (21 attitudes, 6 norms, and 19 perceived controls) after controlling for socioeconomic status. The belief, "I could quit smoking if my husband or significant other recommended it" suggested a promising target for a mass media campaign (population attributable fraction = 0.12, 95% CI = 0.02-0.23). Messages targeting this belief could possibly improve intention rates by up to 12% among this population. The analysis also suggested the potential for regulatory action.
   Conclusions
   This study proposed a method by which campaign planners can develop theory-based mass communication strategies to change health behaviors at the population level. This method might contribute to improving the quality of future mass health communication strategies and further research is needed.
C1 [Nishiuchi, Hiromu] Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan.
   [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa, Japan.
   [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan.
RP Nishiuchi, H (reprint author), Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan.
EM h-nishiuchi@umin.ac.jp
CR Brumback BA, 2004, STAT MED, V23, P749, DOI 10.1002/sim.1657
   Cho HY, 2007, J COMMUN, V57, P293, DOI 10.1111/j.1460-2466.2007.00344.x
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901
   Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918
   Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x
   Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777
   Gollwitzer P. M., 1993, EUROPEAN REV SOCIAL, V4, P141, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]
   Guide to Community Preventive Services, HLTH COMM SOC MARK
   Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496
   Hornik R, 1995, SOC MAR Q, V2, P24
   Hornik R, 2008, AM J PUBLIC HEALTH, V98, P2229, DOI 10.2105/AJPH.2007.125849
   Institute of Medicine, 2002, SPEAK HLTH ASS HLTH
   Montano D. E., 2015, HLTH BEHAV THEORY RE, V5, P95
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d
   Sheeran P, 2002, EUROPEAN REV SOCIAL, P1, DOI DOI 10.1002/0470013478.CH1
   Sjolander A, 2011, STAT METHODS MED RES, V20, P415, DOI 10.1177/0962280209349880
   Taguri M, 2012, BIOSTATISTICS, V13, P455, DOI 10.1093/biostatistics/kxr038
   Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352
   Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4
NR 22
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2016
VL 11
IS 7
AR e0158328
DI 10.1371/journal.pone.0158328
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS5CG
UT WOS:000380797500012
PM 27441626
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chong, SY
   Chittleborough, CR
   Gregory, T
   Mittinty, MN
   Lynch, JW
   Smithers, LG
AF Chong, Shiau Yun
   Chittleborough, Catherine R.
   Gregory, Tess
   Mittinty, Murthy N.
   Lynch, John W.
   Smithers, Lisa G.
TI Parenting Practices at 24 to 47 Months and IQ at Age 8: Effect-Measure
   Modification by Infant Temperament
SO PLOS ONE
LA English
DT Article
ID DIFFERENTIAL SUSCEPTIBILITY; COGNITIVE-DEVELOPMENT; POSTNATAL
   DEPRESSION; EARLY-CHILDHOOD; MOTHERS; CONSEQUENCES; INTELLIGENCE;
   INFERENCE; LANGUAGE; QUALITY
AB Cognitive development might be influenced by parenting practices and child temperament. We examined whether the associations between parental warmth, control and intelligence quotient (IQ) may be heightened among children in difficult temperament. Participants were from the Avon Longitudinal Study of Parents and Children (n = 7,044). Temperament at 6 months was measured using the Revised Infant Temperament Questionnaire and classified into 'easy' and 'difficult'. Parental warmth and control was measured at 24 to 47 months and both were classified into 2 groups using latent class analyses. IQ was measured at 8 years using the Wechsler Intelligence Scale for Children and dichotomized (<85 and >= 85) for analyzing effect-measure modification by temperament. Linear regression adjusted for multiple confounders and temperament showed lower parental warmth was weakly associated with lower IQ score [beta = -0.52 (95% CI 1.26, 0.21)], and higher parental control was associated with lower IQ score [beta = -2.21 (-2.95, -1.48)]. Stratification by temperament showed no increased risk of having low IQ in temperamentally difficult children [ risk ratio (RR) = 0.97 95% CI 0.65, 1.45)] but an increased risk among temperamentally easy children (RR = 1.12 95% CI 0.95, 1.32) when parental warmth was low. There was also no increased risk of having low IQ in temperamentally difficult children (RR = 1.02 95% CI 0.69, 1.53) but there was an increased risk among temperamentally easy children (RR = 1.30 95% CI 1.11, 1.53) when parental control was high. For both parental warmth and control, there was some evidence of negative effect-measure modification by temperament on the risk-difference scale and the risk-ratio scale. It may be more appropriate to provide parenting interventions as a universal program rather than targeting children with difficult temperament.
C1 [Chong, Shiau Yun; Chittleborough, Catherine R.; Gregory, Tess; Mittinty, Murthy N.; Lynch, John W.; Smithers, Lisa G.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia.
   [Gregory, Tess] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.
   [Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.
RP Chong, SY (reprint author), Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia.
EM shiauyun.chong@adelaide.edu.au
RI Lynch, John W/N-9472-2019; Lynch, John W/A-4797-2008; Smithers,
   Lisa/D-1605-2009; , ALSPAC/R-2016-2018; Chittleborough,
   Catherine/A-7436-2011
OI Lynch, John W/0000-0003-2781-7902; Lynch, John W/0000-0003-2781-7902;
   Smithers, Lisa/0000-0002-6585-7836; Chittleborough,
   Catherine/0000-0003-3196-7137; Chong, Shiau Yun/0000-0001-6743-9382
FU University of Adelaide International Scholarship; Fraser Mustard Centre
   PhD Scholarship; Australia Fellowship from the National Health and
   Medical Research Council of Australia; Australia Fellowship; Medical
   Research Council [MC_PC_15018]
FX Ms Chong is funded by a University of Adelaide International Scholarship
   (www.adelaide.edu.au/) and a Fraser Mustard Centre PhD Scholarship
   (www.frasermustardcentre.sa.edu.au). Prof Lynch was supported by an
   Australia Fellowship from the National Health and Medical Research
   Council of Australia (grant number 570120)(www.nhmrc.gov.au/). Dr
   Smithers and Dr Mittinty were also supported by funds from the Australia
   Fellowship awarded to Prof Lynch. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bates JE, 1998, DEV PSYCHOL, V34, P982, DOI 10.1037/0012-1649.34.5.982
   Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x
   Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x
   Byford M, 2012, INT J EPIDEMIOL, V41, P263, DOI 10.1093/ije/dyr188
   Canals J, 2011, ACTA PAEDIATR, V100, P1331, DOI 10.1111/j.1651-2227.2011.02306.x
   Carey W, 1977, INFANT TEMPERAMENT Q
   CAREY WB, 1978, PEDIATRICS, V61, P735
   CAREY WB, 1986, J DEV BEHAV PEDIATR, V7, P120, DOI 10.1097/00004703-198604000-00009
   CAREY WB, 1970, J PEDIATR-US, V77, P188, DOI 10.1016/S0022-3476(70)80322-5
   Chong SY, 2015, INFANT BEHAV DEV, V40, P20, DOI 10.1016/j.infbeh.2015.04.001
   Collins L. M., 2010, LATENT CLASS LATENT
   COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
   D'Angiulli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007692
   Dixon WE, 2000, MERRILL PALMER QUART, V46, P417
   Eshel N., 2006, B WORLD HEALTH ORGAN, V84, P992
   ESTRADA P, 1987, DEV PSYCHOL, V23, P210, DOI 10.1037/0012-1649.23.2.210
   Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P850, DOI 10.1111/j.1469-7610.2005.01472.x
   Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066
   Gardner JM, 2003, J PEDIATR-US, V143, P634, DOI 10.1067/S0022-3476(03)00455-4
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008
   Greenland S, 2012, MODERN EPIDEMIOLOGY, P71
   Grolnick W. S., 2002, PSYCHOL PARENTAL CON
   Grolnick WS, 2007, DEV PSYCHOL, V43, P991, DOI 10.1037/0012-1649.43.4.991
   Grolnick WS, 2002, DEV PSYCHOL, V38, P143, DOI 10.1037//0012-1649.38.1.143
   Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607
   HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012
   Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334
   Jones G, 2006, J ECON GROWTH, V11, P71, DOI 10.1007/s10887-006-7407-2
   Kerckhoff AC, 2001, SOCIOL EDUC, V74, P1, DOI 10.2307/2673142
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   Knol MJ, 2009, EPIDEMIOLOGY, V20, P161, DOI 10.1097/EDE.0b013e31818f6651
   Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627
   Lanza S, 2012, HDB PYSHOLOGY RES ME
   Lanza ST, 2011, P LCA P LTA US GUID
   Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602
   Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x
   Matheny A, 1989, TEMPERAMENT CHILDHOO, P263
   MAZIADE M, 1987, AM J PSYCHIAT, V144, P144
   McClelland MM, 2012, RES HUM DEV, V9, P278, DOI 10.1080/15427609.2012.729907
   McClowry S, 2012, HDB TEMPERAMENT, P607
   MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288
   Poehlmann J, 2012, J CHILD PSYCHOL PSYC, V53, P1018, DOI 10.1111/j.1469-7610.2012.02564.x
   Rothbart M. K., 2006, HDB CHILD PSYCHOL, V3, P99, DOI DOI 10.1002/9780470147658.CHPSY0303
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sims DM, 2013, J CLIN CHILD ADOLESC, V42, P208, DOI 10.1080/15374416.2012.738453
   Stright AD, 2008, CHILD DEV, V79, P186, DOI 10.1111/j.1467-8624.2007.01119.x
   Tamis-LeMonda CS, 2004, CHILD DEV, V75, P1806, DOI 10.1111/j.1467-8624.2004.00818.x
   Thomas A., 1977, TEMPERAMENT DEV
   Thomas A, 1963, BEHAV INDIVIDUALITY
   THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6
   Van Zeijl J, 2007, J FAM PSYCHOL, V21, P626, DOI 10.1037/0893-3200.21.4.626
   VanderWeele TJ, 2014, EPIDEMIOLOGIC METHOD, V3, P33, DOI DOI 10.1515/EM-2013-0005
   VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c
   von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x
   Vygotsky L. S., 1962, THOUGHT LANGUAGE
   Waylen A, 2008, PARENTING ORDINARY F
   Weshsler D, 1992, WECHSLER INTELLIGENC
NR 57
TC 1
Z9 1
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2016
VL 11
IS 3
AR e0152452
DI 10.1371/journal.pone.0152452
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH9LB
UT WOS:000373116500045
PM 27027637
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pfaffel, A
   Kollmayer, M
   Schober, B
   Spiel, C
AF Pfaffel, Andreas
   Kollmayer, Marlene
   Schober, Barbara
   Spiel, Christiane
TI A Missing Data Approach to Correct for Direct and Indirect Range
   Restrictions with a Dichotomous Criterion: A Simulation Study
SO PLOS ONE
LA English
DT Article
ID SAMPLE SELECTION BIAS; PREDICTIVE-VALIDITY; DEPENDENT-VARIABLES;
   STANDARD ERROR; TEST-SCORES; UNRELIABILITY; DISTRIBUTIONS; VARIANCE;
   ACCURACY; FORMULAS
AB A recurring methodological problem in the evaluation of the predictive validity of selection methods is that the values of the criterion variable are available for selected applicants only. This so-called range restriction problem causes biased population estimates. Correction methods for direct and indirect range restriction scenarios have widely studied for continuous criterion variables but not for dichotomous ones. The few existing approaches are inapplicable because they do not consider the unknown base rate of success. Hence, there is a lack of scientific research on suitable correction methods and the systematic analysis of their accuracies in the cases of a naturally or artificially dichotomous criterion. We aim to overcome this deficiency by viewing the range restriction problem as a missing data mechanism. We used multiple imputation by chained equations to generate complete criterion data before estimating the predictive validity and the base rate of success. Monte Carlo simulations were conducted to investigate the accuracy of the proposed correction in dependence of selection ratio, predictive validity, and base rate of success in an experimental design. In addition, we compared our proposed missing data approach with Thorndike's well-known correction formulas that have only been used in the case of continuous criterion variables so far. The results show that the missing data approach is more accurate in estimating the predictive validity than Thorndike's correction formulas. The accuracy of our proposed correction increases as the selection ratio and the correlation between predictor and criterion increase. Furthermore, the missing data approach provides a valid estimate of the unknown base rate of success. On the basis of our findings, we argue for the use of multiple imputation by chained equations in the evaluation of the predictive validity of selection methods when the criterion is dichotomous.
C1 [Pfaffel, Andreas; Kollmayer, Marlene; Schober, Barbara; Spiel, Christiane] Univ Vienna, Fac Psychol, Dept Appl Psychol Work, Educ,Econ, Vienna, Austria.
RP Pfaffel, A (reprint author), Univ Vienna, Fac Psychol, Dept Appl Psychol Work, Educ,Econ, Vienna, Austria.
EM andreas.pfaffel@univie.ac.at
RI Kollmayer, Marlene/J-8512-2018; Spiel, Christiane/B-2671-2017
OI Kollmayer, Marlene/0000-0001-8239-5330; Spiel,
   Christiane/0000-0002-7082-4879; Pfaffel, Andreas/0000-0002-4540-053X
FU Open Access Publishing Fund of the University of Vienna
FX This article was supported by the Open Access Publishing Fund of the
   University of Vienna.
CR ABRAHAMS NM, 1971, J APPL PSYCHOL, V55, P449, DOI 10.1037/h0031761
   ALEXANDER RA, 1986, BRIT J MATH STAT PSY, V39, P90, DOI 10.1111/j.2044-8317.1986.tb00849.x
   Ayyub B. M., 2011, PROBABILITY STATISTI
   BERK RA, 1983, AM SOCIOL REV, V48, P386, DOI 10.2307/2095230
   Bobko P, 2001, ORGAN RES METHODS, V4, P46, DOI 10.1177/109442810141003
   Carretta TR., 2011, AVIATION PSYCHOL APP, V1, P3, DOI DOI 10.1027/2192-0923/A00002
   Chan W, 2004, PSYCHOL METHODS, V9, P369, DOI 10.1037/1082-989X.3.369
   Chernyshenko OS, 1999, EDUC PSYCHOL MEAS, V59, P951, DOI 10.1177/00131649921970279
   CLEARY PD, 1984, J HEALTH SOC BEHAV, V25, P334, DOI 10.2307/2136429
   COHEN AC, 1967, TECHNOMETRICS, V9, P15, DOI 10.2307/1266315
   Demirtas H, 2008, J STAT COMPUT SIM, V78, P69, DOI 10.1080/10629360600903866
   Duan B, 1997, EDUC PSYCHOL MEAS, V57, P254, DOI 10.1177/0013164497057002005
   Enders C. K., 2010, APPLIED MISSING DATA
   Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9
   GROSS AL, 1987, J APPL PSYCHOL, V72, P604
   GROSS AL, 1983, APPL PSYCH MEAS, V7, P227, DOI 10.1177/014662168300700210
   HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352
   HECKMAN JJ, 1976, ANN ECON SOC MEAS, V5, P475
   HOLMES DJ, 1990, PSYCHOMETRIKA, V55, P19, DOI 10.1007/BF02294740
   Hunter JE, 2006, J APPL PSYCHOL, V91, P594, DOI 10.1037/0021-9010.91.3.594
   KEMERY ER, 1988, J APPL PSYCHOL, V73, P688, DOI 10.1037/0021-9010.73.4.688
   Kobrin JL, 2008, REPORT NO 2008 5, P16
   Li JCH, 2011, BRIT J MATH STAT PSY, V64, P367, DOI 10.1348/2044-8317.002007
   LINN RL, 1981, J APPL PSYCHOL, V66, P655, DOI 10.1037/0021-9010.66.6.655
   LINN RL, 1983, J EDUC MEAS, V20, P1, DOI 10.1111/j.1745-3984.1983.tb00185.x
   Little R. J., 2002, STAT ANAL
   Lord FM, 1968, STATISTICAL THEORIES, DOI http://doi.apa.org/psycinfo/1968-35040-000
   MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19
   McCullagh P, 1989, GENERALIZED LINEAR M
   Medical University of Vienna, 2015, ZULASSUNG
   Medical University of Vienna, 2015, MEDAT AUFNAHMEVERFAH
   MENDOZA JL, 1993, PSYCHOMETRIKA, V58, P601, DOI 10.1007/BF02294830
   MILLSAP RE, 1989, J APPL PSYCHOL, V74, P456, DOI 10.1037/0021-9010.74.3.456
   MUTHEN BO, 1993, BRIT J MATH STAT PSY, V46, P255, DOI 10.1111/j.2044-8317.1993.tb01015.x
   Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786
   Powers DE, 2004, J APPL PSYCHOL, V89, P208, DOI 10.1037/0021-9010.89.2.208
   R Core Team, 2014, LANG ENV STAT COMP
   Raju NS, 2003, APPL PSYCH MEAS, V27, P52, DOI 10.1177/0146621602239476
   REE MJ, 1994, J APPL PSYCHOL, V79, P298, DOI 10.1037/0021-9010.79.2.298
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rubin DB, 2004, MULTIPLE IMPUTATION
   Sackett PR, 2000, J APPL PSYCHOL, V85, P112, DOI 10.1037/0021-9010.85.1.112
   Schafer J. L., 1997, ANALYSIS OF INCOMPLE
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Schmidt FL, 2006, PERS PSYCHOL, V59, P281, DOI 10.1111/j.1744-6570.2006.00037.x
   Sireci SG, 2006, EDUC PSYCHOL MEAS, V66, P305, DOI 10.1177/0013164405282455
   Sjoberg S, 2012, SCAND J PSYCHOL, V53, P368, DOI 10.1111/j.1467-9450.2012.00956.x
   Society for Industrial and Organizational Psychology (SIOP), 2003, PRINCIPLES FOR THE V
   Thorndike R. L., 1949, PERSONNEL SELECTION
   Ulrich R, 2004, BRIT J MATH STAT PSY, V57, P235, DOI 10.1348/0007110042307203
   University of Vienna, 2015, AUFNAHMEVERFAHREN
   van Buuren S, 2012, FLEXIBLE IMPUTATION
   van Buuren SG, 2011, J STAT SOFTW, P45
   Venables WN, 2002, MODERN APPLIED STATI
   von Hippel PT, 2004, AM STAT, V58, P160, DOI 10.1198/0003130043204
   WEITZMAN RA, 1982, J EDUC MEAS, V19, P179, DOI 10.1111/j.1745-3984.1982.tb00126.x
   Wiberg M., 2009, PRACTICAL ASSESSMENT, V14, P1
   Wolfe JH, 2010, MIL PSYCHOL, V22, P356, DOI 10.1080/08995605.2010.491845
   Zimmerman DW, 2000, APPL PSYCH MEAS, V24, P267, DOI 10.1177/01466210022031741
NR 59
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2016
VL 11
IS 3
AR e0152330
DI 10.1371/journal.pone.0152330
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH5EH
UT WOS:000372807800046
PM 27019277
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dipnall, JF
   Pasco, JA
   Berk, M
   Williams, LJ
   Dodd, S
   Jacka, FN
   Meyer, D
AF Dipnall, Joanna F.
   Pasco, Julie A.
   Berk, Michael
   Williams, Lana J.
   Dodd, Seetal
   Jacka, Felice N.
   Meyer, Denny
TI Fusing Data Mining, Machine Learning and Traditional Statistics to
   Detect Biomarkers Associated with Depression
SO PLOS ONE
LA English
DT Article
ID CELL DISTRIBUTION WIDTH; MULTIPLE IMPUTATION; REGRESSION;
   CLASSIFICATION; BILIRUBIN; RISK; ANTIOXIDANT; DISEASE; INFLAMMATION;
   DIAGNOSIS
AB Background
   Atheoretical large-scale data mining techniques using machine learning algorithms have promise in the analysis of large epidemiological datasets. This study illustrates the use of a hybrid methodology for variable selection that took account of missing data and complex survey design to identify key biomarkers associated with depression from a large epidemiological study.
   Methods
   The study used a three-step methodology amalgamating multiple imputation, a machine learning boosted regression algorithm and logistic regression, to identify key biomarkers associated with depression in the National Health and Nutrition Examination Study (2009-2010). Depression was measured using the Patient Health Questionnaire-9 and 67 biomarkers were analysed. Covariates in this study included gender, age, race, smoking, food security, Poverty Income Ratio, Body Mass Index, physical activity, alcohol use, medical conditions and medications. The final imputed weighted multiple logistic regression model included possible confounders and moderators.
   Results
   After the creation of 20 imputation data sets from multiple chained regression sequences, machine learning boosted regression initially identified 21 biomarkers associated with depression. Using traditional logistic regression methods, including controlling for possible confounders and moderators, a final set of three biomarkers were selected. The final three biomarkers from the novel hybrid variable selection methodology were red cell distribution width (OR 1.15; 95% CI 1.01, 1.30), serum glucose (OR 1.01; 95% CI 1.00, 1.01) and total bilirubin (OR 0.12; 95% CI 0.05, 0.28). Significant interactions were found between total bilirubin with Mexican American/Hispanic group (p = 0.016), and current smokers (p<0.001).
   Conclusion
   The systematic use of a hybrid methodology for variable selection, fusing data mining techniques using a machine learning algorithm with traditional statistical modelling, accounted for missing data and complex survey sampling methodology and was demonstrated to be a useful tool for detecting three biomarkers associated with depression for future hypothesis generation: red cell distribution width, serum glucose and total bilirubin.
C1 [Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia.
   [Dipnall, Joanna F.; Meyer, Denny] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia.
   [Pasco, Julie A.] Univ Melbourne, Dept Med, St Albans, Vic, Australia.
   [Pasco, Julie A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.
   [Pasco, Julie A.; Berk, Michael; Dodd, Seetal] Barwon Hlth, Univ Hosp Geelong, Geelong, Vic, Australia.
   [Berk, Michael; Dodd, Seetal; Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia.
   [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.
   [Berk, Michael] Orygen, Parkville, Vic, Australia.
   [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia.
   [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia.
RP Dipnall, JF (reprint author), Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia.; Dipnall, JF (reprint author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia.
EM jdipnall@deakin.edu.au
RI Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019
OI Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946;
   Williams, Lana/0000-0002-1377-1272; Dodd, Seetal/0000-0002-7918-4636
FU NHMRC [1059660, 1064272]
FX Michael Berk is supported by a NHMRC Senior Principal Research
   Fellowship 1059660 and Lana J Williams is supported by a NHMRC Career
   Development Fellowship 1064272. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI [10.2337/dc10-S062, 10.2337/dc11-S062, 10.2337/dc10-s062]
   American Diabetes Association, 2009, DIABETES CARE S1, V32, pS1, DOI [10.2337/dc09-S001, DOI 10.2337/DC09-S001]
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845
   Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024
   Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169
   Boksa P, 2013, J PSYCHIATR NEUROSCI, V38, P75, DOI 10.1503/jpn.130018
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x
   (CDC). CfDCaP. National Center for Health Statistics (NCHS), 2009, NHANES LAB PROC MAN
   Centers for Disease Control and Prevention National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR
   Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NAT HLTH NUTR EX SUR
   Chaovalitwongse W, 2010, SPRINGER SER OPTIM A, V38, P1, DOI 10.1007/978-0-387-88630-5
   Council NR, 2006, FOOD INS HUNG US ASS
   Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139
   De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2
   Dipnall JF, 2014, METHODS
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Essau CA, 2010, J AFFECT DISORDERS, V127, P185, DOI 10.1016/j.jad.2010.05.016
   FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887
   Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504
   Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223
   Friedman J, 2001, SPRINGER SERIES STAT
   Friedman J, 2009, R PACKAGE VERSION, V1, P1, DOI DOI 10.18637/JSS.V033.I01
   Friedman JH, 1997, COMP SCI STAT, V29, P3
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3
   Hastie T., 2005, MATH INTELL, V27, P83, DOI DOI 10.1007/BF02985802
   Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006
   Li C, 2013, STATA J, V13, P795, DOI 10.1177/1536867X1301300407
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Linoff GS, 2011, DATA MINING TECHNIQU
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Longadge R, 2013, ARXIV13051707
   Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004
   Malandrino N, 2012, DIABETOLOGIA, V55, P226, DOI 10.1007/s00125-011-2331-1
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mezuk B, 2013, HEALTH PSYCHOL, V32, P254, DOI 10.1037/a0029014
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033
   Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI DOI 10.1613/JAIR.614
   Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002
   Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416
   Patel P., 2010, DIABETES, V100, P13
   Pearce N, 2012, INT J EPIDEMIOL, V41, P393, DOI 10.1093/ije/dys049
   Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55
   Raghunathan T, 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186
   Royston P, 2011, J STAT SOFTW, V45, P1
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schaefer R, 1986, J STATISTICAL COMPUT, V25, P75, DOI [10.1080/00949658608810925, DOI 10.1080/00949658608810925]
   Schonlau M., 2005, STATA J, V5, P330
   Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3
   Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776
   Seref O, 2007, DATA MINING SYSTEMS
   Spell DW, 2004, CANCER DETECT PREV, V28, P37, DOI 10.1016/j.cdp.2003.10.002
   StataCorp L, 2015, STAT MULT IMP REF MA
   Sterne JA, 2009, BMJ-BRIT MED J, P338
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Tabachnick B. G, 2012, USING MULTIVARIATE S
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x
   Tovar D, 2012, METHODS MOL BIOL, V829, P593, DOI 10.1007/978-1-61779-458-2_37
   van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465
   van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179
   Van Ness PH, 2007, J CLIN EPIDEMIOL, V60, P1239, DOI 10.1016/j.jclinepi.2007.03.006
   Van Voorhees BW, 2008, ANN FAM MED, V6, P503, DOI 10.1370/afm.887
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
   WINOKUR A, 1988, AM J PSYCHIAT, V145, P325
   Witten IH, 2011, MOR KAUF D, P1
   Wood Angela M, 2004, Clin Trials, V1, P368
   World Health Organisation, 2006, GLOB DAT BOD MASS IN
   Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460
   Yoo I, 2012, J MED SYST, V36, P2431, DOI 10.1007/s10916-011-9710-5
   Zhang DS, 2004, IEEE T SYST MAN CY C, V34, P513, DOI 10.1109/TSMCC.2004.829279
NR 85
TC 11
Z9 11
U1 1
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2016
VL 11
IS 2
AR e0148195
DI 10.1371/journal.pone.0148195
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9PR
UT WOS:000369554000050
PM 26848571
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Azzoni, L
   Barbour, R
   Papasavvas, E
   Glencross, DK
   Stevens, WS
   Cotton, MF
   Violari, A
   Montaner, LJ
AF Azzoni, Livio
   Barbour, Russell
   Papasavvas, Emmanouil
   Glencross, Deborah K.
   Stevens, Wendy S.
   Cotton, Mark F.
   Violari, Avy
   Montaner, Luis J.
TI Early ART Results in Greater Immune Reconstitution Benefits in
   HIV-Infected Infants: Working with Data Missingness in a Longitudinal
   Dataset
SO PLOS ONE
LA English
DT Article
ID ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; HIV-1-INFECTED
   CHILDREN; MICROBIAL TRANSLOCATION; INTERLEUKIN-7 LEVELS; PREDICTIVE
   MODELS; INNATE IMMUNITY; PLASMA-LEVELS; RECOVERY; RESPONSES
AB Background
   Early initiation of anti-retroviral treatment (ART) decreases mortality as compared to deferred treatment, but whether it preserves immune cells from early loss or promotes their recovery remains undefined. Determination of complex immunological endpoints in infants is often marred by missing data due to missed visits and/or inadequate sampling. Specialized methods are required to address missingness and facilitate data analysis.
   Methods
   We characterized the changes in cellular and humoral immune parameters over the first year of life in 66 HIV-infected infants (0-1 year of age) enrolled in the CHER study starting therapy within 12 weeks of birth (n = 42) or upon disease progression (n = 24). A convenience cohort of 23 uninfected infants aged 0-6 months born to mothers with HIV-1 infection was used as controls. Flow cytometry and ELISA were used to evaluate changes in natural killer (NK) cells, plasmacytoid dendritic cells (pDC), and CD4(+) or CD8(+) T-cell frequencies. Data missingness was assessed using Little's test. Complete datasets for analysis were created using Multiple Imputation (MI) or Bayesian modeling and multivariate analysis was conducted on the imputed datasets.
   Results
   HIV-1-infected infants had greater frequency of CD4(+) T cells with naive phenotype, as well as higher serum IL-7 levels than HIV exposed/uninfected infants. The elevated data missingness was completely at random, allowing the use of both MI and Bayesian modeling. Both methods indicate that early ART initiation results in higher CD4(+) T cell frequency, lower expression of CD95 in CD8(+) T cell, and preservation of naive T cell subsets. In contrast, innate immune effectors appeared to be similar independently of the timing of ART initiation.
   Conclusions
   Early ART initiation in infants with perinatal HIV infection reduces immune activation and preserves an early expansion of naive T-cells with undiminished innate cell numbers, giving greater immune reconstitution than achieved with deferred ART. Both statistical approaches concurred in this finding.
C1 [Azzoni, Livio; Papasavvas, Emmanouil; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.
   [Barbour, Russell] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA.
   [Glencross, Deborah K.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa.
   [Glencross, Deborah K.; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa.
   [Cotton, Mark F.] Univ Stellenbosch, Dept Paediat & Child Hlth, Childrens Infect Dis Clin Res Unit, Cape Town, South Africa.
   [Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa.
RP Montaner, LJ (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM Montaner@wistar.org
FU National Institute of Allergy and Infectious Disease (NIAID) [AI062512];
   Philadelphia Foundation (Robert I. Jacobs Fund); Stengel-Miller family;
   Commonwealth of Pennsylvania; Commonwealth Universal Research
   Enhancement Program; Pennsylvania Department of Health; National Cancer
   Institute Wistar Cancer Center [P30 CA10815]; NIMH [5P30MH062294-12];
   Center for Interdisciplinary Research on AIDS; National Institute of
   Allergy and Infectious Diseases (NIAID) of the US National Institutes
   for Health (NIH), through the Comprehensive International Program of
   Research on AIDS (CIPRA) network [U19 AI53217]; Departments of Health of
   the Western Cape; Gauteng, South Africa; GlaxoSmithKline plc; Dean of
   Yale's School of Public Health
FX This work was primarily supported by a grant to L.J. Montaner by the
   National Institute of Allergy and Infectious Disease (NIAID AI062512,
   www.niaid.nih.gov). Additional support was provided by The Philadelphia
   Foundation (Robert I. Jacobs Fund), https://www.philafound.org; The
   Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania
   and from the Commonwealth Universal Research Enhancement Program
   (www.portal.state.pa.us/portal/server.pt/community/health_research_progr
   am_cure/14189), Pennsylvania Department of Health (www.health.pa.gov),
   as well as by the National Cancer Institute Wistar Cancer Center Grant
   (P30 CA10815, www.cancer.gov/). Dr. Barbour's work was supported by NIMH
   grant 5P30MH062294-12 (https://www.nimh.nih.gov) to Paul Cleary, Dean of
   Yale's School of Public Health. This grant supports the Center for
   Interdisciplinary Research on AIDS. Support for the CIPRA-SA CHER study
   was provided by the National Institute of Allergy and Infectious
   Diseases (NIAID, www.niaid.nih.gov) of the US National Institutes for
   Health (NIH), through the Comprehensive International Program of
   Research on AIDS (CIPRA) network, grant number U19 AI53217. The
   Departments of Health of the Western Cape
   (https://www.westerncape.gov.za/dept/health) and Gauteng
   (www.health.gpg.gov.za), South Africa and GlaxoSmithKline plc
   (www.gsk.com) provided additional support. The CIPRA-SA CHER study was
   conducted under the supervision of the USA Food and Drug Administration
   (IND n. 71494). The content of this publication does not necessarily
   reflect the views or policies of NIAID, nor does mention of trade names,
   commercial projects, or organizations imply endorsement by the US
   Government. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100
   Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x
   Azzoni L, 2005, J INFECT DIS, V191, P1451, DOI 10.1086/429300
   Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764
   Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f
   Blackwell M, 2017, SOCIOL METHOD RES, V46, P342, DOI 10.1177/0049124115589052
   Blanco A, 2008, J IMMUNOL, V180, P530, DOI 10.4049/jimmunol.180.1.530
   BONAGURA VR, 1992, J PEDIATR-US, V121, P195, DOI 10.1016/S0022-3476(05)81187-4
   Boulassel MR, 2007, VIRAL IMMUNOL, V20, P649, DOI 10.1089/vim.2007.0047
   Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675
   Cagigi A, 2014, PEDIATR INFECT DIS J, V33, pE126, DOI 10.1097/INF.0000000000000144
   Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796
   Chiappini E, 2003, JAIDS-J ACQ IMM DEF, V33, P601, DOI 10.1097/00126334-200308150-00008
   Coetzee LM, 2009, CYTOM PART B-CLIN CY, V76B, P375, DOI 10.1002/cyto.b.20478
   Correa R, 2003, J CLIN IMMUNOL, V23, P401, DOI 10.1023/A:1025325718213
   Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9
   CRAWLY M, 2005, STAT INTRO USING R
   DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795
   Gelman A, 2007, DATA ANAL USING REGR
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gorelick MH, 2006, J CLIN EPIDEMIOL, V59, P1115, DOI 10.1016/j.jclinepi.2004.11.029
   Holmes TH, 2014, J IMMUNOL METHODS, V414, P32, DOI 10.1016/j.jim.2014.08.001
   Honaker J, 2011, J STAT SOFTW, V45, P1
   Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x
   Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898
   Jordan KA, 2006, VIROLOGY, V347, P117, DOI 10.1016/j.virol.2005.12.002
   Kaambwa Billingsley, 2012, BMC Res Notes, V5, P330, DOI 10.1186/1756-0500-5-330
   Kopka J, 2005, J CLIN VIROL, V33, P237, DOI 10.1016/j.jcv.2004.11.014
   Le J, 2014, THER DRUG MONIT, V36, P510, DOI 10.1097/FTD.0000000000000039
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Little RJA, 1987, STAT ANAL MISSING DA
   Little TD, 2014, J PEDIATR PSYCHOL, V39, P151, DOI 10.1093/jpepsy/jst048
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704
   Mansoor N, 2009, CLIN IMMUNOL, V130, P280, DOI 10.1016/j.clim.2008.09.006
   Mansourian M, 2014, J TROP PEDIATRICS, V60, P61, DOI 10.1093/tropej/fmt078
   Mason A, 2012, BAYESIAN ANAL, V7, P109, DOI 10.1214/12-BA704
   Newell ML, 1994, PEDIATRICS, V94, P815
   Owen MJ, 2013, EVERYONES STAT SOFTW
   Papasavvas E, 2011, PEDIATR INFECT DIS J, V30, P877, DOI 10.1097/INF.0b013e31821d141e
   Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106
   PLAEGERMARSHALL S, 1994, CLIN IMMUNOL IMMUNOP, V71, P19, DOI 10.1006/clin.1994.1046
   Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V67, P455, DOI 10.1097/QAI.0000000000000342
   Resino S, 2006, J ANTIMICROB CHEMOTH, V57, P798, DOI 10.1093/jac/dkl032
   Resino S, 2001, CLIN EXP IMMUNOL, V125, P266, DOI 10.1046/j.1365-2249.2001.01612.x
   Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836
   Rosso R, 2010, SCAND J IMMUNOL, V71, P45, DOI 10.1111/j.1365-3083.2009.02345.x
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rubin DB, 2008, MULTIPLE IMPUTATION
   Ruel T, 2009, CLIN IMMUNOL, V131, P410, DOI 10.1016/j.clim.2009.01.016
   Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x
   Simani OE, 2014, AIDS, V28, P531, DOI 10.1097/QAD.0000000000000127
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Ssewanyana I, 2009, AIDS RES HUM RETROV, V25, P65, DOI 10.1089/aid.2008.0138
   Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003
   Tobin NH, 2014, CURR HIV-AIDS REP, V11, P1, DOI 10.1007/s11904-013-0189-1
   VOICULESCU C, 1994, FEMS IMMUNOL MED MIC, V9, P217, DOI 10.1111/j.1574-695X.1994.tb00496.x
   Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228
   White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944
   Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040
   Woodward P, 2005, J STAT SOFTWARE, V14
   Woodward P., 2011, BAYESIAN ANAL MADE S
   Xiao L, 2014, J AM STAT ASSOC, V109, P1, DOI 10.1080/01621459.2013.830070
   Ye P, 2004, CURR HIV RES, V2, P177, DOI 10.2174/1570162043484898
   Ziegner U, 1999, CLIN DIAGN LAB IMMUN, V6, P718
NR 65
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 15
PY 2015
VL 10
IS 12
AR e0145320
DI 10.1371/journal.pone.0145320
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CY9HZ
UT WOS:000366719300058
PM 26671450
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Devleesschauwer, B
   Haagsma, JA
   Angulo, FJ
   Bellinger, DC
   Cole, D
   Dopfer, D
   Fazil, A
   Fevre, EM
   Gibb, HJ
   Hald, T
   Kirk, MD
   Lake, RJ
   de Noordhout, CM
   Mathers, CD
   McDonald, SA
   Pires, SM
   Speybroeck, N
   Thomas, MK
   Torgerson, PR
   Wu, F
   Havelaar, AH
   Praet, N
AF Devleesschauwer, Brecht
   Haagsma, Juanita A.
   Angulo, Frederick J.
   Bellinger, David C.
   Cole, Dana
   Doepfer, Doerte
   Fazil, Aamir
   Fevre, Eric M.
   Gibb, Herman J.
   Hald, Tine
   Kirk, Martyn D.
   Lake, Robin J.
   de Noordhout, Charline Maertens
   Mathers, Colin D.
   McDonald, Scott A.
   Pires, Sara M.
   Speybroeck, Niko
   Thomas, M. Kate
   Torgerson, Paul R.
   Wu, Felicia
   Havelaar, Arie H.
   Praet, Nicolas
TI Methodological Framework for World Health Organization Estimates of the
   Global Burden of Foodborne Disease
SO PLOS ONE
LA English
DT Article
ID ADJUSTED LIFE YEARS; SYSTEMATIC ANALYSIS; DISABILITY WEIGHTS;
   NETHERLANDS; VALUES
AB Background
   The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in 2007 by the World Health Organization to estimate the global burden of foodborne diseases (FBDs). This paper describes the methodological framework developed by FERG's Computational Task Force to transform epidemiological information into FBD burden estimates.
   Methods and Findings
   The global and regional burden of 31 FBDs was quantified, along with limited estimates for 5 other FBDs, using Disability-Adjusted Life Years in a hazard-and incidence-based approach. To accomplish this task, the following workflow was defined: outline of disease models and collection of epidemiological data; design and completion of a database template; development of an imputation model; identification of disability weights; probabilistic burden assessment; and estimating the proportion of the disease burden by each hazard that is attributable to exposure by food (i.e., source attribution). All computations were performed in R and the different functions were compiled in the R package 'FERG'. Traceability and transparency were ensured by sharing results and methods in an interactive way with all FERG members throughout the process.
   Conclusions
   We developed a comprehensive framework for estimating the global burden of FBDs, in which methodological simplicity and transparency were key elements. All the tools developed have been made available and can be translated into a user-friendly national toolkit for studying and monitoring food safety at the local level.
C1 [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.
   [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Insitute Hlth & Soc IRSS, B-1200 Brussels, Belgium.
   [Devleesschauwer, Brecht; Praet, Nicolas] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.
   [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Haagsma, Juanita A.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.
   [Angulo, Frederick J.; Cole, Dana] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Bellinger, David C.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.
   [Bellinger, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Doepfer, Doerte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.
   [Fazil, Aamir; Thomas, M. Kate] Publ Hlth Agcy Canada, Guelph, ON, Canada.
   [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, England.
   [Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya.
   [Gibb, Herman J.] Gibb Epidemiol Consulting, Arlington, VA USA.
   [Hald, Tine; Pires, Sara M.] Danish Tech Univ, Natl Food Inst, Lyngby, Denmark.
   [Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.
   [Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand.
   [Mathers, Colin D.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.
   [McDonald, Scott A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland.
   [Wu, Felicia] Michigan State Univ, Dept Agr Food & Resource Econ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.
   [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [Havelaar, Arie H.] Univ Utrecht, Utrecht, Netherlands.
RP Devleesschauwer, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.
EM brechtdv@gmail.com
RI Pires, Sara/M-2506-2019; Torgerson, Paul/A-7510-2010; Torgerson, Paul
   R/M-4447-2013; Devleesschauwer, Brecht/G-9895-2018; Hald,
   Tine/B-5477-2016
OI Pires, Sara/0000-0002-7751-1509; Torgerson, Paul/0000-0003-4277-9983;
   Torgerson, Paul R/0000-0003-4277-9983; Devleesschauwer,
   Brecht/0000-0002-2867-6892; Hald, Tine/0000-0002-1115-9792; Kirk,
   Martyn/0000-0001-5432-5984; Fevre, Eric/0000-0001-8931-4986
FU World Health Organization (WHO); Gibb Epidemiology Consulting, LLC;
   European Centre for Disease Control and Prevention (Solna, Sweden);
   Medical Research Council [G1100783]
FX This study was commissioned and paid for by the World Health
   Organization (WHO). Copyright in the original work on which this article
   is based belongs to WHO. The authors have been given permission to
   publish this article. Gibb Epidemiology Consulting, LLC, provided
   support in the form of salaries for author [HJG], but did not have any
   additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific
   roles of this author are articulated in the 'author contributions'
   section.; We would like to acknowledge the assistance of the WHO
   Secretariat over the life of the FERG initiative, particularly Claudia
   Stein, Tanja Kuchenmuller, Amy Cawthorne, Yuki Minato, Tim Corrigan,
   Kurt Straif (IARC), Philippe Verger, Arve Lee Willingham and Danilo Lo
   Fo Wong. We acknowledge the Institute for Health Metrics and Evaluation
   (Seattle, WA, USA) for providing data on the global burden of selected
   diseases. The European Centre for Disease Control and Prevention (Solna,
   Sweden) supported the work by providing their outcome trees and
   sponsoring a study on disability weights. The findings and conclusions
   of this report are those of the authors and do not necessarily represent
   the official views, decisions or policies of the World Health
   Organization, US Centers for Disease Control and Prevention, the US
   Government or other institutions listed. FJA and DC are employees of the
   US Government. This work was part of their official duties.
CR [Anonymous], 2010, WHO IN EST GLOB BURD
   [Anonymous], 2011, WHO IN EST GLOB BURD
   [Anonymous], 2013, 5 FORM M FOOD BORN D
   Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080
   Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711
   de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9
   Devleesschauwer B, 2015, INT J PARASITOL, V45, P95, DOI 10.1016/j.ijpara.2014.05.006
   Devleesschauwer B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1196
   Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z
   Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A
   Gibb HJ, 2010, WHO ESTIMATES UNPUB
   Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531
   Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2
   Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029
   Hald T, ESTIMATES RELA UNPUB
   Havelaar AH, 2010, WHO ESTIMATES UNPUB
   Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029
   Kirk MD, 2010, WHO ESTIMAT IN PRESS
   Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006
   Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205
   Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459
   Kuchenmuller T, 2009, EURO SURVEILL, V14
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740
   McDonald SA, 2015, B WORLD HEALTH ORGAN, V93, P228, DOI 10.2471/BLT.14.139972
   Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
   Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429
   Pires SM, AETIOLOGY SPEC UNPUB
   Plummer M., 2003, P 3 INT WORKSH DISTR, V3, P20
   Plummer M, 2014, R PACKAGE VERSION 3
   Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21
   Pruss-Ustun A, 2003, ENV BURDEN DIS SERIE
   R Core Team, 2015, R LANG ENV STAT COMP
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19
   Torgerson P, 2010, WHO ESTIMAT IN PRESS
   UN Population Division, 2013, WORLD POP PROSP 2012
   Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
   WHO, 2014, WHOHTMTB201311
   World Health Organization (WHO), 2013, WHOHISHSIGHE20134
NR 49
TC 36
Z9 36
U1 2
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 3
PY 2015
VL 10
IS 12
AR e0142498
DI 10.1371/journal.pone.0142498
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX9QI
UT WOS:000366040000006
PM 26633883
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Masconi, KL
   Matsha, TE
   Erasmus, RT
   Kengne, AP
AF Masconi, Katya L.
   Matsha, Tandi E.
   Erasmus, Rajiv T.
   Kengne, Andre P.
TI Effects of Different Missing Data Imputation Techniques on the
   Performance of Undiagnosed Diabetes Risk Prediction Models in a
   Mixed-Ancestry Population of South Africa
SO PLOS ONE
LA English
DT Article
ID MULTIPLE IMPUTATION; SCORE; REGRESSION; VALUES
AB Background
   Imputation techniques used to handle missing data are based on the principle of replacement. It is widely advocated that multiple imputation is superior to other imputation methods, however studies have suggested that simple methods for filling missing data can be just as accurate as complex methods. The objective of this study was to implement a number of simple and more complex imputation methods, and assess the effect of these techniques on the performance of undiagnosed diabetes risk prediction models during external validation.
   Methods
   Data from the Cape Town Bellville-South cohort served as the basis for this study. Imputation methods and models were identified via recent systematic reviews. Models' discrimination was assessed and compared using C-statistic and non-parametric methods, before and after recalibration through simple intercept adjustment.
   Results
   The study sample consisted of 1256 individuals, of whom 173 were excluded due to previously diagnosed diabetes. Of the final 1083 individuals, 329 (30.4%) had missing data. Family history had the highest proportion of missing data (25%). Imputation of the outcome, undiagnosed diabetes, was highest in stochastic regression imputation (163 individuals). Overall, deletion resulted in the lowest model performances while simple imputation yielded the highest C-statistic for the Cambridge Diabetes Risk model, Kuwaiti Risk model, Omani Diabetes Risk model and Rotterdam Predictive model. Multiple imputation only yielded the highest C-statistic for the Rotterdam Predictive model, which were matched by simpler imputation methods.
   Conclusions
   Deletion was confirmed as a poor technique for handling missing data. However, despite the emphasized disadvantages of simpler imputation methods, this study showed that implementing these methods results in similar predictive utility for undiagnosed diabetes when compared to multiple imputation.
C1 [Masconi, Katya L.; Erasmus, Rajiv T.] NHLS, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa.
   [Masconi, Katya L.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa.
   [Masconi, Katya L.; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.
   [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa.
   [Kengne, Andre P.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.
RP Kengne, AP (reprint author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.
EM andre.kengne@mrc.ac.za
OI Matsha, Tandi/0000-0001-5251-030X
FU South African National Research Foundation; Carl & Emily Fuchs
   Foundation
FX KLM was supported by a scholarship from the South African National
   Research Foundation and the Carl & Emily Fuchs Foundation. The authors
   received no other specific funding for this work.
CR Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725
   Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013
   Alzola CF, 2006, INTRO S HMISC DESIGN, P310
   [Anonymous], 2013, CITY CAPE TOWN 2011
   Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213
   Baker J, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-47
   Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353
   Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302
   Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005
   Buuren S., 2011, J STAT SOFTWARE, V45
   City of Cape Town, 2006, CITY CAPE TOWN CENSU
   CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9
   DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317
   Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014
   Graham JW, 1996, MULTIVAR BEHAV RES, V31, P197, DOI 10.1207/s15327906mbr3102_3
   Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592
   Griffin SJ, 2000, DIABETES METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R
   Harrell FE, 2001, REGRESSION MODELING, Vxxii
   Kengne AP, 2014, CRIT REV CL LAB SCI, V51, P1, DOI 10.3109/10408363.2013.853025
   Little R. J. A., 2002, STAT ANAL MISSING DA
   LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664
   Masconi K, 2015, DIABETOLOGY METABOLI
   Masconi KL, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0028-0
   Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246
   Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014
   R Foundation, 2015, R PROJECT STAT COMPU
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410
   Rubin DB, 2004, MULTIPLE IMPUTATION
   Schafer J. L, 1997, ANAL INCOMPLETE MULT
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676
   Steyerberg E. W., 2009, CLIN PREDICTION MODE
   Vach W, 1997, STAT MED, V16, P57
   Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I
   van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015
   World Health Organization, 2003, WHONMHMNC031
NR 37
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2015
VL 10
IS 9
AR e0139210
DI 10.1371/journal.pone.0139210
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS1CR
UT WOS:000361800700191
PM 26406594
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Laukka, EJ
   Lovden, M
   Kalpouzos, G
   Papenberg, G
   Keller, L
   Graff, C
   Li, TQ
   Fratiglioni, L
   Backman, L
AF Laukka, Erika J.
   Lovden, Martin
   Kalpouzos, Gregoria
   Papenberg, Goran
   Keller, Lina
   Graff, Caroline
   Li, Tie-Qiang
   Fratiglioni, Laura
   Backman, Lars
TI Microstructural White Matter Properties Mediate the Association between
   APOE and Perceptual Speed in Very Old Persons without Dementia
SO PLOS ONE
LA English
DT Article
ID APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; HEALTHY-ADULTS; MISSING DATA;
   COGNITIVE DECLINE; EPSILON-4 ALLELE; TRACT INTEGRITY; HUMAN BRAIN;
   LIFE-SPAN; AGE
AB Background
   Reduced white matter integrity, as indicated by lower fractional anisotropy (FA) and higher mean diffusivity (MD), has been related to poorer perceptual speed (PS) performance. As the epsilon 4 allele has been associated with lower white matter integrity in old age, this represents a potential mechanism through which APOE may affect PS.
   Objective
   To examine whether the association between APOE and PS is mediated by white matter microstructure in very old persons without dementia.
   Method
   Participants were selected from the population-based SNAC-K study. After excluding persons with dementia, preclinical dementia, and other neurological disorders, 652 persons (age range 78-90) were included in the study, of which 89 had data on diffusion tensor imaging (DTI). We used structural equation modeling to form seven latent white matter factors (FA and MD) and one latent PS factor. Separate analyses were performed for FA and MD and mediational analyses were carried out for tracts where significant associations were observed to both APOE and PS.
   Results
   APOE was associated with white matter microstructure in 2 out of 14 tracts; e4 carriers had significantly lower FA in forceps major and higher MD in the cortico-spinal tract. Allowing the white matter microstructure indicators in these tracts to mediate the association between APOE and PS resulted in a markedly attenuated association between these variables. Bootstrapping statistics in the subsample with DTI data (n = 89) indicated that FA in forceps major significantly mediated the association between APOE and PS (indirect effect: -0.070, 95% bias corrected CIs -0.197 to -0.004).
   Conclusion
   Lower white matter integrity may represent one of several mechanisms through which APOE affects PS performance in elderly persons free of dementia and preclinical dementia.
C1 [Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Papenberg, Goran; Keller, Lina; Fratiglioni, Laura; Backman, Lars] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.
   [Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Papenberg, Goran; Keller, Lina; Fratiglioni, Laura; Backman, Lars] Stockholm Univ, S-10691 Stockholm, Sweden.
   [Keller, Lina; Graff, Caroline] Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Stockholm, Sweden.
   [Graff, Caroline] Karolinska Univ, Huddinge Hosp, Dept Geriatr Med, Stockholm, Sweden.
   [Li, Tie-Qiang] Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
   [Fratiglioni, Laura; Backman, Lars] Stockholm Gerontol Res Ctr, Stockholm, Sweden.
RP Laukka, EJ (reprint author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.
EM Erika.Jonsson.Laukka@ki.se
RI graff, caroline/A-2545-2009
OI Graff, Caroline/0000-0002-9949-2951
FU Swedish Ministry of Health and Social Affairs; Swedish Research Council;
   Swedish Council for Working Life and Social Research; Swedish Brain
   Power; Gun and Bertil Stohne's foundation; Osterman's foundation;
   foundation for age-related diseases at Karolinska Institutet; Alexander
   von Humboldt Research Award; participating County Councils and
   Municipalities
FX SNAC-K is financially supported by the Swedish Ministry of Health and
   Social Affairs, the participating County Councils and Municipalities,
   and the Swedish Research Council. This work was further funded by grants
   from the Swedish Council for Working Life and Social Research (EL, ML,
   LF, LB), the Swedish Research Council (EL, ML, LF, LB), Swedish Brain
   Power (LF, LB), Gun and Bertil Stohne's foundation (GK), Osterman's
   foundation (GK), the foundation for age-related diseases at Karolinska
   Institutet (EL), an Alexander von Humboldt Research Award (LB), and a
   donation from the af Jochnick Foundation (LB). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Bartzokis G, 2006, ARCH GEN PSYCHIAT, V63, P63, DOI 10.1001/archpsyc.63.1.63
   Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Bennett IJ, 2014, NEUROSCIENCE, V276, P187, DOI 10.1016/j.neuroscience.2013.11.026
   Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004
   Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620
   Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206
   Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544
   Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI [10.1194/jlr.r400004-JLR200, 10.1194/jlr.r400004]
   FINKBEINER C, 1979, PSYCHOMETRIKA, V44, P409, DOI 10.1007/BF02296204
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90
   Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053
   Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
   JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838
   Kanchibhotla C, 2013, AGEING RES REV, V12, P391, DOI 10.1016/j.arr.2012.10.003
   Kantarci K, 2012, NEUROLOGY, V78, P232, DOI 10.1212/WNL.0b013e31824365ab
   Kline R. B., 1998, PRINCIPLES PRACTICE
   Lagergren M, 2004, AGING CLIN EXP RES, V16, P158
   Laukka EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081419
   Laukka EJ, 2013, PSYCHOL AGING, V28, P262, DOI 10.1037/a0030829
   Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094
   Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333
   Lovden M, 2014, NEUROIMAGE, V102, P520, DOI 10.1016/j.neuroimage.2014.08.020
   Lovden M, 2013, HUM BRAIN MAPP, V34, P1386, DOI 10.1002/hbm.21518
   Lyall DM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.89
   Lyall DM, 2014, NEUROBIOL AGING, V35
   Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003
   Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768
   Nyberg L, 2014, SCAND J PSYCHOL, V55, P263, DOI 10.1111/sjop.12099
   Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005
   O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632
   Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66
   Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023
   Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044
   Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4
   Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028
   Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049
   Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8
   Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055
   Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052
   Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5
   Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640
   Welmer AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065815
   Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c
   Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280
   Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003
   Zade D, 2010, J STROKE CEREBROVASC, V19, P261, DOI 10.1016/j.jstrokecerebrovasdis.2009.05.001
   ZAZZO R, 1974, ACTUALITES PEDAGOGIQ, V7
NR 63
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2015
VL 10
IS 8
AR e0134766
DI 10.1371/journal.pone.0134766
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4HF
UT WOS:000359121100075
PM 26252210
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lakon, CM
   Hipp, JR
AF Lakon, Cynthia M.
   Hipp, John R.
TI On Social and Cognitive Influences: Relating Adolescent Networks,
   Generalized Expectancies, and Adolescent Smoking
SO PLOS ONE
LA English
DT Article
ID HEALTH BELIEF MODEL; CIGARETTE-SMOKING; TIME PERSPECTIVE;
   RISK-PERCEPTION; EARLY DEATH; DRUG-USE; BEHAVIOR; MORTALITY; SELECTION;
   ALCOHOL
AB We examine the moderating role of friendship and school network characteristics in relationships between 1) youths' friends smoking behavior and youths' own generalized expectancies regarding risk and future orientation and 2) generalized expectancies of youths' friends and youths' own generalized expectancies. We then relate these constructs to smoking. Using a longitudinal sample from the National Longitudinal Study of Adolescent Health (N=15,142), the relationship between friends' generalized expectancies and youths' expectancies is stronger for those more central in the network, with more reachability, or stronger network ties, and weaker for those with denser friendship networks. Risk expectancies exhibited an inverted U shaped relationship with smoking at the next time point, whereas future orientation expectancies displayed a nonlinear accelerating negative relationship. There was also a feedback effect in which smoking behavior led to higher risk expectancies and lower future orientation expectancies in instrumental variable analyses.
C1 [Lakon, Cynthia M.] Univ Calif Irvine, Program Publ Hlth, Dept Populat Hlth & Dis Prevent, Irvine, CA USA.
   [Hipp, John R.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA 92697 USA.
   [Hipp, John R.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA.
RP Hipp, JR (reprint author), Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA 92697 USA.
EM hippj@uci.edu
FU National Institute on Drug Abuse (NIDA); National Institutes of Health
   (NIH) [R21 DA03115201A1]
FX This work was supported by National Institute on Drug Abuse (NIDA), and
   National Institutes of Health (NIH) grant R21 DA03115201A1. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abel G, 2002, DRUG-EDUC PREV POLIC, V9, P325, DOI 10.1080/09687630210157636
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Albert D, 2011, J RES ADOLESCENCE, V21, P211, DOI 10.1111/j.1532-7795.2010.00724.x
   ARY DV, 1988, J BEHAV MED, V11, P361, DOI 10.1007/BF00844936
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BAUMAN KE, 1984, J APPL SOC PSYCHOL, V14, P28, DOI 10.1111/j.1559-1816.1984.tb02218.x
   BENTHIN A, 1993, J ADOLESCENCE, V16, P153, DOI 10.1006/jado.1993.1014
   BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674
   BILLY JOG, 1985, SOC PSYCHOL QUART, V48, P27, DOI 10.2307/3033779
   BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brezina T, 2009, CRIMINOLOGY, V47, P1091, DOI 10.1111/j.1745-9125.2009.00170.x
   Burk WJ, 2007, INT J BEHAV DEV, V31, P397, DOI 10.1177/0165025407077762
   Caldwell RM, 2006, J YOUTH ADOLESCENCE, V35, P591, DOI 10.1007/s10964-006-9031-z
   Chen P, 2011, DEV PSYCHOL, V47, P1633, DOI 10.1037/a0025327
   CHRISTIANSEN BA, 1989, J CONSULT CLIN PSYCH, V57, P93, DOI 10.1037/0022-006X.57.1.93
   COHN LD, 1995, HEALTH PSYCHOL, V14, P217, DOI 10.1037/0278-6133.14.3.217
   CONRAD KM, 1992, BRIT J ADDICT, V87, P1711
   DeLay D, 2013, J RES ADOLESCENCE, V23, P464, DOI 10.1111/jora.12017
   Duke NN, 2011, J PEDIATR HEALTH CAR, V25, P224, DOI 10.1016/j.pedhc.2010.03.004
   Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x
   ENNETT ST, 1993, J HEALTH SOC BEHAV, V34, P226, DOI 10.2307/2137204
   Fischhoff B, 2000, PUBLIC OPIN QUART, V64, P189, DOI 10.1086/317762
   FLAMENT C., 1963, APPL GRAPH THEORY GR
   Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390
   Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Harary F., 1965, STRUCTURAL MODELS IN
   Harris K. M., 2009, NATL LONGITUDINAL ST
   Haynie DL, 2001, AM J SOCIOL, V106, P1013, DOI 10.1086/320298
   Hine DW, 1997, J SOC ISSUES, V53, P35, DOI 10.1111/0022-4537.419974
   Hirschi T., 1969, CAUSES DELINQUENCY
   HOUSE JS, 1982, AM J EPIDEMIOL, V116, P123, DOI 10.1093/oxfordjournals.aje.a113387
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jessor R, 1977, PROBLEM BEHAV PSYCHO
   KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792
   KASTENBAUM R, 1961, J GEN PSYCHOL, V65, P203, DOI 10.1080/00221309.1961.9920473
   Keough KA, 1999, BASIC APPL SOC PSYCH, V21, P149, DOI 10.1207/S15324834BA210207
   Kirke DM, 2004, SOC NETWORKS, V26, P3, DOI 10.1016/j.socnet.2003.12.001
   Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x
   Lakon CM, 2010, AM J PUBLIC HEALTH, V100, P1218, DOI 10.2105/AJPH.2009.167973
   Mathys C, 2013, J RES ADOLESCENCE, V23, P513, DOI 10.1111/jora.12031
   McDade TW, 2011, SOC SCI MED, V73, P391, DOI 10.1016/j.socscimed.2011.06.005
   Mercken L, 2007, ADDICTION, V102, P1483, DOI 10.1111/j.1360-0443.2007.01905.x
   Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954
   Moody J, 2002, SOC FORCES, V81, P25, DOI 10.1353/sof.2002.0056
   Moody J, 1998, SPAN SAS PROGRAMS AN
   NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6
   Paxton P, 2011, NONRECURSIVE MODELS
   Nguyen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036324
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Rotter J. B, 1954, SOCIAL LEARNING CLIN
   Rotter JB, 1972, APPL SOCIAL LEARNING
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schaefer David R, 2012, Am J Public Health, V102, pe12, DOI 10.2105/AJPH.2012.300705
   SCHOENBACH VJ, 1986, AM J EPIDEMIOL, V123, P577, DOI 10.1093/oxfordjournals.aje.a114278
   Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004
   Song AV, 2009, J ADOLESCENT HEALTH, V45, P618, DOI 10.1016/j.jadohealth.2009.04.022
   STACY AW, 1991, J ABNORM PSYCHOL, V100, P502, DOI 10.1037/0021-843X.100.4.502
   Valente TW, 2005, J ADOLESCENT HEALTH, V37, P323, DOI 10.1016/j.jadohealth.2004.10.016
   Wahl SK, 2005, NICOTINE TOB RES, V7, P613, DOI 10.1080/14622200500185579
   WEINSTEIN ND, 1989, PSYCHOL BULL, V105, P31, DOI 10.1037/0033-2909.105.1.31
   Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271
NR 63
TC 14
Z9 14
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 23
PY 2014
VL 9
IS 12
AR e115668
DI 10.1371/journal.pone.0115668
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ9UY
UT WOS:000348563300061
PM 25536039
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wickel, EE
AF Wickel, Eric E.
TI Reporting the Reliability of Accelerometer Data with and without Missing
   Values
SO PLOS ONE
LA English
DT Article
ID MEASURING PHYSICAL-ACTIVITY; GENERALIZABILITY THEORY; CHILDREN;
   IMPUTATION; MODERATE; ADULTS; TIME
AB Objectives: Participants with complete accelerometer data often represent a low proportion of the total sample and, in some cases, may be distinguishable from participants with incomplete data. Because traditional reliability methods characterize the consistency of complete data, little is known about reliability properties for an entire sample. This study employed Generalizability theory to report an index of reliability characterizing complete (7 days) and observable (1 to 7 days) accelerometer data.
   Design: Cross-sectional.
   Methods: Accelerometer data from the Study of Early Child Care and Youth Development were analyzed in this study. Missing value analyses were conducted to describe the pattern and mechanism of missing data. Generalizability coefficients were derived from variance components to report reliability parameters for complete data and also for the entire observable sample. Analyses were conducted separately by age (9, 11, 12, and 15 yrs) and daily wear time criteria (6, 8, 10, and 12 hrs).
   Results: Participants with complete data were limited (<34%) and, most often, data were not considered to be missing completely at random. Across conditions, reliability coefficients for complete data were between 0.74 and 0.87. Relatively lower reliability properties were found across all observable data, ranging from 0.52 to 0.67. Sample variability increased with longer wear time criteria, but decreased with advanced age.
   Conclusions: A reliability coefficient that includes all participants, not just those with complete data, provides a global perspective of reliability that could be used to further understand group level associations between activity and health outcomes.
C1 Univ Tulsa, Tulsa, OK 74104 USA.
RP Wickel, EE (reprint author), Univ Tulsa, Tulsa, OK 74104 USA.
EM eric-wickel@utulsa.edu
FU University of Tulsa
FX Internal funding from the University of Tulsa was provided to EEW. The
   funder had no role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001
   Brennan R. L, 2001, GEN THEORY
   Brennan RL, 2001, J EDUC MEAS, V38, P295, DOI 10.1111/j.1745-3984.2001.tb01129.x
   Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e
   Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667
   CRONBACH L J, 1972, P410
   Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156
   Herrmann SD, 2013, J PHYS ACT HEALTH, V10, P742, DOI 10.1123/jpah.10.5.742
   Holbrook EA, 2013, ADAPT PHYS ACT Q, V30, P59, DOI 10.1123/apaq.30.1.59
   Ishikawa S, 2013, ARCH PHYS MED REHAB, V94, P132, DOI 10.1016/j.apmr.2012.07.027
   Ishikawa S, 2011, J REHABIL RES DEV, V48, P1187, DOI 10.1682/JRRD.2010.09.0190
   Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546
   Kim Y, 2012, ADAPT PHYS ACT Q, V29, P346, DOI 10.1123/apaq.29.4.346
   Lee PH, 2013, AM J CLIN NUTR, V97, P965, DOI 10.3945/ajcn.112.052738
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a
   Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b
   Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98
   Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b
   Morrow Jr J, 2002, PHYS ACTIVITY ASSESS, P37
   Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295
   Rich C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002290
   Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136
   Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schafer J. L, 1997, ANAL INCOMPLETE MULT
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Shavelson RJ, 1991, GENERALIZABILITY THE
   Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485
   Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
   Wickel EE, 2010, MED SCI SPORT EXER, V42, P1528, DOI 10.1249/MSS.0b013e3181d107c4
   Zhuang J, 2013, RES Q EXERCISE SPORT, V84, pS48, DOI 10.1080/02701367.2013.851060
NR 34
TC 1
Z9 1
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2014
VL 9
IS 12
AR e114402
DI 10.1371/journal.pone.0114402
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX4MS
UT WOS:000346907200084
PM 25478692
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Roda, C
   Nicolis, I
   Momas, I
   Guihenneuc, C
AF Roda, Celina
   Nicolis, Ioannis
   Momas, Isabelle
   Guihenneuc, Chantal
TI New Insights into Handling Missing Values in Environmental
   Epidemiological Studies
SO PLOS ONE
LA English
DT Article
ID MULTIPLE IMPUTATION; BIRTH COHORT; FORMALDEHYDE; EXPOSURE; DESIGN
AB Missing data are unavoidable in environmental epidemiologic surveys. The aim of this study was to compare methods for handling large amounts of missing values: omission of missing values, single and multiple imputations (through linear regression or partial least squares regression), and a fully Bayesian approach. These methods were applied to the PARIS birth cohort, where indoor domestic pollutant measurements were performed in a random sample of babies' dwellings. A simulation study was conducted to assess performances of different approaches with a high proportion of missing values (from 50% to 95%). Different simulation scenarios were carried out, controlling the true value of the association (odds ratio of 1.0, 1.2, and 1.4), and varying the health outcome prevalence. When a large amount of data is missing, omitting these missing data reduced statistical power and inflated standard errors, which affected the significance of the association. Single imputation underestimated the variability, and considerably increased risk of type I error. All approaches were conservative, except the Bayesian joint model. In the case of a common health outcome, the fully Bayesian approach is the most efficient approach (low root mean square error, reasonable type I error, and high statistical power). Nevertheless for a less prevalent event, the type I error is increased and the statistical power is reduced. The estimated posterior distribution of the OR is useful to refine the conclusion. Among the methods handling missing values, no approach is absolutely the best but when usual approaches (e. g. single imputation) are not sufficient, joint modelling approach of missing process and health association is more efficient when large amounts of data are missing.
C1 [Roda, Celina; Nicolis, Ioannis; Momas, Isabelle; Guihenneuc, Chantal] Univ Paris 05, Sorbonne Paris Cite, Lab Sante Publ & Environm, EA 4064,Fac Pharm, Paris, France.
   [Momas, Isabelle] Direct Act Sociale Enfance & Sante, Mairie Paris, Paris, France.
RP Momas, I (reprint author), Univ Paris 05, Sorbonne Paris Cite, Lab Sante Publ & Environm, EA 4064,Fac Pharm, Paris, France.
EM isabelle.momas@parisdescartes.fr
RI Roda, Celina/R-1004-2016; Nicolis, Ioannis/C-3302-2012
OI Roda, Celina/0000-0003-0786-5085; Nicolis, Ioannis/0000-0001-7207-7689
FU Paris council, within its Social, Childhood and Health Direction
   (DASES); French National Agency for Food, Environment, and Occupational
   health Safety (Anses); French Institute for Public Health Surveillance
   (InVS); French Environment and Energy Management Agency (ADEME); French
   Scientific and Technical Construction Center (CSTB)
FX The PARIS cohort is supported by the Paris council, within its Social,
   Childhood and Health Direction (DASES). The environmental investigation
   of the cohort received financial support from the French National Agency
   for Food, Environment, and Occupational health Safety (Anses) and the
   French Institute for Public Health Surveillance (InVS). Celina Roda
   received a doctoral grant from the French Environment and Energy
   Management Agency (ADEME) and the French Scientific and Technical
   Construction Center (CSTB). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175
   Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026
   Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072
   Brock GN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-12
   Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673
   Carpenter J, 2005, CLADISTICS, V21, P1, DOI 10.1111/j.1096-0031.2004.00049.x
   Carrigan G, 2007, J STAT SOFTW, V19, P1
   Clarisse B, 2007, EUR J EPIDEMIOL, V22, P203, DOI 10.1007/s10654-007-9109-2
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404
   Dassonville C, 2009, INDOOR AIR, V19, P314, DOI 10.1111/j.1600-0668.2009.00594.x
   Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501
   Gajda D, 2010, ELECTRON J STAT, V4, P361, DOI 10.1214/09-EJS527
   Gelman A., 2003, BAYESIAN DATA ANAL
   Gilks W.R., 1996, MARKOV CHAIN MONTE C
   Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033
   Jia CR, 2008, ENVIRON INT, V34, P922, DOI 10.1016/j.envint.2008.02.002
   Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499
   Klebanoff MA, 2008, AM J EPIDEMIOL, V168, P355, DOI 10.1093/aje/kwn071
   Lee KJ, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-3
   Little R. J. A., 2002, STAT ANAL MISSING DA
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Roda C, 2013, ENVIRON RES, V123, P46, DOI 10.1016/j.envres.2013.03.001
   Roda C, 2011, ENVIRON HEALTH PERSP, V119, P1653, DOI 10.1289/ehp.1003222
   Rubin D. B., 1987, MULTIPLE IMPUTATION
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rubin DB, 2004, MULTIPLE IMPUTATION
   Schafer J. L., 1997, MONOGRAPHS STAT APPL
   Scheffer J., 2002, RES LETT INFORM MATH, V3, P153, DOI DOI 10.1159/000100481
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Steyerberg E. W., 2009, CLIN PREDICTION MODE
   Tenenhaus M., 1998, REGRESSION PLS THEOR
   Vach W, 2005, ENCY BIOSTATISTICS
NR 34
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2014
VL 9
IS 9
AR e104254
DI 10.1371/journal.pone.0104254
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS5NP
UT WOS:000344317700004
PM 25226278
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Granville, K
   Fan, ZZ
AF Granville, Kevin
   Fan, Zhaozhi
TI Buckley-James Estimator of AFT Models with Auxiliary Covariates
SO PLOS ONE
LA English
DT Article
ID FAILURE TIME REGRESSION; CENSORED-DATA; MEASUREMENT ERROR;
   LINEAR-REGRESSION
AB In this paper we study the Buckley-James estimator of accelerated failure time models with auxiliary covariates. Instead of postulating distributional assumptions on the auxiliary covariates, we use a local polynomial approximation method to accommodate them into the Buckley-James estimating equations. The regression parameters are obtained iteratively by minimizing a consecutive distance of the estimates. Asymptotic properties of the proposed estimator are investigated. Simulation studies show that the efficiency gain of using auxiliary information is remarkable when compared to just using the validation sample. The method is applied to the PBC data from the Mayo Clinic trial in primary biliary cirrhosis as an illustration.
C1 [Granville, Kevin] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada.
   [Fan, Zhaozhi] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.
RP Fan, ZZ (reprint author), Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.
EM zhaozhi@mun.ca
OI Granville, Kevin/0000-0003-3912-015X
FU USRA from the National Sciences and Engineering Research Council of
   Canada; National Sciences and Engineering Research Council of Canada
FX The research of Kevin Granville was partially supported by USRA from the
   National Sciences and Engineering Research Council of Canada. The
   research of Zhaozhi Fan was partially supported by a Discovery Grant
   from the National Sciences and Engineering Research Council of Canada.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], 2011, PRIM BIL CIRRH PBC
   BUCKLEY J, 1979, BIOMETRIKA, V66, P429
   Carrol RJ, 1995, MEASUREMENT ERROR NO
   COX DR, 1972, J R STAT SOC B, V34, P187
   Cox DR, 1984, ANAL SURVIVAL DATA
   Fan ZZ, 2009, J NONPARAMETR STAT, V21, P771, DOI 10.1080/10485250902915903
   FLEMING TR, 1991, COUNTING PROCESSES S
   Fuller W. A., 1987, MEASUREMENT ERROR MO
   Granville K, 2012, J BIOM BIOSTAT, V3, P1, DOI [10.4172/2155-6180.1000152., DOI 10.4172/2155-6180.1000152, 10.4172/2155-6180.1000152]
   He WQ, 2007, STAT MED, V26, P4817, DOI 10.1002/sim.2892
   Hu CC, 2002, SCAND J STAT, V29, P637, DOI 10.1111/1467-9469.00310
   Hu P, 1998, BIOMETRICS, V54, P1407, DOI 10.2307/2533667
   JAMES IR, 1984, ANN STAT, V12, P590, DOI 10.1214/aos/1176346507
   Jin ZZ, 2006, BIOMETRIKA, V93, P147, DOI 10.1093/biomet/93.1.147
   Kalbfleisch J. D., 2002, STAT ANAL FAILURE TI
   LAI TL, 1991, ANN STAT, V19, P1370, DOI 10.1214/aos/1176348253
   Liu YY, 2010, J MULTIVARIATE ANAL, V101, P679, DOI 10.1016/j.jmva.2009.09.008
   Liu YY, 2009, BIOMETRICS, V65, P1184, DOI 10.1111/j.1541-0420.2009.01198.x
   Nadaraya TA, 1964, THEOR PROBAB APPL, V10, P186
   National Institutes of Health, 2011, PRIM BILL CIRRH
   PRENTICE RL, 1982, BIOMETRIKA, V69, P331, DOI 10.1093/biomet/69.2.331
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Wand M. P., 1995, KERNEL SMOOTHING
   Wang NY, 1998, J AM STAT ASSOC, V93, P249, DOI 10.2307/2669621
   Watson G. S., 1964, INDIAN J STAT A, V26, P359
   Yu MG, 2010, BIOMETRICS, V66, P405, DOI 10.1111/j.1541-0420.2009.01295.x
   Zhou H, 2000, J ROY STAT SOC B, V62, P657, DOI 10.1111/1467-9868.00255
   ZHOU HB, 1995, BIOMETRIKA, V82, P139
NR 28
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2014
VL 9
IS 8
AR e104817
DI 10.1371/journal.pone.0104817
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN8UD
UT WOS:000340879300054
PM 25127479
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pizzi, C
   Cole, TJ
   Richiardi, L
   dos-Santos-Silva, I
   Corvalan, C
   De Stavola, B
AF Pizzi, Costanza
   Cole, Tim J.
   Richiardi, Lorenzo
   dos-Santos-Silva, Isabel
   Corvalan, Camila
   De Stavola, Bianca
TI Prenatal Influences on Size, Velocity and Tempo of Infant Growth:
   Findings from Three Contemporary Cohorts
SO PLOS ONE
LA English
DT Article
ID SYSTOLIC BLOOD-PRESSURE; CATCH-UP GROWTH; BIRTH COHORT; WEIGHT-GAIN;
   CHILDHOOD GROWTH; SYSTEMATIC REVIEWS; EARLY DETERMINANTS;
   POSTNATAL-GROWTH; LATER LIFE; OBESITY
AB Background: Studying prenatal influences of early life growth is relevant to life-course epidemiology as some of its features have been linked to the onset of later diseases.
   Methods: We studied the association between prenatal maternal characteristics (height, age, parity, education, pre-pregnancy body mass index (BMI), smoking, gestational diabetes and hypertension) and offspring weight trajectories in infancy using SuperImposition by Translation And Rotation (SITAR) models, which parameterize growth in terms of three biologically interpretable parameters: size, velocity and tempo. We used data from three contemporary cohorts based in Portugal (GXXI, n = 738), Italy (NINFEA, n = 2,925), and Chile (GOCS, n = 959).
   Results: Estimates were generally consistent across the cohorts for maternal height, age, parity and pre-pregnancy overweight/obesity. Some exposures only affected one growth parameter (e. g. maternal height (per cm): 0.4% increase in size (95% confidence interval (CI): 0.3; 0.5)), others were either found to affect size and velocity (e. g. pre-pregnancy underweight vs normal weight: smaller size (-4.9%, 95% CI: -6.5; -3.3), greater velocity (5.9%, 95% CI: 1.9; 10.0)), or to additionally influence tempo (e. g. pre-pregnancy overweight/obesity vs normal weight: increased size (7.9%, 95% CI: 4.9; 10.8), delayed tempo (0.26 months, 95% CI: 0.11; 0.41), decreased velocity (24.9%, 95% CI: -10.8; 0.9)).
   Conclusions: By disentangling the growth parameters of size, velocity and tempo, we found that prenatal maternal characteristics, especially maternal smoking, pre-pregnancy overweight and underweight, parity and gestational hypertension, are associated with different aspects of infant weight growth. These results may offer insights into the mechanisms governing infant growth.
C1 [Pizzi, Costanza; Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy.
   [Pizzi, Costanza; Richiardi, Lorenzo] CPO Piemonte, Turin, Italy.
   [Pizzi, Costanza; De Stavola, Bianca] Univ London London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1E 7HT, England.
   [Cole, Tim J.] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.
   [dos-Santos-Silva, Isabel] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England.
   [Corvalan, Camila] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.
RP Pizzi, C (reprint author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy.
EM costanza.pizzi@unito.it
RI Cole, Tim J/B-7883-2008; Corvalan, Camila/B-2914-2011; richiardi,
   lorenzo/J-3480-2018
OI Cole, Tim J/0000-0001-5711-8200; Corvalan, Camila/0000-0003-3766-7709;
   richiardi, lorenzo/0000-0003-0316-9402; De Stavola, Bianca
   Lucia/0000-0001-7853-0528; dos Santos Silva, Isabel/0000-0002-6596-8798
FU Compagnia San-Paolo Foundation; Piedmont Region; Italian Ministry of
   University and Research; Programa Operacional de Sade - Saude XXI,
   Quadro Comunitario de Apoio III; Administracao Regional de Saude Norte;
   Fondecyt [1060785, 1090252, 1120326]; Medical Research Council
   [MR/J004839/1]
FX NINFEA cohort was partially funded by Compagnia San-Paolo Foundation,
   Piedmont Region and Italian Ministry of University and Research. GXXI
   cohort was funded by Programa Operacional de Sade - Saude XXI, Quadro
   Comunitario de Apoio III and by Administracao Regional de Saude Norte.
   GOCS cohort was funded by Fondecyt projects 1060785, 1090252 and
   1120326. TJC is funded by Medical Research Council grant MR/J004839/1.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   Barker DJ, 1998, MOTHERS BABIES HLTH
   Beath KJ, 2007, STAT MED, V26, P2547, DOI 10.1002/sim.2718
   Bulk-Bunschoten AMW, 2002, PAEDIATR PERINAT EP, V16, P361, DOI 10.1046/j.1365-3016.2002.00440.x
   Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115
   Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F
   Corvalan C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318
   De Stavola BL, 2004, AM J EPIDEMIOL, V159, P671, DOI 10.1093/aje/kwh097
   Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a
   Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Fall CHD, 2011, ANN HUM BIOL, V38, P410, DOI 10.3109/03014460.2011.592513
   Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047
   Harville EW, 2012, AM J EPIDEMIOL, V176, pS150, DOI 10.1093/aje/kws231
   Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f
   Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387
   Hui LL, 2010, ANN EPIDEMIOL, V20, P827, DOI 10.1016/j.annepidem.2010.07.001
   Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002
   Johnson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019918
   KRAMER MS, 1987, PEDIATRICS, V80, P502
   Larsen PS, 2013, PAEDIATR PERINAT EP, V27, P393, DOI 10.1111/ppe.12060
   Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3
   Mihrshahi S, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-99
   Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x
   Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x
   Ong KK, 2010, ENDOCR DEV, V19, P53, DOI 10.1159/000316897
   Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/01.PDR.0000036602.81878.6D
   Pizzi C, 2014, J R STAT SOC A STAT, V177, P371, DOI 10.1111/rssa.12020
   Pizzi C, 2012, J EPIDEMIOL COMMUN H, V66, P976, DOI 10.1136/jech-2011-200065
   Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481
   Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132
   Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292
   Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Skrondal A., 2004, GEN LATENT VARIABLE
   Touwslager RN, 2011, J PEDIAT, V158
   Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027
   Vansteelandt S, 2012, CAUSALITY STAT PERSP
   Vohr BR, 1999, DIABETES CARE, V22, P1284, DOI 10.2337/diacare.22.8.1284
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
NR 42
TC 16
Z9 16
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2014
VL 9
IS 2
AR e90291
DI 10.1371/journal.pone.0090291
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC3BU
UT WOS:000332390800099
PM 24587314
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Naik, AW
   Kangas, JD
   Langmead, CJ
   Murphy, RF
AF Naik, Armaghan W.
   Kangas, Joshua D.
   Langmead, Christopher J.
   Murphy, Robert F.
TI Efficient Modeling and Active Learning Discovery of Biological Responses
SO PLOS ONE
LA English
DT Article
ID SYSTEMS BIOLOGY; MISSING DATA; PREDICTION; SELECTION
AB High throughput and high content screening involve determination of the effect of many compounds on a given target. As currently practiced, screening for each new target typically makes little use of information from screens of prior targets. Further, choices of compounds to advance to drug development are made without significant screening against off-target effects. The overall drug development process could be made more effective, as well as less expensive and time consuming, if potential effects of all compounds on all possible targets could be considered, yet the cost of such full experimentation would be prohibitive. In this paper, we describe a potential solution: probabilistic models that can be used to predict results for unmeasured combinations, and active learning algorithms for efficiently selecting which experiments to perform in order to build those models and determining when to stop. Using simulated and experimental data, we show that our approaches can produce powerful predictive models without exhaustive experimentation and can learn them much faster than by selecting experiments at random.
C1 [Naik, Armaghan W.; Kangas, Joshua D.; Langmead, Christopher J.; Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.
   [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA.
   [Murphy, Robert F.] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany.
   [Murphy, Robert F.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany.
RP Murphy, RF (reprint author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.
EM murphy@cmu.edu
FU National Institutes of Health [R01 GM075205, T32 EB009403-01]
FX Research reported in this publication was supported by the National
   Institutes of Health under Award Numbers R01 GM075205 and T32
   EB009403-01. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Allison PD, 2000, SOCIOL METHOD RES, V28, P301, DOI 10.1177/0049124100028003003
   Angluin D, 2010, LECT NOTES ARTIF INT, V6331, P194, DOI 10.1007/978-3-642-16108-7_18
   [Anonymous], 2013, CONN MAP
   Balcan MF, 2009, J COMPUT SYST SCI, V75, P78, DOI 10.1016/j.jcss.2008.07.003
   Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5
   Chen P, 2004, IEEE T PATTERN ANAL, V26, P1051, DOI 10.1109/TPAMI.2004.52
   Cohn DA, 1996, J ARTIF INTELL RES, V4, P129, DOI 10.1613/jair.295
   Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498
   Een N, 2004, LECT NOTES COMPUT SC, V2919, P502
   Even-Dar E, 2002, COMPUTATIONAL LEARNI, P193
   Fujiwara Y, 2008, J CHEM INF MODEL, V48, P930, DOI 10.1021/ci700085q
   Heckman J, 1998, ECONOMETRICA, V66, P1017, DOI 10.2307/2999630
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a
   Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159
   Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006
   Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57
   Murphy RF, 2011, NAT CHEM BIOL, V7, P327, DOI 10.1038/nchembio.576
   Pan GQ, 2004, LECT NOTES COMPUT SC, V3258, P453
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Saar-Tsechansky M, 2004, MACH LEARN, V54, P153, DOI 10.1023/B:MACH.0000011806.12374.c3
   Sahinidis NV, 2003, LECT NOTES COMPUT SC, V2861, P1
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t
   Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020
NR 27
TC 14
Z9 14
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2013
VL 8
IS 12
AR e83996
DI 10.1371/journal.pone.0083996
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276GT
UT WOS:000328737700075
PM 24358322
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Derrett, S
   Wilson, S
   Samaranayaka, A
   Langley, J
   Wyeth, E
   Ameratunga, S
   Lilley, R
   Davie, G
   Mauiliu, M
AF Derrett, Sarah
   Wilson, Suzanne
   Samaranayaka, Ari
   Langley, John
   Wyeth, Emma
   Ameratunga, Shanthi
   Lilley, Rebbecca
   Davie, Gabrielle
   Mauiliu, Melbourne
TI Prevalence and Predictors of Disability 24-Months after Injury for
   Hospitalised and Non-Hospitalised Participants: Results from a
   Longitudinal Cohort Study in New Zealand
SO PLOS ONE
LA English
DT Article
ID OF-LIFE OUTCOMES; MAJOR TRAUMA; FUNCTIONAL CONSEQUENCES; DIAGNOSIS
   MATRIX; HEALTH-STATUS; WOMEN; CARE
AB Introduction: Most studies investigating disability outcomes following injury have examined hospitalised patients. It is not known whether variables associated with disability outcomes are similar for injured people who are not hospitalised.
   Aims: This paper compares the prevalence of disability 24 months after injury for participants in the Prospective Outcomes of Injury Study who were hospitalised and those non-hospitalised, and also seeks to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised participants.
   Methods: Participants, aged 18-64 years, were recruited from an injury claims register managed by New Zealand's no-fault injury compensation insurer after referral by health care professionals. A wide range of pre-injury socio-demographic, health and psychosocial characteristics were collected, as well as injury-related characteristics; outcome is assessed using the WHODAS. Multivariable models estimating relative risks of disability for hospitalised and non-hospitalised participants were developed using Poisson regression methods.
   Results: Of 2856 participants, analyses were restricted to 2184 (76%) participants for whom both pre-injury and 24 month WHODAS data were available. Of these, 25% were hospitalised. In both hospitalised and non-hospitalised groups, 13% experience disability (WHODAS >= 10) 24 months after injury; higher than pre-injury (5%). Of 28 predictor variables, seven independently placed injured participants in the hospitalised group at increased risk of disability 24 months after injury; eight in the non-hospitalised. Only four predictors (pre-injury disability, two or more pre-injury chronic conditions, pre-injury BMI>30 and trouble accessing healthcare services) were common to both the hospitalised and non-hospitalised groups. There is some evidence to suggest that among the hospitalised group, Maori ori have higher risk of disability relative to nonMaori.
   Conclusions: At 24 months considerable disability is borne, equally, by hospitalised and non-hospitalised groups. However, predictors of disability are not necessarily consistent between the hospitalised and non-hospitalised groups, suggesting caution in generalising results from one group to the other.
C1 [Derrett, Sarah; Wilson, Suzanne; Samaranayaka, Ari; Langley, John; Lilley, Rebbecca; Davie, Gabrielle; Mauiliu, Melbourne] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.
   [Wyeth, Emma] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Ngai Tahu Maori Hlth Res Unit, Dunedin, New Zealand.
   [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand.
   [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Hlth & Social Serv, Palmerston North, New Zealand.
RP Derrett, S (reprint author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.
EM s.l.derrett@massey.ac.nz
OI Ameratunga, Shanthi/0000-0001-8042-2251; Derrett,
   Sarah/0000-0003-2867-0498; Wyeth, Emma/0000-0002-6869-5190; Davie,
   Gabrielle/0000-0001-5466-5364
FU Health Research Council of New Zealand; Accident Compensation
   Corporation, New Zealand
FX This study is funded by the Health Research Council of New Zealand
   (2007-2013), and was co-funded by the Accident Compensation Corporation,
   New Zealand (2007-2010). The views and conclusions expressed herein are
   the authors and may not reflect those of the funders. The Accident
   Compensation Corporation sent out invitations to eligible potential
   participants on the research team's behalf, and also provided, following
   participants' consent, information from the electronic record about
   participants' injuries. The funders had no role in study design,
   analysis, decision to publish, or preparation of the manuscript.
CR Accident Compensation Corporation, 2010, ANNUAL REPORT 2010
   American Psychiatric Association Committee of Nomenclature and Statistics, 1980, DIAGNOSTIC AND STATI
   Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343
   Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91
   Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833
   Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x
   Derrett S., 2009, Injury Prevention, V15, P351, DOI 10.1136/ip.2009.022558a
   Derrett S, 2012, AUSTRALAS EPIDEMIOL, V19, P17
   Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909
   Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044
   Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076
   Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b
   Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.000109758.75406.F8
   Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62
   Jerusalem M., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000
   Kendrick D, 2013, INJURY PREV, V19, P370, DOI 10.1136/injuryprev-2012-040658
   Langley JD, 2013, INJURY PREV, V19, P428, DOI 10.1136/injuryprev-2012-040685
   Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93
   Mauri Ora Associates, 2010, ORI EXPERIENCE OF AC
   Ministry of Health, 2012, TUPU OLA MOUI PACIFI
   Ministry of Health, 2010, TATAU KAHUKURA MA OR
   Ministry of Health, 2008, PORTRAIT HLTH KEY RE
   Ministry of Social Development, 2000, DIRECT MEASUREMENT O
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3
   Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06
   Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708
   Polinder S, 2011, EPIDEMIOL REV, V34, P17
   Portney KE, 1997, AM BEHAV SCI, V40, P632, DOI 10.1177/0002764297040005009
   Ratima K, 2007, HAUORA MA ORI STANDA
   Robroek SJW, 2013, SCANDANAVIAN JOURNAL, DOI [10.5271/ sjweh. 3354., DOI 10.5271/SJWEH.3354.]
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rumball-Smith JML, 2009, NEW ZEAL MED J, V122, P68
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740
   Smith DL, 2008, DISABIL HEALTH J, V1, P79, DOI 10.1016/j.dhjo.2008.01.001
   Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050
   Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea
   Sport and Recreation New Zealand, 2004, THE NEW ZEALAND PHYS
   StataCorp, 2011, STATA RELEASE 12 STA
   Statistics New Zealand, 2007, QUICKSTATS ABOUT MA
   Statistics New Zealand, 2006, 2006 CENSUS OF POPUL
   Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10
   T Ustun, 2010, MEASURING HEALTH AND
   Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038
   Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F
   Ware J, 2000, SF 36H HEALTH SURVEY
   Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68
   World Health Organization, 2011, BMI CLASSIFICATION
   Wyeth EH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-120
   Wyeth EH, 2010, ETHNIC HEALTH, V15, P303, DOI 10.1080/13557851003721194
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 52
TC 17
Z9 17
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2013
VL 8
IS 11
AR e80194
DI 10.1371/journal.pone.0080194
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259PW
UT WOS:000327539800063
PM 24278258
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, JH
   Park, HY
   Bae, S
   Lim, YH
   Hong, YC
AF Kim, Jin Hee
   Park, Hye Yin
   Bae, Sanghyuk
   Lim, Youn-Hee
   Hong, Yun-Chul
TI Diethylhexyl Phthalates Is Associated with Insulin Resistance via
   Oxidative Stress in the Elderly: A Panel Study
SO PLOS ONE
LA English
DT Article
ID IN-UTERO EXPOSURE; DI(2-ETHYLHEXYL) PHTHALATE; TEMPORAL VARIABILITY;
   METABOLIC SYNDROME; NATIONAL-HEALTH; URINE SAMPLES; MISSING DATA; INDOOR
   AIR; MALE RATS; GLUCOSE
AB Background: Insulin resistance (IR) is believed to be the underlying mechanism of metabolic syndrome and type 2 diabetes mellitus (DM). Recently, a few studies have demonstrated that phthalates could cause oxidative stress which would contribute to the development of IR. Therefore, we evaluated whether exposure to phthalates affects IR, and oxidative stress is involved in the phthalates-IR pathway.
   Methods: We recruited 560 elderly participants, and obtained blood and urine samples during repeated medical examinations. For the determination of phthalate exposure, we measured urinary levels of mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) as metabolites of diethylhexyl phthalates (DEHP), and mono-n-butyl phthalate (MnBP) as a metabolite of di-butyl phthalate (DBP). Malondialdehyde (MDA), an oxidative stress biomarker, was also measured in urine samples. We measured serum levels of fasting glucose and insulin, and derived the homeostatic model assessment (HOMA) index to assess IR. A mixed-effect model and penalized regression spline were used to estimate the associations among phthalate metabolites, MDA, and IR.
   Results: The molar sum of MEHHP and MEOHP (Sigma DEHP) were significantly associated with HOMA (beta = 0.26, P = 0.040), and the association was apparent among participants with a history of DM (beta = 0.88, P = 0.037) and among females (beta = 0.30, P = 0.022). However, the relation between MnBP and HOMA was not found. When we evaluated whether oxidative stress is involved in increases of HOMA by Sigma DEHP, MDA levels were significantly associated with increases of Sigma DEHP (beta = 0.11, P < 0.001) and HOMA (beta = 0.49, P = 0.049).
   Conclusions: Our study results suggest that exposure to DEHP in the elderly population increases IR, which is related with oxidative stress, and that participants with a history of DM and females are more susceptible to DEHP exposure.
C1 [Kim, Jin Hee; Hong, Yun-Chul] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea.
   [Kim, Jin Hee; Bae, Sanghyuk; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul, South Korea.
   [Park, Hye Yin; Bae, Sanghyuk; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Lim, Youn-Hee] Seoul Natl Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Seoul, South Korea.
RP Hong, YC (reprint author), Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea.
EM ychong1@snu.ac.kr
FU Ministry of Environment, Republic of Korea
FX This study was supported by the Susceptible Population Research Program
   (2008-2010) of the Ministry of Environment, Republic of Korea. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309
   Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003
   Eckardt Kristin, 2008, Archives of Physiology and Biochemistry, V114, P287, DOI [10.1080/13813450802404761, 10.1080/13813450802404761 ]
   Eriksson JW, 2007, FEBS LETT, V581, P3734, DOI 10.1016/j.febslet.2007.06.044
   Fischer P, 2003, EUR RESPIR J, V21, p34S, DOI 10.1183/09031936.03.00402503
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243
   Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x
   Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311
   Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011
   Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212
   Healey N, 2009, RADIAT PROT DOSIM, V134, P143, DOI 10.1093/rpd/ncp068
   Hoang Khiet C, 2007, J Cardiometab Syndr, V2, P276, DOI 10.1111/j.1559-4564.2007.07491.x
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571, DOI 10.1289/ehp.6564
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515
   James-Todd T, 2012, ENVIRON HEALTH PERSP, V120, P1307, DOI 10.1289/ehp.1104717
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005
   Kim JH, 2012, TOXICOL LETT, V214, P263, DOI 10.1016/j.toxlet.2012.09.006
   Kim JH, 2012, ENVIRON HEALTH PERSP, V120, P1378, DOI 10.1289/ehp.1104406
   Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3
   Lamb RE, 2008, INT J CLIN PRACT, V62, P1087, DOI 10.1111/j.1742-1241.2008.01789.x
   Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002
   Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011
   Lim S, 2010, ANN NY ACAD SCI, V1201, P166, DOI 10.1111/j.1749-6632.2010.05622.x
   Lind PM, 2012, DIABETES CARE, V35, P1519, DOI 10.2337/dc11-2396
   Marx J, 2002, SCIENCE, V296, P686, DOI 10.1126/science.296.5568.686
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690
   Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006
   Petersen KF, 2002, AM J CARDIOL, V90, p11G
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048
   ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/i.cmet.2007.08.011
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x
   Zarich S W, 2006, Minerva Cardioangiol, V54, P195
NR 56
TC 39
Z9 44
U1 1
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2013
VL 8
IS 8
AR e71392
DI 10.1371/journal.pone.0071392
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205ER
UT WOS:000323425700045
PM 23977034
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gras, L
   Geskus, RB
   Jurriaans, S
   Bakker, M
   van Sighem, A
   Bezemer, D
   Fraser, C
   Prins, JM
   Berkhout, B
   de Wolf, F
AF Gras, Luuk
   Geskus, Ronald B.
   Jurriaans, Suzanne
   Bakker, Margreet
   van Sighem, Ard
   Bezemer, Daniela
   Fraser, Christophe
   Prins, Jan M.
   Berkhout, Ben
   de Wolf, Frank
CA ATHENA Natl Observational Cohort
TI Has the Rate of CD4 Cell Count Decline before Initiation of
   Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic
   among MSM?
SO PLOS ONE
LA English
DT Article
ID PATTERN-MIXTURE MODELS; PLASMA VIRAL LOAD; SET-POINT; PROGNOSTIC
   MARKERS; AMSTERDAM COHORT; DUAL INFECTIONS; HOMOSEXUAL-MEN;
   TRANSMISSION; AIDS; VIRULENCE
AB Introduction: Studies suggest that the HIV-1 epidemic in the Netherlands may have become more virulent, leading to faster disease progression if untreated. Analysis of CD4 cell count decline before antiretroviral therapy (ART) initiation, a surrogate marker for disease progression, may be hampered by informative censoring as ART initiation is more likely with a steeper CD4 cell count decline.
   Methods: Development of CD4 cell count from 9 to 48 months after seroconversion was analyzed using a mixed-effects model and 2 models that jointly modeled CD4 cell counts and time to censoring event (start ART, <100 CD4 cells/mm(3), or AIDS) among therapy-naive MSM HIV-1 seroconverters in the Netherlands. These models make different assumptions about the censoring process.
   Results: All 3 models estimated lower median CD4 cell counts 9 months after seroconversion in later calendar years (623, 582, and 541 cells/mm(3) for 1984-1995 [n = 111], 1996-2002 [n = 139], and 2003-2007 seroconverters [n = 356], respectively, shared-parameter model). Only the 2 joint-models found a trend for a steeper decline of CD4 cell counts with seroconversion in later calendar years (overall p-values 0.002 and 0.06 for the pattern-mixture and the shared-parameter model, respectively). In the shared-parameter model the median decline from 9 to 48 months was 276 cellsmm(3) for 1984-1995 seroconverters and 308 cells/mm(3) for 2003-2007 seroconverters (difference in slope, p = 0.045).
   Conclusion: Mixed-effects models underestimate the CD4 cell decline prior to starting ART. Joint-models suggest that CD4 cell count declines more rapidly in patients infected between 2003 and 2007 compared to patients infected before 1996.
C1 [Gras, Luuk; van Sighem, Ard; Bezemer, Daniela; de Wolf, Frank] Stichting HIV Monitoring, Amsterdam, Netherlands.
   [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands.
   [Jurriaans, Suzanne; Bakker, Margreet; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [Fraser, Christophe; de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England.
   [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands.
   [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [Geskus, Ronald B.] Publ Hlth Serv Amsterdam, Dept Res, Cluster Infect Dis, Amsterdam, Netherlands.
RP Gras, L (reprint author), Stichting HIV Monitoring, Amsterdam, Netherlands.
EM l.a.gras@amc.uva.nl
RI Geskus, Ronald B/H-3684-2019; Fraser, Christophe/A-8109-2008
OI Fraser, Christophe/0000-0003-2399-9657
FU Netherlands Ministry of Health, Welfare and Sport; Netherlands National
   Institute for Public Health and the Environment; Medical Research
   Council [G0800596, G0600719B, MR/K010174/1, MR/K010174/1B]
FX The ATHENA observational clinical cohort is part of Stichting HIV
   Monitoring, Amsterdam, the Netherlands and is supported by a grant of
   the Netherlands Ministry of Health, Welfare and Sport. The Amsterdam
   Cohort Studies on HIV infection and AIDS, a collaboration between the
   Public Health Service of Amsterdam, the Academic Medical Centre of the
   University of Amsterdam, Sanquin Blood Supply Foundation and the
   University Medical Centre Utrecht, are part of Stichting HIV Monitoring
   and are financially supported by the Netherlands National Institute for
   Public Health and the Environment. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123
   Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca
   Bekele Yonas, 2011, Ethiop Med J, V49, P187
   Celum C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012598, DOI 10.1371/J0URNAL.P0NE.0012598]
   Cornelissen M, 2007, AIDS, V21, P807, DOI 10.1097/QAD.0b013e3280f3c08a
   Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777
   Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911
   Fife K, 2011, INFECTED PARTNERS PL
   Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104
   Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021
   Geskus RB, 2005, JAIDS-J ACQ IMM DEF, V39, P321, DOI 10.1097/01.qai.0000142017.25897.06
   Geskus RB, 2012, STAT METHODS MED RES, DOI [10.1177/0962280212445840, DOI 10.1177/0962280212445840]
   Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65
   Gras L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007365
   Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e
   Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525
   Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418
   Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728
   Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876
   Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9
   Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e
   Levering WHBM, 2008, CYTOM PART B-CLIN CY, V74B, P79, DOI 10.1002/cyto.b.20370
   LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302
   Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494
   Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003
   Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454
   Muller V, 2006, AIDS, V20, P889
   Rachinger A, 2011, J INFECT DIS, V203, P1621, DOI 10.1093/infdis/jir164
   Rizopoulos D, 2010, J STAT SOFTWARE, V35
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Santagostino A, 1999, HAEMATOLOGICA, V84, P499
   SCHELLEKENS PTA, 1992, AIDS, V6, P665, DOI 10.1097/00002030-199207000-00008
   Schellens IMM, 2011, AIDS, V25, P1691, DOI 10.1097/QAD.0b013e32834981b3
   Stolte I, 2011, MONITORING HUMAN IMM
   Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468
   Thijs H, 2002, BIOSTATISTICS, V3, P245, DOI 10.1093/biostatistics/3.2.245
   van der Helm JJ, 2009, OVERVIEW AMSTERDAM C
   van der Kuyl AC, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-60
   van der Kuyl AC, 2010, AIDS, V24, P1607, DOI 10.1097/QAD.0b013e32833b318f
   van der Kuyl AC, 2009, CLIN INFECT DIS, V48, P973, DOI 10.1086/597356
   van Manen D, 2011, AIDS, V25, P2217, DOI 10.1097/QAD.0b013e32834bec9c
   Veugelers PJ, 1997, J INFECT DIS, V176, P112, DOI 10.1086/514012
   Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0
NR 43
TC 10
Z9 10
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2013
VL 8
IS 5
AR e64437
DI 10.1371/journal.pone.0064437
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 155HH
UT WOS:000319738100026
PM 23724048
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Carlson, JE
   Holsinger, KE
AF Carlson, Jane E.
   Holsinger, Kent E.
TI Developmental Plasticity in Protea as an Evolutionary Response to
   Environmental Clines in the Cape Floristic Region
SO PLOS ONE
LA English
DT Article
ID MULTIPLE COMPARISON PROCEDURES; PHENOTYPIC PLASTICITY; SOUTH-AFRICA;
   ECOLOGICAL SPECIATION; ONTOGENIC CONTINGENCY; BIODIVERSITY HOTSPOT;
   NATURAL-SELECTION; LOCAL ADAPTATION; PLANT DIVERSITY; TRAITS
AB Local adaptation along steep environmental gradients likely contributes to plant diversity in the Cape Region of South Africa, yet existing analyses of trait divergence are limited to static measurements of functional traits rather than trajectories of individual development. We explore whether five taxa of evergreen shrubs (Protea section Exsertae) differ in their developmental trajectories and capacity for plasticity using two environmentally-distinct common gardens in South Africa. We measured seedlings in the summer-dry season and winter-wet season of each of two consecutive years to characterize ontogeny and plasticity within years, as same-age leaf cohorts mature, and between years, i.e., from leaf one cohort to the next. We compared patterns of development between gardens to assess whether trait trajectories are programmed versus plastic and examined whether developmental differences covaried with characteristics of a seedling's home environment. We detected plasticity in developmental trajectories for leaf area, stomatal size, stomatal pore index, and to a limited extent specific leaf area, but not for stomatal density. We showed that the species growing in the harshest environments exhibits both the smallest increase in leaf area between years and the least change in SLA and photosynthetic rates as leaves age within years. These results show that within this clade, species have diverged in developmental trajectories and plasticity as well as in mean trait values. Some of these differences may be associated with adaptation to cold and drought stress within an environmentally-complex region. Citation: Carlson JE, Holsinger KE (2012) Developmental Plasticity in Protea as an Evolutionary Response to Environmental Clines in the Cape Floristic Region. PLoS ONE 7(12): e52035. doi:10.1371/journal.pone.0052035
C1 [Carlson, Jane E.; Holsinger, Kent E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.
RP Holsinger, KE (reprint author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.
EM kent.holsinger@uconn.edu
RI Holsinger, Kent/A-7435-2009
OI Holsinger, Kent/0000-0003-4312-3804
FU United States National Science Foundation [DEB-0716622, DEB-1046328]
FX This work was supported by grants from the United States National
   Science Foundation: DEB-0716622 and DEB-1046328. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agrawal AA, 2008, J ECOL, V96, P536, DOI 10.1111/j.1365-2745.2008.01365.x
   Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767
   ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0
   Bell DL, 1999, AM J BOT, V86, P807, DOI 10.2307/2656702
   Bukhov NG, 2004, CHLOROPHYLL FLUORESC
   Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x
   Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348
   Clausen J D, 1940, WASH PUBL
   COOK SA, 1968, EVOLUTION, V22, P496, DOI 10.1111/j.1558-5646.1968.tb03988.x
   Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6
   Cowling RM, 2002, DIVERSITY DISTRIBUTI, V8
   DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3
   DIGGLE PK, 1994, AM J BOT, V81, P1354, DOI 10.2307/2445411
   Diggle PK, 2002, EVOL ECOL, V16, P267, DOI 10.1023/A:1019680527788
   Distler T, 2009, ANN MO BOT GARD, V96, P470, DOI 10.3417/2008034
   Dunlap JM, 2001, CAN J BOT, V79, P528, DOI 10.1139/cjb-79-5-528
   Edwards EJ, 2006, NEW PHYTOL, V172, P479, DOI 10.1111/j31469-8137.2006.01850.x
   Ellis AG, 2006, J ECOL, V94, P322, DOI 10.1111/j.1365-2745.2005.01074.x
   FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x
   Forster MA, 2009, ANN BOT-LONDON, V103, P95, DOI 10.1093/aob/mcn210
   Forsyth GG, 2007, CSIR REPORT NUMBER C
   Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.002031.x, 10.1111/j.1365-3040.2009.02031.x]
   Friar EA, 2006, EVOLUTION, V60, P1777
   Geber MA, 2003, INTERNATIONAL JOURNA, V164
   Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x
   Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5
   Goldblatt P., 2000, CAPE PLANTS A CONSPE
   GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726
   Grime J. P., 1979, PLANT STRATEGIES VEG
   Heschel S, 2001, INT J PLANT SCI, V162, P1253
   Jones C. S., 2001, B SOC ARGENT BOT, V36, P171
   Jones CS, 1993, AM J BOT, V80, P78
   Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x
   Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104
   Latimer AM, 2009, OECOLOGIA, V160, P151, DOI 10.1007/s00442-009-1275-3
   Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171
   Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006
   Littell R. C., 2006, SAS MIXED MODELS
   Maherali H, 2009, NEW PHYTOL, V183, P908, DOI 10.1111/j.1469-8137.2009.02845.x
   Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x
   Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835
   Paakkonen E, 1998, ANN BOT-LONDON, V82, P49, DOI 10.1006/anbo.1998.0656
   Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z
   Prunier R, JOURNAL OF EVOLUTION
   Prunier R, 2010, MOL ECOL, V19, P3968, DOI 10.1111/j.1365-294X.2010.04779.x
   Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052
   Rebelo A. G., 2006, PROTEA ATLAS PROJECT
   Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368
   Reynoso G.A., 2001, ACTA HORT ISHS, V545, P245
   RICHARDSON DM, 1990, S AFR J BOT, V56, P214, DOI 10.1016/S0254-6299(16)31089-4
   Rosenzweig M. L., 1995, SPECIES DIVERSITY SP
   Rubin D. B., 1987, MULTIPLE IMPUTATION
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635
   Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141
   SAS Institute Inc, 2008, SAS STAT 9 2 USERS G
   SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163
   Saville DJ, 2003, CAN J EXP PSYCHOL, V57, P167, DOI 10.1037/h0087423
   Schlichting CD, 1998, PHENOTYPIC EVOLUTION
   Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006
   Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006
   Schulze RE, 2007, WRC REPORT 1489 1 06
   Stock WD, 1997, VEGETATION SO AFRICA
   Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x
   SULTAN SE, 1992, EVOL TREND PLANT, V6, P61
   Valente LM, 2010, EVOLUTION, V64, P745, DOI 10.1111/j.1558-5646.2009.00856.x
   van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x
   Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364
   WATSON MA, 1995, TRENDS ECOL EVOL, V10, P474
   West-Eberhard M. J., 2003, DEV PLASTICITY EVOLU
   Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263
   Yuan Y, 2000, PROCEEDINGS OF THE 2
NR 72
TC 5
Z9 5
U1 0
U2 47
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 13
PY 2012
VL 7
IS 12
AR e52035
DI 10.1371/journal.pone.0052035
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 055AH
UT WOS:000312386600054
PM 23272203
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bethell, EJ
   Holmes, A
   MacLarnon, A
   Semple, S
AF Bethell, Emily J.
   Holmes, Amanda
   MacLarnon, Ann
   Semple, Stuart
TI Evidence That Emotion Mediates Social Attention in Rhesus Macaques
SO PLOS ONE
LA English
DT Article
ID SELECTIVE ATTENTION; FACIAL EXPRESSIONS; NONHUMAN-PRIMATES; BEHAVIOR;
   ANXIETY; TESTOSTERONE; THREAT; FACES; STRESS; GAZE
AB Background: Recent work on non-human primates indicates that the allocation of social attention is mediated by characteristics of the attending animal, such as social status and genotype, as well as by the value of the target to which attention is directed. Studies of humans indicate that an individual's emotion state also plays a crucial role in mediating their social attention; for example, individuals look for longer towards aggressive faces when they are feeling more anxious, and this bias leads to increased negative arousal and distraction from other ongoing tasks. To our knowledge, no studies have tested for an effect of emotion state on allocation of social attention in any non-human species.
   Methodology: We presented captive adult male rhesus macaques with pairs of adult male conspecific face images - one with an aggressive expression, one with a neutral expression - and recorded gaze towards these images. Each animal was tested twice, once during a putatively stressful condition (i.e. following a veterinary health check), and once during a neutral (or potentially positive) condition (i.e. a period of environmental enrichment). Initial analyses revealed that behavioural indicators of anxiety and stress were significantly higher after the health check than during enrichment, indicating that the former caused a negative shift in emotional state.
   Principle Findings: The macaques showed initial vigilance for aggressive faces across both conditions, but subsequent responses differed between conditions. Following the health check, initial vigilance was followed by rapid and sustained avoidance of aggressive faces. By contrast, during the period of enrichment, the macaques showed sustained attention towards the same aggressive faces.
   Conclusions/Significance: These data provide, to our knowledge, the first evidence that shifts in emotion state mediate social attention towards and away from facial cues of emotion in a non-human animal. This work provides novel insights into the evolution of emotion-attention interactions in humans, and mechanisms of social behaviour in non-human primates, and may have important implications for understanding animal psychological wellbeing.
C1 [Bethell, Emily J.; MacLarnon, Ann; Semple, Stuart] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.
   [Holmes, Amanda] Univ Roehampton, Dept Psychol, London, England.
RP Bethell, EJ (reprint author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.
EM E.J.Bethell@ljmu.ac.uk
OI Bethell, Emily/0000-0002-0371-8873; MacLarnon, Ann/0000-0003-2722-4998
FU Roehampton University; Universities Federation for Animal Welfare;
   Primate Society of Great Britain
FX This work was supported by a postgraduate bursary from Roehampton
   University and grants from Universities Federation for Animal Welfare
   and the Primate Society of Great Britain. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534
   Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x
   Anestis SF, 2010, EVOL ANTHROPOL, V19, P66, DOI 10.1002/evan.20253
   Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H
   Aureli F, 2003, PRIMATE PSYCHOL
   Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1
   Bar-Haim Y, 2011, J CHILD PSYCHOL PSYC, V52, P861, DOI 10.1111/j.1469-7610.2011.02368.x
   Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008
   Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636
   Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157
   Chiao JY, 2010, P R SOC B, V277, P529, DOI 10.1098/rspb.2009.1650
   Chichinadze K, 2011, PHYSIOL BEHAV, V94, P595
   Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0
   Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649
   Dalmaso M, BIOL LETT IN PRESS
   Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421
   Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044
   Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025
   Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857
   Dobson S, 2012, PHILOS T R SOC B, V367, P1901, DOI 10.1098/rstb.2011.0224
   Doyle LA, 2008, AM J PRIMATOL, V70, P542, DOI 10.1002/ajp.20526
   Einhauser W, 2006, VISION RES, V46, P1194, DOI 10.1016/j.visres.2005.08.032
   Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009
   Fernandes AC, 2010, 40 ANN M NEUR
   Fontenot MB, 2006, J AM ASSOC LAB ANIM, V45, P35
   Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788
   Fridmun EP, 2002, MED PRIMATOLOGY HIST
   Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760
   Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006
   Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222
   Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052
   Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003
   Holmes A, 2009, PSYCHOPHYSIOLOGY, V46, P62, DOI 10.1111/j.1469-8986.2008.00750.x
   Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P390, DOI 10.1016/j.neubiorev.2005.04.003
   Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P413, DOI 10.1016/j.neubiorev.2005.05.002
   Josephs RA, 2012, PSYCHONEUROENDOCRINO, V37, P752, DOI 10.1016/j.psyneuen.2011.09.006
   Kalin NH, 1998, BEHAV NEUROSCI, V112, P286, DOI 10.1037/0735-7044.112.2.286
   King HM, 2012, PSYCHONEUROENDOCRINO, V37, P396, DOI 10.1016/j.psyneuen.2011.07.010
   Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010
   Lacreuse A, 2010, HORM BEHAV, V58, P854, DOI 10.1016/j.yhbeh.2010.08.010
   LeDoux J, 1996, EMOTION BRAIN MYSTER
   Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075
   Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598
   MAESTRIPIERI D, 1993, ETHOLOGY, V95, P19
   Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459
   Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003
   Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010
   Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518
   Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023
   Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264
   Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246
   NC3Rs, 2011, NAT CTR REPL REF RED
   Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150
   Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169
   Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483
   Reamer L, 2010, APPL ANIM BEHAV SCI, V124, P68, DOI 10.1016/j.applanim.2010.01.012
   Richards AB, 2009, HORM BEHAV, V56, P140, DOI 10.1016/j.yhbeh.2009.03.021
   Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032
   Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013
   Shively CA, 2009, NEUROSCI BIOBEHAV R, V33, P133, DOI 10.1016/j.neubiorev.2008.06.006
   van Honk J, 1999, HORM BEHAV, V36, P17, DOI 10.1006/hbeh.1999.1521
   Waller BM, 2008, PHYSIOL BEHAV, V95, P93, DOI 10.1016/j.physbeh.2008.05.002
   Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156
   West BT, 2007, LINEAR MIXED MODELS
   WHITESIDE JA, 1976, CHILD DEV, V47, P290
   Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016
   Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698
NR 69
TC 40
Z9 40
U1 0
U2 56
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2012
VL 7
IS 8
AR e44387
DI 10.1371/journal.pone.0044387
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 997ZH
UT WOS:000308206500067
PM 22952968
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fontela, PS
   Quach, C
   Buckeridge, D
   Pai, M
   Platt, RW
AF Fontela, Patricia S.
   Quach, Caroline
   Buckeridge, David
   Pai, Madukhar
   Platt, Robert W.
TI Surveillance Length and Validity of Benchmarks for Central
   Line-Associated Bloodstream Infection Incidence Rates in Intensive Care
   Units
SO PLOS ONE
LA English
DT Article
ID NETWORK NHSN REPORT; MISSING DATA; SYSTEM; NETHERLANDS; HOSPITALS;
   ENGLAND
AB Introduction: Several national and regional central line-associated bloodstream infections (CLABSI) surveillance programs do not require continuous hospital participation. We evaluated the effect of different hospital participation requirements on the validity of annual CLABSI incidence rate benchmarks for intensive care units (ICUs).
   Methods: We estimated the annual pooled CLABSI incidence rates for both a real regional (< 100 ICUs) and a simulated national (600 ICUs) surveillance program, which were used as a reference for the simulations. We simulated scenarios where the annual surveillance participation was randomly or non-randomly reduced. Each scenario's annual pooled CLABSI incidence rate was estimated and compared to the reference rates in terms of validity, bias, and proportion of simulation iterations that presented valid estimates (ideal if >= 90%).
   Results: All random scenarios generated valid CLABSI incidence rates estimates (bias -0.37 to 0.07 CLABSI/1000 CVC-days), while non-random scenarios presented a wide range of valid estimates (0 to 100%) and higher bias (-22.18 to 1.27 CLABSI/1000 CVC-days). In random scenarios, the higher the number of participating ICUs, the shorter the participation required to generate >= 90% valid replicates. While participation requirements in a countrywide program ranged from 3 to 13 surveillance blocks (1 block = 28 days), requirements for a regional program ranged from 9 to 13 blocks.
   Conclusions: Based on the results of our model of national CLABSI reporting, the shortening of participation requirements may be suitable for nationwide ICU CLABSI surveillance programs if participation months are randomly chosen. However, our regional models showed that regional programs should opt for continuous participation to avoid biased benchmarks.
C1 [Fontela, Patricia S.; Quach, Caroline; Buckeridge, David; Pai, Madukhar; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Fontela, Patricia S.; Quach, Caroline; Platt, Robert W.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada.
RP Fontela, PS (reprint author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
EM robert.platt@mcgill.ca
RI Fontela, Patricia/S-6455-2019
OI Platt, Robert/0000-0002-5981-8443; Quach, Caroline/0000-0002-1170-9475;
   Pai, Madhukar/0000-0003-3667-4536
CR Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673
   Coello R, 2001, INFECT CONT HOSP EP, V22, P393, DOI 10.1086/501923
   Cooke EM, 2000, J HOSP INFECT, V46, P1, DOI 10.1053/jhin.2000.0801
   Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001
   Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001
   Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1
   EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8
   Fontela PS, 2011, AM J INFECT CONTROL, V39, P329, DOI 10.1016/j.ajic.2010.07.007
   Geubbels ELPE, 2000, INFECT CONT HOSP EP, V21, P311, DOI 10.1086/501762
   Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585
   Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009
   Perla RJ, 2009, AM J INFECT CONTROL, V37
   Quach C, 2006, RAPPORT SURVEILLANCE
   Quach C, 2005, RAPPORT SURVEILLANCE
   Quach C, 2007, RAPPORT SURVEILLANCE
   Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408
   Robert J, 2000, INFECT CONT HOSP EP, V21, P12, DOI 10.1086/501690
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   WENZEL RP, 1983, INFECT CONT HOSP EP, V4, P371, DOI 10.1017/S0195941700059774
NR 22
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2012
VL 7
IS 5
AR e36582
DI 10.1371/journal.pone.0036582
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TC
UT WOS:000305335000041
PM 22586480
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guinovart, C
   Dobano, C
   Bassat, Q
   Nhabomba, A
   Quinto, L
   Manaca, MN
   Aguilar, R
   Rodriguez, MH
   Barbosa, A
   Aponte, JJ
   Mayor, AG
   Renom, M
   Moraleda, C
   Roberts, DJ
   Schwarzer, E
   Le Souef, PN
   Schofield, L
   Chitnis, CE
   Doolan, DL
   Alonso, PL
AF Guinovart, Caterina
   Dobano, Carlota
   Bassat, Quique
   Nhabomba, Augusto
   Quinto, Llorenc
   Manaca, Maria Nelia
   Aguilar, Ruth
   Rodriguez, Mauricio H.
   Barbosa, Arnoldo
   Aponte, John J.
   Mayor, Alfredo G.
   Renom, Montse
   Moraleda, Cinta
   Roberts, David J.
   Schwarzer, Evelin
   Le Souef, Peter N.
   Schofield, Louis
   Chitnis, Chetan E.
   Doolan, Denise L.
   Alonso, Pedro L.
TI The Role of Age and Exposure to Plasmodium falciparum in the Rate of
   Acquisition of Naturally Acquired Immunity: A Randomized Controlled
   Trial
SO PLOS ONE
LA English
DT Article
ID PLACEBO-CONTROLLED TRIAL; TANZANIAN INFANTS; MALARIA VACCINE;
   SULFADOXINE-PYRIMETHAMINE; MOZAMBICAN CHILDREN; SPF66 VACCINE;
   FOLLOW-UP; EFFICACY; SUSCEPTIBILITY; PREVENTION
AB Background: The rate of acquisition of naturally acquired immunity (NAI) against malaria predominantly depends on transmission intensity and age, although disentangling the effects of these is difficult. We used chemoprophylaxis to selectively control exposure to P. falciparum during different periods in infancy and explore the effect of age in the build-up of NAI, measured as risk of clinical malaria.
   Methods and Findings: A three-arm double-blind randomized placebo-controlled trial was conducted in 349 infants born to Mozambican HIV-negative women. The late exposure group (LEG) received monthly Sulfadoxine-Pyrimethamine (SP) plus Artesunate (AS) from 2.5-4.5 months of age and monthly placebo from 5.5-9.5 months; the early exposure group (EEG) received placebo from 2.5-4.5 months and SP+AS from 5.5-9.5 months; and the control group (CG) received placebo from 2.5-9.5 months. Active and passive case detection (PCD) were conducted from birth to 10.5 and 24 months respectively. The primary endpoint was time to first or only episode of malaria in the second year detected by PCD. The incidence of malaria during the second year was of 0.50, 0.51 and 0.35 episodes/PYAR in the LEG, EEG and CG respectively (p = 0.379 for the adjusted comparison of the 3 groups). The hazard ratio of the adjusted comparison between the LEG and the CG was 1.38 (0.83-2.28, p = 0.642) and that between the EEG and the CG was 1.35 (0.81-2.24, p = 0.743).
   Conclusions: After considerably interfering with exposure during the first year of life, there was a trend towards a higher risk of malaria in the second year in children who had received chemoprophylaxis, but there was no significant rebound. No evidence was found that the age of first exposure to malaria affects the rate of acquisition of NAI. Thus, the timing of administration of antimalarial interventions like malaria vaccines during infancy does not appear to be a critical determinant.
C1 [Guinovart, Caterina; Dobano, Carlota; Bassat, Quique; Quinto, Llorenc; Aguilar, Ruth; Rodriguez, Mauricio H.; Barbosa, Arnoldo; Aponte, John J.; Mayor, Alfredo G.; Renom, Montse; Moraleda, Cinta; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain.
   [Guinovart, Caterina; Dobano, Carlota; Bassat, Quique; Nhabomba, Augusto; Quinto, Llorenc; Manaca, Maria Nelia; Aguilar, Ruth; Rodriguez, Mauricio H.; Barbosa, Arnoldo; Aponte, John J.; Mayor, Alfredo G.; Renom, Montse; Moraleda, Cinta; Alonso, Pedro L.] CISM, Maputo, Mozambique.
   [Guinovart, Caterina; Dobano, Carlota; Bassat, Quique; Quinto, Llorenc; Aguilar, Ruth; Aponte, John J.; Mayor, Alfredo G.; Alonso, Pedro L.] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.
   [Roberts, David J.] John Radcliffe Hosp, Blood Res Labs, NHSBT Oxford, Oxford OX3 9DU, England.
   [Roberts, David J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England.
   [Schwarzer, Evelin] Univ Turin, Sch Med, Dept Genet Biol & Biochem, Turin, Italy.
   [Le Souef, Peter N.] Univ Western Australia, Immunogenet Res Grp, Perth, WA 6009, Australia.
   [Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.
   [Chitnis, Chetan E.] Int Ctr Genet Engn & Biotechnol, New Delhi, India.
   [Doolan, Denise L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia.
RP Guinovart, C (reprint author), Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain.
EM caterina.guinovart@cresib.cat
RI Dobano, Carlota/N-4119-2014; Bassat, Quique/P-2341-2016; Doolan,
   Denise/F-1969-2015; Mayor, Alfredo/H-7488-2017; Aguilar,
   Ruth/D-2147-2018
OI Dobano, Carlota/0000-0002-6751-4060; Bassat, Quique/0000-0003-0875-7596;
   Mayor, Alfredo/0000-0003-3890-2897; Aguilar, Ruth/0000-0003-3277-3107;
   Doolan, Denise/0000-0001-7354-8817; Le Souef, Peter/0000-0003-0930-1654;
   Schwarzer, Evelin/0000-0003-2791-1894; Barbosa,
   Arnoldo/0000-0001-8652-7396; Chitnis, Chetan/0000-0002-8773-9865
FU EU [18902]; Instituto de Salud Carlos III (Ayuda de incentivacion a la
   participacion en proyectos del Espacio Europeo de Investigacion);
   Spanish Ministerio de Educacion y Ciencia [A107190024]; Spanish Ministry
   of Health [CM04/00028, CM05/00134]; Spanish Ministerio de Ciencia e
   Innovacion [RYC-2008-02631]; Instituto de Salud Carlos III
   [CP-04/00220]; National Blood Service; Howard Hughes Medical Institute;
   BioMalPar program [LSHP-CT-2004-503578]; Pfizer; NHMRC/EU [406702];
   Spanish Agency for International Cooperation and Development (AECID)
FX The study was funded by an EU Framework Program 6 STREP project (Malaria
   age exposure, Project reference 18902), the Instituto de Salud Carlos
   III (Ayuda de incentivacion a la participacion en proyectos del Espacio
   Europeo de Investigacion), and the Spanish Ministerio de Educacion y
   Ciencia (Project reference A107190024). CG and QB were supported by a
   grant from the Spanish Ministry of Health (Contrato post-Formacion
   Sanitaria Especializada, Fondo de Investigaciones Sanitarias, Instituto
   de Salud Carlos III, ref. CM04/00028 and CM05/00134, respectively), CD
   by a Ramon y Cajal grant from the Spanish Ministerio de Ciencia e
   Innovacion (RYC-2008-02631), and AGM by a Miguel Servet grant from the
   Instituto de Salud Carlos III (CP-04/00220). DJR was supported by the
   National Blood Service, the Howard Hughes Medical Institute, and the
   BioMalPar program (European Grant number LSHP-CT-2004-503578). DLD was
   supported by a Pfizer Australia Senior Research Fellowship. LS is an
   International Research Scholar of the Howard Hughes Medical Institute
   and was supported by NH&MRC/EU Collaboration Grant # 406702. The Manhica
   Health Research Centre receives core funding from the Spanish Agency for
   International Cooperation and Development (AECID). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x
   Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773
   Acosta CJ, 1999, TROP MED INT HEALTH, V4, P368, DOI 10.1046/j.1365-3156.1999.00406.x
   Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3
   Alonso PL, 2002, POPULATION HLTH DEV, V1, P189
   Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242
   Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6
   BAIRD JK, 1993, AM J TROP MED HYG, V49, P707, DOI 10.4269/ajtmh.1993.49.707
   Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366
   BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7
   Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381
   Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988
   COLE TJ, 1990, EUR J CLIN NUTR, V44, P45
   Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08
   Galindo CM, 2000, PARASITE IMMUNOL, V22, P437, DOI 10.1046/j.1365-3024.2000.00322.x
   Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36
   HELLGREN U, 1990, T ROY SOC TROP MED H, V84, P469, DOI 10.1016/0035-9203(90)90002-V
   Kuczmarski R J, 2000, Adv Data, P1
   Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915
   Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9
   Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3
   Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011
   Roysten P., 2004, STATA J, V3, P227, DOI DOI 10.1037//1082-989X.7.2.147
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4
   Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5
   Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2
   Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7
   Smith PG, 1992, METHODS FIELD TRIALS
NR 31
TC 24
Z9 24
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2012
VL 7
IS 3
AR e32362
DI 10.1371/journal.pone.0032362
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 929KK
UT WOS:000303060800015
PM 22412865
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Reichmann, WM
   Walensky, RP
   Case, A
   Novais, A
   Arbelaez, C
   Katz, JN
   Losina, E
AF Reichmann, William M.
   Walensky, Rochelle P.
   Case, Amy
   Novais, Anna
   Arbelaez, Christian
   Katz, Jeffrey N.
   Losina, Elena
TI Estimation of the Prevalence of Undiagnosed and Diagnosed HIV in an
   Urban Emergency Department
SO PLOS ONE
LA English
DT Article
ID INNER-CITY EMERGENCY; IMMUNODEFICIENCY VIRUS-INFECTION; SEVERITY INDEX;
   ADOLESCENTS; ADULTS; WOMEN
AB Objective: To estimate the prevalence of undiagnosed HIV, the prevalence of diagnosed HIV, and proportion of HIV that is undiagnosed in populations with similar demographics as the Universal Screening for HIV in the Emergency Room (USHER) Trial and the Brigham and Women's Hospital (BWH) Emergency Department (ED) in Boston, MA. We also sought to estimate these quantities within demographic and risk behavior subgroups.
   Method: We used data from the USHER Trial, which was a randomized clinical trial of HIV screening conducted in the BWH ED. Since eligible participants were HIV-free at time of enrollment, we were able to calculate the prevalence of undiagnosed HIV. We used data from the Massachusetts Department of Public Health (MA/DPH) to estimate the prevalence of diagnosed HIV since the MA/DPH records the number of persons within MA who are HIV-positive. We calculated the proportion of HIV that is undiagnosed using these estimates of the prevalence of undiagnosed and diagnosed HIV. Estimates were stratified by age, sex, race/ethnicity, history of testing, and risk behaviors.
   Results: The overall expected prevalence of diagnosed HIV in a population similar to those presenting to the BWH ED was 0.71% (95% CI: 0.63%, 0.78%). The prevalence of undiagnosed HIV was estimated at 0.22% (95% CI: 0.10%, 0.42%) and resultant overall prevalence was 0.93%. The proportion of HIV-infection that is undiagnosed in this ED-based setting was estimated to be 23.7% (95% CI: 11.6%, 34.9%) of total HIV-infections.
   Conclusions: Despite different methodology, our estimate of the proportion of HIV that is undiagnosed in an ED-setting was similar to previous estimates based on national surveillance data. Universal routine testing programs in EDs should use these data to help plan their yield of HIV detection.
C1 [Reichmann, William M.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
   [Reichmann, William M.; Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Walensky, Rochelle P.; Losina, Elena] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA.
   [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.
   [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.
   [Case, Amy; Novais, Anna; Arbelaez, Christian] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA.
   [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.
   [Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.
   [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
RP Reichmann, WM (reprint author), Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.
EM wreichmann@partners.org
OI Walensky, Rochelle P./0000-0002-8795-379X; Losina,
   ELENA/0000-0002-3424-0892
FU National Institute of Mental Health [R01 MH073445, R01 MH65869];
   National Institute of Arthritis and Skin Diseases [K24 AR 057827]; Doris
   Duke Charitable Foundation
FX This research was funded by the National Institute of Mental Health (R01
   MH073445, R01 MH65869), National Institute of Arthritis and Skin
   Diseases (K24 AR 057827) and the Doris Duke Charitable Foundation,
   Clinical Scientist Development Award to Rochelle P. Walensky. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alpert PL, 1996, ANN EMERG MED, V28, P159, DOI 10.1016/S0196-0644(96)70056-2
   Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Branson BM, 2006, MMWR RECOMM REP, V55, pCE11
   Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45
   Clauss H, 2011, AIDS PATIENT CARE ST, V25, P207, DOI 10.1089/apc.2010.0196
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404
   EFRON B, 1986, STAT SCI, V1, P1, DOI DOI 10.1214/SS/1177013815
   Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x
   Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6
   FLEMING P, 2002, 9 C RETR OPP INF SEA
   Goggin MA, 2000, J EMERG MED, V19, P13, DOI 10.1016/S0736-4679(00)00175-X
   KELEN GD, 1989, JAMA-J AM MED ASSOC, V262, P516, DOI 10.1001/jama.262.4.516
   KELEN GD, 1995, CLIN INFECT DIS, V21, P867, DOI 10.1093/clinids/21.4.867
   KELEN GD, 1988, NEW ENGL J MED, V318, P1645, DOI 10.1056/NEJM198806233182503
   LINDSELL CJ, ANN EMERG MED S1, V58, pS23
   Nagachinta T, 1996, INFECT CONT HOSP EP, V17, P174
   PISCULLI M, 2011, AIDS BEHAV, P1
   Reichmann WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008728
   REICHMANN WM, PLOS ONE, V5, pE8728
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
   SCHOENBAUM EE, 1993, AM J PUBLIC HEALTH, V83, P363, DOI 10.2105/AJPH.83.3.363
   STURM JT, 1991, ANN EMERG MED, V20, P276, DOI 10.1016/S0196-0644(05)80939-4
   US Census Bureau, POP EST
   WALENSKY, 2010, COMMUNICATION   0413
   Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003
   Wuerz RC, 2001, ACAD EMERG MED, V8, P170, DOI 10.1111/j.1553-2712.2001.tb01283.x
   Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x
   MMWR MORB MORTAL WKL, V60, P689
NR 29
TC 6
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2011
VL 6
IS 11
AR e27701
DI 10.1371/journal.pone.0027701
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 855HV
UT WOS:000297555400089
PM 22110730
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Womack, JA
   Goulet, JL
   Gibert, C
   Brandt, C
   Chang, CC
   Gulanski, B
   Fraenkel, L
   Mattocks, K
   Rimland, D
   Rodriguez-Barradas, MC
   Tate, J
   Yin, MT
   Justice, AC
AF Womack, Julie A.
   Goulet, Joseph L.
   Gibert, Cynthia
   Brandt, Cynthia
   Chang, Chung Chou
   Gulanski, Barbara
   Fraenkel, Liana
   Mattocks, Kristin
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Tate, Janet
   Yin, Michael T.
   Justice, Amy C.
CA Vet Aging Cohort Study Project
TI Increased Risk of Fragility Fractures among HIV Infected Compared to
   Uninfected Male Veterans
SO PLOS ONE
LA English
DT Article
ID BONE-MINERAL DENSITY; HUMAN-IMMUNODEFICIENCY-VIRUS; OSTEOPOROSIS CARE
   GAP; ANTIRETROVIRAL THERAPY; MISSING DATA; ELDERLY-MEN; WOMEN;
   OSTEOPENIA; PREVALENCE; CORTICOSTEROIDS
AB Background: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors.
   Methodology/Principal Findings: Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m(2); p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)].
   Conclusions/Significance: HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.
C1 [Womack, Julie A.; Goulet, Joseph L.; Brandt, Cynthia; Gulanski, Barbara; Fraenkel, Liana; Mattocks, Kristin; Tate, Janet; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
   [Gibert, Cynthia] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA.
   [Gibert, Cynthia] George Washington Univ, Dept Med, Washington, DC USA.
   [Brandt, Cynthia] Yale Univ, Yale Ctr Med Informat, New Haven, CT USA.
   [Chang, Chung Chou] Univ Pittsburgh, Sch Med, Sect Decis Sci & Clin Syst Modeling, Pittsburgh, PA USA.
   [Gulanski, Barbara; Mattocks, Kristin; Justice, Amy C.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA.
   [Fraenkel, Liana] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA.
   [Rimland, David] Vet Affairs Med Ctr, Atlanta, GA 30033 USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Med Serv, Michael E De Bakey Vet Affairs VA Med Ctr, Houston, TX 77030 USA.
   [Yin, Michael T.] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA.
RP Womack, JA (reprint author), VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
EM julie.womack@va.gov
OI Goulet, Joseph/0000-0002-0842-804X
FU VA Office, Academic Affiliations, Information Research & Development
   Medical Informatics; National Institute on Alcohol Abuse and Alcoholism
   [U10 AA 13566]; VHA Public Health Strategic Health Core Group
FX Funding: Dr. Womack is funded by the VA Office, Academic Affiliations,
   Information Research & Development Medical Informatics Fellowship
   Program. Veterans Aging Cohort Study funded by the National Institute on
   Alcohol Abuse and Alcoholism (U10 AA 13566) and VHA Public Health
   Strategic Health Core Group. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allison PD, 2001, MISSING DATA
   Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246
   Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015
   Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05
   Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660
   Bolland MJ, 2007, CLIN ENDOCRINOL, V67, P270, DOI 10.1111/j.1365-2265.2007.02875.x
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/01.aids.0000076322.42412.6f
   BUHR AJ, 1959, LANCET, V1, P531
   Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785
   Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd
   *CDC, 2004, HIV AIDS SURV REP
   Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468
   Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195
   Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993
   CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9
   Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789
   Fultz SL, 2006, MED CARE, V44, P25
   Gallant JE, 1998, CHEST, V114, P1258, DOI 10.1378/chest.114.5.1258
   Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001
   Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792
   Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819
   Hippisley-Cox J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4229
   Hoffmann M, 2000, J NEUROVIROL, V6, P229, DOI 10.3109/13550280009015825
   JUSTICE AC, 2006, MED CARE, V44, P52
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5
   Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1734-y
   Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lindau TR, 1999, ACTA ORTHOP SCAND, V70, P124, DOI 10.3109/17453679909011248
   McComsey Grace A, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P86, DOI 10.1177/154510970400300303
   McQueen MM, 2003, CURR ORTHOPAED, V17, P360, DOI 10.1016/S0268-0890(03)00097-5
   Nguyen TV, 2001, AM J EPIDEMIOL, V153, P587, DOI 10.1093/aje/153.6.587
   Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0
   Papaioannou A, 2008, OSTEOPOROSIS INT, V19, P581, DOI 10.1007/s00198-007-0483-0
   Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9
   Piliero PJ, 2002, AIDS, V16, P1565, DOI 10.1097/00002030-200207260-00019
   Prior J, 2007, OSTEOPOROSIS INT, V18, P1345, DOI 10.1007/s00198-007-0428-7
   RAY M, AIDS, V24, P123
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108
   Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1813, DOI 10.1359/JBMR.050609
   Steinke DT, 2002, GUT, V50, P100, DOI 10.1136/gut.50.1.100
   STELLBRINK H, 2009, ASSESSMENT SAFETY EF
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Szulc P, 2005, OSTEOPOROSIS INT, V16, P1184, DOI 10.1007/s00198-005-1970-9
   Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330
   TEBAS P, 2000, AIDS, V14, P63
   Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109
   Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828
   van Diepen S, 2008, CIRCULATION, V118, P1946, DOI 10.1161/CIRCULATIONAHA.108.784009
   Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993
   WANG GC, AM J EPIDEMIOL, V171, P1144
   WARRINER AH, CURR RHEUMATOL REP, V12, P163
   Weber R, 2006, ARCH INTERN MED, V166, P1632
   2008, LANCET, V372, P293
NR 59
TC 160
Z9 161
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 16
PY 2011
VL 6
IS 2
AR e17217
DI 10.1371/journal.pone.0017217
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 721YC
UT WOS:000287392700061
PM 21359191
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Brinkhof, MWG
   Spycher, BD
   Yiannoutsos, C
   Weigel, R
   Wood, R
   Messou, E
   Boulle, A
   Egger, M
   Sterne, JAC
AF Brinkhof, Martin W. G.
   Spycher, Ben D.
   Yiannoutsos, Constantin
   Weigel, Ralf
   Wood, Robin
   Messou, Eugene
   Boulle, Andrew
   Egger, Matthias
   Sterne, Jonathan A. C.
CA Int Epidemiological Database Evalu
TI Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART
   Programmes in Sub-Saharan Africa
SO PLOS ONE
LA English
DT Article
ID HIV-INFECTED PATIENTS; RAPID SCALE-UP; ANTIRETROVIRAL THERAPY;
   SOUTH-AFRICA; INCOME COUNTRIES; SURVIVAL CURVES; COHORT PROFILE;
   RISK-FACTORS; MISSING DATA; OUTCOMES
AB Background: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up.
   Methods and Findings: Treatment-naive patients starting combination ART in five programmes in Cote d'Ivoire, Kenya, Malawi and South Africa were eligible. Patients whose last visit was at least nine months before the closure of the database were considered lost to follow-up. We filled missing survival times in these patients by multiple imputation, using estimates of mortality from studies that traced patients lost to follow-up. Data were analyzed using Weibull models, adjusting for age, sex, ART regimen, CD4 cell count, clinical stage and treatment programme. A total of 15,915 HIV-infected patients (median CD4 cell count 110 cells/mu L, median age 35 years, 68% female) were included; 1,001 (6.3%) were known to have died and 1,285 (14.3%) were lost to follow-up in the first year of ART. Crude estimates of mortality at one year ranged from 5.7% (95% CI 4.9-6.5%) to 10.9% (9.6-12.4%) across the five programmes. Estimated mortality hazard ratios comparing patients lost to follow-up with those remaining in care ranged from 6 to 23. Adjusted estimates based on these hazard ratios ranged from 10.2% (8.9-11.6%) to 16.9% (15.0-19.1%), with relative increases in mortality ranging from 27% to 73% across programmes.
   Conclusions: Naive survival analysis ignoring excess mortality in patients lost to follow-up may greatly underestimate overall mortality, and bias ART programme evaluations. Adjusted mortality estimates can be obtained based on excess mortality rates in patients lost to follow-up.
C1 [Brinkhof, Martin W. G.; Spycher, Ben D.; Egger, Matthias] Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland.
   [Yiannoutsos, Constantin] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA.
   [Weigel, Ralf] Kamuzu Cent Hosp, Lighthouse Trust, Lilongwe, Malawi.
   [Weigel, Ralf] Minist Hlth, Lilongwe, Malawi.
   [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire.
   [Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.
   [Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England.
RP Brinkhof, MWG (reprint author), Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland.
EM egger@ispm.unibe.ch
RI Wood, Robin/G-8509-2011; Spycher, Ben D/B-3308-2008; Boulle,
   Andrew/C-1413-2008
OI Spycher, Ben D/0000-0002-1430-5695; Boulle, Andrew/0000-0002-7713-8062;
   Brinkhof, Martin/0000-0002-9319-665X; Sterne,
   Jonathan/0000-0001-8496-6053; Weigel, Ralf/0000-0001-9034-2634; Egger,
   Matthias/0000-0001-7462-5132
FU Office of AIDS Research (OAR) of the National Institutes of Health
   (NIH); Agence Nationale de Recherches sur le SIDA et les Hepatites
   Virales (ANRS); National Institute of Allergy and Infectious Diseases
   (NIAID) [U01-AI069924, U01-AI069911, U01-AI069919]; United Kingdom
   Medical Research Council (MRC) [G0600599]; NIH [U01-AI069911-04S2]
FX This study was supported by the Office of AIDS Research (OAR) of the
   National Institutes of Health (NIH), the Agence Nationale de Recherches
   sur le SIDA et les Hepatites Virales (ANRS), and the National Institute
   of Allergy and Infectious Diseases (NIAID, grants U01-AI069924,
   U01-AI069911, U01-AI069919). JACS was supported by United Kingdom
   Medical Research Council (MRC) grant G0600599. CY was supported by NIH
   grant U01-AI069911-04S2. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR An M. W., 2008, BIOMETRICS, V65, P301
   Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0
   Bekker LG, 2006, SAMJ S AFR MED J, V96, P315
   Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725
   Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P657
   Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7
   Braitstein P, 2006, LANCET, V367, P817
   Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790
   BRINKHOF MW, 2008, B WORLD HEALTH ORGAN, V86, P497
   Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008
   Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]
   Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101
   Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x
   Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x
   Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286
   GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405
   Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506
   HOCHGESANG M, 2006, AIDS 2006 16 INT AID
   Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x
   LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302
   Maskew M, 2007, SAMJ S AFR MED J, V97, P853
   McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073
   Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469
   Ndiaye B, 2009, ANTIVIR THER, V14, P567
   Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059
   Phiri S., 2004, LIGHTHOUSE CTR COMPR
   Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782
   Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8
   Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004
   Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea
   Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843
   Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739
NR 35
TC 48
Z9 49
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2010
VL 5
IS 11
AR e14149
DI 10.1371/journal.pone.0014149
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 687DK
UT WOS:000284755100028
PM 21152392
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cattaert, T
   Urrea, V
   Naj, AC
   De Lobel, L
   De Wit, V
   Fu, M
   John, JMM
   Shen, HQ
   Calle, ML
   Ritchie, MD
   Edwards, TL
   Van Steen, K
AF Cattaert, Tom
   Urrea, Victor
   Naj, Adam C.
   De Lobel, Lizzy
   De Wit, Vanessa
   Fu, Mao
   John, Jestinah M. Mahachie
   Shen, Haiqing
   Luz Calle, M.
   Ritchie, Marylyn D.
   Edwards, Todd L.
   Van Steen, Kristel
TI FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction
   Technique to Detect Epistasis Using Related Individuals
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; OLD ORDER AMISH; GENE-ENVIRONMENT INTERACTIONS;
   BETA(3)-ADRENERGIC RECEPTOR GENE; QUANTITATIVE TRAIT LOCI;
   DROSOPHILA-MERCATORUM; ECOLOGICAL GENETICS; INSULIN-RESISTANCE;
   ABNORMAL-ABDOMEN; HUMAN-DISEASES
AB We propose a novel multifactor dimensionality reduction method for epistasis detection in small or extended pedigrees, FAM-MDR. It combines features of the Genome-wide Rapid Association using Mixed Model And Regression approach (GRAMMAR) with Model-Based MDR (MB-MDR). We focus on continuous traits, although the method is general and can be used for outcomes of any type, including binary and censored traits. When comparing FAM-MDR with Pedigree-based Generalized MDR (PGMDR), which is a generalization of Multifactor Dimensionality Reduction (MDR) to continuous traits and related individuals, FAM-MDR was found to outperform PGMDR in terms of power, in most of the considered simulated scenarios. Additional simulations revealed that PGMDR does not appropriately deal with multiple testing and consequently gives rise to overly optimistic results. FAM-MDR adequately deals with multiple testing in epistasis screens and is in contrast rather conservative, by construction. Furthermore, simulations show that correcting for lower order (main) effects is of utmost importance when claiming epistasis. As Type 2 Diabetes Mellitus (T2DM) is a complex phenotype likely influenced by gene-gene interactions, we applied FAM-MDR to examine data on glucose area-under-the-curve (GAUC), an endophenotype of T2DM for which multiple independent genetic associations have been observed, in the Amish Family Diabetes Study (AFDS). This application reveals that FAM-MDR makes more efficient use of the available data than PGMDR and can deal with multi-generational pedigrees more easily. In conclusion, we have validated FAM-MDR and compared it to PGMDR, the current state-of-the-art MDR method for family data, using both simulations and a practical dataset. FAM-MDR is found to outperform PGMDR in that it handles the multiple testing issue more correctly, has increased power, and efficiently uses all available information.
C1 [Cattaert, Tom; De Wit, Vanessa; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Inst Montefiore, B-4000 Liege, Belgium.
   [Cattaert, Tom; De Wit, Vanessa; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Grp Interdisciplinaire Genoprote Appl Res, Liege, Belgium.
   [Urrea, Victor; Luz Calle, M.] Univ Vic, Dept Syst Biol, Vic, Spain.
   [Naj, Adam C.; Edwards, Todd L.] Univ Miami, Miami Inst Human Genom, Miami, FL USA.
   [De Lobel, Lizzy] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium.
   [Fu, Mao; Shen, Haiqing] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Ritchie, Marylyn D.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA.
RP Cattaert, T (reprint author), Univ Liege, Inst Montefiore, B-4000 Liege, Belgium.
EM tom.cattaert@ulg.ac.be
RI Ritchie, Marylyn/C-1114-2012; Calle, M.Luz/D-2704-2015; Edwards,
   Todd/B-9750-2012
OI Calle, M.Luz/0000-0001-9334-415X; Urrea Gales,
   Victor/0000-0002-2577-856X; Van Steen, Kristel/0000-0001-9868-5033
FU Fonds de la Recherche Scientifique-FNRS; Ministerio de Ciencia y
   Tecnologia, Spain [MTM2008-06747-C02-00]; Belgian Network [IAP P6/25];
   Belgian State, Science Policy Office; European Community
   [IST-2007-216886]
FX The first author is a Postdoctoral Researcher of the Fonds de la
   Recherche Scientifique-FNRS. This work is also partially supported by
   grant MTM2008-06747-C02-00 from the Ministerio de Ciencia y Tecnologia,
   Spain, by the Belgian Network BIOMAGNET (IAP P6/25), funded by the
   Interuniversity Attraction Poles Programme, initiated by the Belgian
   State, Science Policy Office, and by the IST Programme of the European
   Community, under the PASCAL2 Network of Excellence, IST-2007-216886. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409
   Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274
   Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x
   Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613
   Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085
   Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368
   Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431
   Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243
   CHANDA P, 2009, EUR J HUM GENET
   Chanda P, 2007, AM J HUM GENET, V81, P939, DOI 10.1086/521878
   CHEVERUD JM, 1995, GENETICS, V139, P1455
   Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3
   Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579
   Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463
   Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002
   Damcott CM, 2005, DIABETES, V54, P2245, DOI 10.2337/diabetes.54.7.2245
   Damcott CM, 2004, DIABETES, V53, P3337, DOI 10.2337/diabetes.53.12.3337
   DESALLE R, 1986, GENETICS, V112, P877
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109
   Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807
   Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157
   Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Fu M, 2004, DIABETES, V53, P3292, DOI 10.2337/diabetes.53.12.3292
   Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639
   Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869
   Hartmann B, 2001, MECH DEVELOP, V109, P161, DOI 10.1016/S0925-4773(01)00519-6
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002
   HOLLOCHER H, 1992, GENETICS, V130, P355
   HOLLOCHER H, 1994, GENETICS, V136, P1373
   Hsueh WC, 2003, DIABETES, V52, P550, DOI 10.2337/diabetes.52.2.550
   Hsueh WC, 2001, DIABETES CARE, V24, P672, DOI 10.2337/diacare.24.4.672
   Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595
   Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512
   Ishii T, 2001, METABOLISM, V50, P1301, DOI 10.1053/meta.2001.27228
   Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797
   Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311
   Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207
   Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939
   Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071
   Lou XY, 2008, AM J HUM GENET, V83, P457, DOI [10.1016/j.ajhg.2008.09.001, 10.1016/j.ajhg,2008.09.001]
   Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312
   Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772
   Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128
   Maxwell CA, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-4
   McArdle PF, 2007, HUM HERED, V64, P234, DOI 10.1159/000103861
   Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880
   Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bias.20236
   Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735
   Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473
   Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P767, DOI 10.1002/gepi.20345
   Nettleton D, 2000, BIOMETRICS, V56, P52, DOI 10.1111/j.0006-341X.2000.00052.x
   Onkamo Paivi, 2006, Hum Genomics, V2, P336
   Pollin TI, 2005, DIABETES, V54, P268, DOI 10.2337/diabetes.54.1.268
   Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918
   Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516
   Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276
   Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031
   Sivenius K, 2000, INT J OBESITY, V24, P514, DOI 10.1038/sj.ijo.0801194
   THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445
   Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317
   Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810
   Urhammer SA, 2000, J CLIN ENDOCR METAB, V85, P3151, DOI 10.1210/jc.85.9.3151
   Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398
NR 72
TC 33
Z9 34
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2010
VL 5
IS 4
AR e10304
DI 10.1371/journal.pone.0010304
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 586YT
UT WOS:000276952600021
PM 20421984
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dewan, I
   Kulathinal, S
AF Dewan, Isha
   Kulathinal, Sangita
TI On Testing Dependence between Time to Failure and Cause of Failure when
   Causes of Failure Are Missing
SO PLOS ONE
LA English
DT Article
AB The hypothesis of independence between the failure time and the cause of failure is studied by using the conditional probabilities of failure due to a specific cause given that there is no failure up to certain fixed time. In practice, there are situations when the failure times are available for all units but the causes of failures might be missing for some units. We propose tests based on U-statistics to test for independence of the failure time and the cause of failure in the competing risks model when all the causes of failure cannot be observed. The asymptotic distribution is normal in each case. Simulation studies look at power comparisons for the proposed tests for two families of distributions. The one-sided and the two-sided tests based on Kendall type statistic perform exceedingly well in detecting departures from independence.
C1 [Kulathinal, Sangita] Indic Soc Educ & Dev, Nasik, India.
   [Dewan, Isha] Indian Stat Inst, New Delhi 110016, India.
RP Kulathinal, S (reprint author), Indic Soc Educ & Dev, Nasik, India.
EM sangita.kulathinal@inseed.org
CR Cooke RM, 1996, RELIAB ENG SYST SAFE, V51, P209, DOI 10.1016/0951-8320(95)00118-2
   Dewan I, 2004, SCAND J STAT, V31, P79, DOI 10.1111/j.1467-9469.2004.00374.x
   Dewanji A, 2003, BIOMETRICS, V59, P1063, DOI 10.1111/j.0006-341X.2003.00122.x
   DEWANJI A, 1992, BIOMETRIKA, V79, P855, DOI 10.2307/2337244
   DINSE GE, 1986, J AM STAT ASSOC, V81, P328, DOI 10.2307/2289220
   Goetghebeur E, 1995, BIOMETRIKA, V82, P821, DOI 10.1093/biomet/82.4.821
   GOETGHEBEUR E, 1990, BIOMETRIKA, V77, P207, DOI 10.1093/biomet/77.1.207
   KODELL RL, 1987, COMMUN STAT THEORY, V16, P2565, DOI 10.1080/03610928708829523
   Kundu D, 2000, J STAT PLAN INFER, V87, P221, DOI 10.1016/S0378-3758(99)00193-7
   LAPIDUS G, 1994, ACCIDENT ANAL PREV, V26, P535, DOI 10.1016/0001-4575(94)90044-2
   Lu KF, 2005, LIFETIME DATA ANAL, V11, P29, DOI 10.1007/s10985-004-5638-0
   MIYAKAWA M, 1984, IEEE T RELIAB, V33, P293, DOI 10.1109/TR.1984.5221828
   NAIR VN, 1993, REVIEW, V61, P169
   Puri M. L., 1971, NONPARAMETRIC METHOD
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   SAS Institute Inc, 2000, SAS STAT US GUID VER
NR 16
TC 5
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2007
VL 2
IS 12
AR e1255
DI 10.1371/journal.pone.0001255
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V10JD
UT WOS:000207459400004
PM 18060052
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

EF